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ABSTRACT OF THE DISSERTATION 
Determining the Genetic Contributions of the Williams Syndrome Critical Region to Behavior 
Using Mouse Models and Human Genetics  
by 
Nathan Kopp 
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Washington University in St. Louis, 2019 
Professor Joseph D. Dougherty, Ph.D. Chair 
 
 
Williams syndrome is a neurodevelopmental model caused by the deletion of 26-28 genes on 
chr7q11.23. The loss of these genes affects multiple organ systems resulting in severe 
cardiovascular disease, craniofacial dysmorphology, intellectual impairment, a specific Williams 
syndrome cognitive profile made up of deficits in visual-spatial processing with preserved 
language skills, and a characteristic hypersocial personality. The reciprocal duplication occurs at 
a lower frequency and manifests with diametric phenotypes to the deletion. This suggests that 
this locus harbors dosage sensitive genes that play a role in neurodevelopment. Large efforts 
have been taken to identify which genes are responsible for causing the different aspects of the 
disorder. Only the cardiovascular phenotype has been linked to the hemizgosity of the ELN gene. 
In order to incorporate the complexity of genetic contributions to complex traits, we synthesize 
genetic and behavioral analyses in both humans and mouse models. We performed whole exome 
sequencing on 85 individuals with Williams syndrome to test the hypothesis that genetic 
variation on the remaining chr7q11.23 allele contributes to variation in the social phenotype. We 
xiii 
 
show that the social phenotype consists of deficits in several aspects of social behavior, but 
social motivation is preserved in Williams syndrome. Whole exome sequencing revealed that 
there is little common variation contribution to the variability of the social phenotype but did 
suggest involvement of SNPs in the BAZ1B and GTF2IRD1 genes. Using mouse models, we 
generated three new mouse lines to test the hypothesis that two genes in the syntenic region, 
Gtf2i and Gtf2ird1, share overlapping DNA targets and both contribute to overlapping behavioral 
phenotypes suggesting an oligogenic contribution of these genes to phenotypes relevant to WS. 
Finally, we show that loss of function mutations in both Gtf2i and Gtf2ird1 are not sufficient to 
reproduce the full phenotype that is produced by deleting the entire syntenic Williams syndrome 
critical region in mice. Taken together these data suggest an oligogenic pattern of contribution to 
the phenotypes seen in WS.   
 
 
1 
Chapter 1: Introduction  
 
The aim of human genetics is to identify the genes that contribute to human biology. This 
approach will allow us to study the underlying mechanisms that manifest as interesting human 
phenotypes, such as our complex central nervous system, which gives rise to many diverse 
behaviors. Geneticists have developed and employed many approaches to elucidate genes that 
are important for specific human traits. These include linkage analysis, genome-wide association, 
whole-exome sequencing studies, and whole-genome sequencing studies. These tools have 
driven the progress of genotype-phenotype correlations and resulted in many important 
discoveries.  
 Along with sophisticated approaches, human genetics has been informed by identifying 
genes that cause human diseases. The underlying genetic causes of the disorder highlights the 
functional pathways in which the causal gene plays an important role. From these natural 
experiments the genetic search space is narrowed from the 3 billion base pairs that make up the 
human genome to a specific gene that can then be studied at different levels of genomic and 
biological organization. Some disorders are not caused by the disruption of one gene, but by a 
change in the dosage of many contiguous genes. These copy number variation disorders point to 
a region in the genome that affect multiple aspects of human development, such as 
neurodevelopment, cardiovascular development, and craniofacial development. However, copy 
number disorders offer a unique challenge, because while they emphasize the importance of a 
specific genomic region, there are still many genes and many phenotypes to disentangle. The 
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question then becomes, which genes in the region are responsible for causing the specific 
phenotypes seen in the disorder.  
 Williams-Beuren syndrome (WS) is one such copy number variation disorder. It is 
caused by the deletion of chromosome 7q11.23, referred to as the Williams syndrome critical 
region (WSCR), and results in a constellation of phenotypes that include cardiovascular disease, 
craniofacial dysmorphology, a specific cognitive profile, and a characteristic hypersocial 
personality (1, 2). There are 26-28 genes that are commonly deleted in WS. Large efforts have 
been put forth to connect specific genes in the region to specific phenotypes in the syndrome. 
The only substantiated monogenic contribution of a causal gene in the WSCR is to the 
cardiovascular phenotype driven by the elastin gene (ELN) (3), leaving much more work to be 
done to understand how the genes in this region affect complex phenotypes such as cognition 
and social behavior.  
The research presented in this thesis uses both human genetic techniques as well as 
mouse models to dissect the effect of genes in the WSCR on different aspects of behavior. I 
analyzed the whole-exome sequences of 85 individuals with WS to test if variation on the 
remaining chr7q11.23 allele, as well as exome-wide variation, contributes to the social 
phenotype, providing the largest genetic analysis of individuals with WS. I have also leveraged 
the experimental advantages of the mouse model organism to ask how two genes in the WSCR, 
Gtf2i and Gtf2ird1, interact in the developing mouse brain. I go on to show that in the mouse, 
these genes are not sufficient to produce the behavioral and transcriptional phenotypes of the full 
deletion. I have tested several longstanding hypotheses in the field of Williams syndrome 
genetics through my experiments and provide evidence that the genetic risk for the phenotypes 
observed in WS are not solely driven by these two transcription factors. 
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1.1 History and description of Williams syndrome 
 Williams-Beuren syndrome (OMIM #194050) was first recognized as a syndrome by two 
physicians in the early 1960’s. First, in 1961 Williams et al. described four cases of children that 
were being treated for supravalvular aortic stenosis (SVAS). Williams observed that the children 
were “mentally deficient” and had similar facial features. He thought the similarities could be a 
part of a previously unrecognized syndrome (4). In 1962 Bueren et al. described three more 
patients that had SVAS, intellectual disability, and craniofacial features that were remarkably 
similar to the patients described by Williams et al. Beuren mentioned that all the children had a 
friendly nature and “loved everyone” (5). This observation is the first description of the 
gregarious personality that is now recognized as a hallmark of WS.  
Since the association between the cardiovascular disease, intellectual disability, and 
craniofacial features made by Williams and Beuren, the genetic etiology of WS has been well-
defined. The ELN gene on chromosome seven was discovered to be the cause of familial SVAS , 
in a linkage analysis of one kindred (6). Subsequently, it was shown that individuals with WS 
were hemizygous for the ELN gene and that the hemizygosity extended beyond the ELN locus, 
suggesting that WS is caused by a contiguous deletion on chromosome seven (3).  These findings 
lead to the use of ELN FISH probes as the first clinical genetic test for WS (7). Using artificial 
chromosomes the 1.5Mbp region on chromosome seven that is deleted in WS has been 
delineated (8–10). The region contains 26 genes that are commonly deleted and two more genes 
that are deleted in the longer 1.8Mbp version of the deletion.   The WSCR was found to be 
demarcated by three regions of low copy repeats: the centromeric, medial, and distal regions (9, 
11). Within each region there are three blocks that consist of repeated genes. Block A contains 
the three pseudogenes of the STAG3 gene, PMS2L, and GATS. The medial block B contains the 
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functional genes GTF2I, NCF1, and GTF2IRD2, where the centromeric and telomeric block B 
contains the corresponding pseudogenes. Block C contains POM121, NSUN5, and TRIM50 (11). 
The low copy repeat blocks themselves are demarcated by Alu repeats. These low copy repeats 
facilitate non homologous allelic recombination (NHAR), which leads to the recurrent deletion 
and duplication of the region (12). The most common 1.5Mbp deletion, which occurs in about 
95% of cases, is caused by misalignement of the B centromeric and B medial blocks, which have 
99.6% sequence identity. The less common larger 1.8Mbp deletion, with a prevalence of 3-5% of 
cases, occurs by the misalignment of the A centeromeric and A medial blocks, which have 
98.2% sequence identity (13). This well-defined and common genetic cause of most cases of WS 
makes studying this disorder an excellent opportunity to make genotype-phenotype correlations.  
 Along with the well-characterized genetic cause of WS, the phenotypic spectrum of the 
constellation of symptoms in WS has been thoroughly described and reviewed by many 
researchers (1, 2, 13–16). The cardiovascular disease in WS manifests as SVAS as well as other 
focal artery stenoses and affects all elastic vessels. Other issues also relate to connective tissues 
such as lax skin and join hypermobility have been attributed to ELN haploinsufficiency. The 
facial dysmorphology consists of periorbital fullness, long philtrum, full lips, stellate irises, low 
nasal bridge, micrognathia, microcephaly, and dental problems. The deletion also affects the 
endocrine system and results in precocious puberty, subclinical hypothyroidism, and an 
increased prevalence of diabetes milletus. Neurological symptoms include poor balance and 
coordination, hypotonia, and hyperacusis.  
Of particular interest to this thesis are the cognitive and behavioral phenotypes of WS. 
The deletion of the WSCR has a specific effect on cognition and this gestalt is termed the 
Williams syndrome cognitive profile (WSCP). Individuals with WS have a wide range of 
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intellectual ability as measured by different tests for intelligence quotient (IQ). IQ scores span 
from severe intellectual disability (ID) to average scores of IQ. Despite overall lower levels of IQ 
the WSCP consists of relative strengths in auditory rote memory and verbal skills coupled with 
impairment in visual spatial construction. The definition of the WSCP was standardized by 
Mervis et al. (17).  Along with a specific cognitive profile, WS is associated with a characteristic 
hypersocial personality (14).  The social aspect of WS consists of increased attention to faces. 
Eye tracking studies have shown that individuals with WS fixate on eyes for longer periods of 
time compared to typically developing children (18). In observational studies, children with WS 
tend to focus on the experimenter rather than toys (14).  Individuals with WS are more likely to 
approach strangers and have overall increased global sociability as measured by the Salk 
Institute Sociability Questionnaire (19).  While there are prosocial aspects to the hypersocial 
phenotype of WS, it also consists of a maladaptive component. Individuals with WS have 
difficulties in social cognition and responding appropriately in social situations (20). Beyond 
differences in sociality, individuals with WS have other psychiatric comorbidities, that include 
anxiety, specifically non social anxiety, phobias, and attention deficit/hyperactivity disorder 
(ADHD) (21, 22). Thus, the constellation of symptoms that make up WS gives geneticists a 
unique window into the genetic underpinnings of many different aspects of human cognition and 
behavior.  
 The presence of the low copy repeats that are responsible for the recurrent deletion of the 
WSCR should also predispose the region to duplications. The first case of an individual with the 
duplication was described in 2005 (23). The duplication of the region results in dup7q11.23 
syndrome (OMIM #609757).  The symptoms of 7q11.23 have been described by Mervis and 
Morris (24, 25). The phenotypes are generally more mild than in the deletion of the region. Mild 
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craniofacial dysmorphology has been reported but it is not as consistent as in WS. There are 
some cases that have cardiovascular anomalies that present as dilated blood vessels. However, 
the most consistent phenotype of the duplication is language delay. The duplication has been 
associated with autism spectrum disorders (ASD) (26), but in a rigorous study of ASD 
symptomology in 7q11.23 dup syndrome and WS, it was found there is a similar prevalence of 
ASD diagnosis in both disorders (27, 28). However, in contrast to the social fearlessness in WS, 
it was reported that there is a higher proportion of children with the duplication that have 
separation anxiety (29). The observation of some diametric phenotypes in 7q11.23dup syndrome 
compared to WS corroborates the idea that genes in this region are dosage sensitive and affect 
aspects of human behavior. One goal of the work I have done was to use human genetics to 
provide evidence for the role of specific genes in the WSCR to the behavioral phenotypes.  
1.2 Genotype-phenotype correlations using human genetics 
 The knowledge that the WSCR causes WS and dup7q11.23 has launched many efforts to 
try and dissect the region to identify which genes are responsible for specific symptoms in each 
disorder. One avenue of research has been to make these genotype-phenotype correlations 
directly in humans. Human research in WS has employed three strategies: 1) compare 
individuals with atypically small deletions of the WSCR to individuals with the typical deletion 
to ask what the differences are when some genes are spared, 2) use iPSC lines derived from 
patients with WS, dup7q11.23, and atypical deletions to test molecular and cellular effects of the 
region, and 3) using classical human genetic strategies to identify variation in the general 
population in this region that is associated with phenotypes of interest. While each strategy has 
unique benefits and limitations, each has provided insight into the genetic contributions of the 
WSCR to different phenotypes seen in WS.   
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1.2.1 Atypical deletions 
 WS is caused by the deletion of 1.5Mbp, which covers 26 genes, in 95% of cases. In 3-
5% of cases of WS, a 1.8Mbp deletion removes one copy of two more genes, NCF1 and 
GTF2IRD2. In addition, there are a very small percentage of cases that are caused by atypically 
small deletions that maintain the normal copy number of a subset of genes. Researchers have 
explicated the different phenotypes of individuals with atypical deletions to understand the 
contribution of the spared genes to the phenotypes observed in typical cases of WS.  
 While most cases of WS are caused by de novo deletions, there are instances of smaller 
inherited deletions that allow the study of atypical deletions across several family members. Two 
families were ascertained based on the presence of SVAS and only a few clinical features of WS.  
These families were tested to show that they had smaller deletions that encompassed the ELN 
gene and the LIMK1 gene. The phenotypes of the family members that had the deletion included 
cardiovascular disease, usually SVAS, a few of the craniofacial features of WS but not all of 
them, and deficits in their visual spatial cognition with auditory rote memory similar to the 
unaffected family members, consistent with the WSCP (30). This, along with expression data 
showing that LIMK1 is present in the brain, led the authors to conclude that the LIMK1 gene is 
important for the manifestation of the visual spatial impairment (30). Another study analyzed the 
two aforementioned families and three more kindred with inherited small deletions. The three 
new deletions all included ELN and LIMK1, and either extended centromerically or 
telomerically. All of the family members had two copies of the GTF2I gene. The affected 
members in each kindred had some craniofacial features, and fit the WSCP with poor visual 
spatial cognition. All affected family members had similar overall IQ that was in the normal 
range. These data gave further support that the LIMK1 gene is sufficient to cause the visual 
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spatial deficit, and since none of the deletions included the GTF2I gene, this gene was 
considered important for contributing to intellectual disability (31). In contrast to the above 
families that support the hypothesis that LIMK1 is sufficient to cause the visual spatial 
phenotype, another study that described four new patients (including two brothers with the same 
inherited deletion) with small deletions that cover LIMK1 showed that they had no visual spatial 
deficits (32).  None of the individuals described in the study had the characteristic facial features 
or intellectual disability. These conflicting results highlight the complexity of using humans with 
atypical deletions to make conclusive genotype-phenotype correlations. The conflicting results 
could be due to confounds from incomplete penetrance of these genes, environmental factors, 
and contributions from other genetic loci in the genome. 
 Other atypical deletions in patients have led to the hypothesis that most of the genetic risk 
of the region is harbored in the telomeric end of the deletion. This is supported by the lack of any 
phenotypes besides SVAS in on of the patients described above that had the typical centromeric 
breakpoint that extended to LIMK1 (32, 33), and three patients described by Botta et al. (34) and 
Heller et al. (35) that had the typical telomeric break point that extended through ELN but spared 
STX1A, who presented with the full phenotypic spectrum of WS. This pattern is also mentioned 
by Hirota et al. (36), who detailed the lack of the WSCP and most craniofacial features in three 
cases with typical centromeric breakpoints but telomeric breakpoints that extend through ELN 
but spare GTF2I  in all cases. These findings, as well as others that are reported (2, 37–40) have 
lead the field to focus on two paralogous transcription factors in the telomeric end of the 
deletion, GTF2IRD1 and GTF2I as major contributors to the WS profile.  
 Two case studies provide specific support for the role of GTF2IRD1 in craniofacial 
development and GTF2I in the intellectual disability and social phenotypes. Tassabehji et al. 
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(39) analyzed the facial features of a patient with a typical centromeric breakpoint and telomeric 
breakpoint that falls within GTF2IRD1 deleting its transcription start site, leaving GTF2I intact. 
The patient did not have the hypersocial phenotype, yet her language development was delayed, 
and she had visual spatial deficits, however, not to the same extent that is normally seen in 
typical WS. Her facial features were intermediate of what is typically seen in WS. Dai et al. (38) 
described another patient with the typical centromeric break point that extended through 
GTF2IRD1 and spared only GTF2I. This patient had all the typical craniofacial features of WS 
and performed higher on verbal tasks but still had difficulty with some spatial tasks, but not as 
large of a deficit as seen in typical WS. Finally, the patient did not show the hypersocial 
phenotype, which led the authors to conclude that GTF2I plays an important role in this domain.  
 Larger deletions that delete the NCF1 and GTF2IRD2 as well as the typical genes in the 
WSCR, can provide insight into the contribution of these two genes. In general individuals with 
larger deletions tend to have more cognitive difficulties (37, 41). Comparing the larger deletion 
groups with a typical deletion group showed similar overall cognitive functioning, but specific 
areas of further deficit in the larger deletion group. These areas pertained to cognitive flexibility 
and spatial perception (41). Individuals with larger deletions also had more social cognition 
problems and obsessive behaviors than the typical deletion (42).  The GTF2IRD2 gene has been 
suggested to cause the slightly more severe phenotype because of its similarity to the other 
member of the GTF2I family and the evidence that it is expressed in the brain. The NCF1gene 
has been shown to modify the cardiovascular phenotype, and deletion of this gene is protective 
against hypertension in WS (43). These studies show that the larger deletion further exacerbates 
the cognitive phenotypes of the typical deletion and modifies the cardiovascular phenotype, 
suggesting that multiple genes contribute to multiple phenotypic domains in WS.  
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Studying atypical deletions in patients with WS has provided insight into the contribution 
of loci within the region to phenotypes in specific cases. This study design has several inherent 
limitations that should caution the field from making too strong of conclusions. First, the atypical 
deletions are rare events and each patient represents a unique deletion, except in the case of 
inherited deletions. This makes it impossible to generalize the conclusions from one case to the 
others and limits the potential to perform and make statistical inferences. Second, there is an 
ascertainment bias towards individuals with ELN deletions, which means the atypical deletions 
rarely affect just one of the genes in the region, making it difficult to test if one gene is sufficient 
to cause a specific phenotype. Third, these studies ignore the consequences of environmental and 
background genetic variation. It would be beneficial to be able to compare typical and atypical 
deletions to their parent’s data to get an idea of the effect size of the deletion in the context of 
other inherited genetic variation. Finally, each of the cases is described by different clinicians 
with different and biased expertise for specific phenotypes. This makes it difficult to directly 
compare phenotypes across studies especially when some of the phenotypes weren’t 
investigated. Overall, the study of atypical human deletions consistently shows that several genes 
can contribute in some degree to many phenotypes, such as craniofacial features, the WSCP, and 
overall cognitive ability. The telomeric end of the deletion seems to harbor the largest risk for 
most of the phenotypes observed in WS (2, 34, 36, 38).  
1.2.2   Human induced pluripotent stem cell (iPSCs) studies 
Patients with atypical deletions of WS allows for the study of the effects of specific genes 
or sets of genes on observable clinical phenotypes, but does not permit the study of underlying 
cellular or molecular changes. The advent of human derived induced pluripotent stem cells 
(iPSCs) as a model for human disease circumvents the need to obtain specific tissues from a 
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human patient – particularly a challenge for the brain – and let’s researchers query cellular 
morphology and function, and look at the disruption of different molecular pathways. The 
Williams syndrome field has adopted these approaches to study the effects of the deletion and 
duplication of the region at a cellular level in different affected tissues (44–49). This strategy has 
highlighted the roles of GTF2I (44) as well as other genes, such as BAZ1B (49) and FZD9 (46).  
 Two early iPSC studies looked at the effect of the typical deletion on cardiovascular (47) 
and neuronal phenotypes, establishing this technique as a model for the study of WS (48). 
Kinnear et al. used iPSC to test the cardiovascular phenotype of cells with the WSCR. They 
showed that when the cells were differentiated into vascular smooth muscle cells, the WS cell 
lines were more immature based on lower expression of markers in mature smooth muscle cells. 
They went on to show that rapamycin can rescue this immaturity phenotype (47). Khattak et al. 
used the same patient’s cells to investigate the functioning of iPSC derived neurons with the WS 
deletion. The main electrophysiological deficit was in the repolarization of the cells due to lower 
expression of potassium channels. This study also profiled the transcriptomes of the WS derived 
neurons and wild type (WT) derived neurons and found that synaptic genes were among the most 
differentially expressed (48). Since these studies used stem cells from the same patient that was 
selected for severe cardiovascular disease, they don’t represent independent biological 
experiments. Further, the patient was also diagnosed with clinical autism, which has a higher 
prevalence in WS, but this could affect the interpretation of the neural phenotypes that are not 
generalizable to typical cases of WS. These studies show the potential for identifying 
physiological differences at the cellular level in cases of typical deletions, however they did not 
attempt to make specific genotype-phenotype correlations.  
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 iPSCs can be used to make assertions about the contribution of specific genes to specific 
cellular phenotypes, which helps understand the functional roles of genes in the WSCR. Adamo 
et al. performed RNA-seq experiments in iPSCs from four separate patients with WS, two 
patients with 7q11.23dup syndrome, and three related normal controls and three external control 
cell lines, and showed that there were symmetrical changes in expression of genes in disease 
related pathways. They performed a similar experiment after differentiating the iPSCs into 
neurons, and observed enrichment of genes involved in axon guidance, cell polarity, and 
transmission of nerve impulses. To test the specific contributions of GTF2I, they performed 
RNAi knockdown of GTF2I in the 7q11.23dup and WT cell lines, and showed that about 10-
20% of the transcriptional changes observed in the full WS deletion can be attributed to GTF2I. 
They went on to show that GTF2I interacts with the chromatin modifiers LSD1, a histone 
demethylase, and HDAC2, a histone deacetylase (44). They argue that most the transcriptional 
changes caused by decreased dosage of GTF2I are indirect, and propose that the dysregulation of 
the GTF2I target, BEND4, is a likely candidate that contributes to the downstream transcriptional 
changes. They remark that there is considerable variation between patient cell lines and the 
expression of BEND4, which highlights the importance of considering the genetic background. 
Overall, this study does suggest that GTF2I plays a role in the transcriptional phenotype, but 
does not account for all of it.  
 Additional iPSC studies provided evidence for functional roles of genes on the 
centromeric end of the deletion in neuronal phenotypes (46, 49), which the atypical deletion 
human studies have suggested do not contribute to the phenotypic spectrum of WS. Neural 
progenitor cells derived from typical deletion WS cases showed increased apoptosis that was not 
seen in cell lines derived from WT or an atypical case, whose deletion spanned from CLDN3 to 
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RFC2. Reasoning that FZD9, which is not deleted in the atypical case, and regulates 
programmed cell death, the authors showed that knocking down FZD9 in the WT cell lines could 
recapitulate the apoptosis phenotype and overexpressing FZD9 in the WS cell lines could 
ameliorate the apoptosis phenotype (46).  Transcriptional profiling of WS and WT derived 
neuronal cell lines along with BAZ1B knockdown showed as much as 42% of the transcriptional 
difference between WS and WT neurons were caused by decreased expression of BAZ1B. The 
transcriptional changes along with genes bound by BAZ1B, suggested a role for this gene in the 
regulation of Wnt signaling as well as synaptic development. Decreased expression of BAZ1B 
resulted in neural progenitor cells maintaining a proliferative state, which prevented proper 
differentiation into neurons. This phenotype could be rescued by antagonizing Wnt/Beta-catenin 
signaling (49). Together, these two iPSC studies strengthen the evidence for genes in the 
centromeric end of the deletion to play an important role in neural development, which could 
lead to the striking cognitive and behavioral phenotypes of WS. They also further implicate 
specific pathways such as Wnt signaling and synaptic functioning in the pathogenesis of WS.  
 It has been shown for WS that iPSCs are a valuable model to understand cellular and 
molecular phenotypes caused by the typical deletion as well as by specific genes in the region. 
While this model has its advantages it also has several limitations. iPSCs study designs allow for 
the testing of disease relevant tissues using human cells, however, the cells are artificially 
differentiated outside the context of the organ-specific microenvironment. This can lead to 
unforeseen changes in the biological functioning of the cells. Further, the study of cells in vitro 
precludes making associations with the cellular changes directly to behavior at the organismal 
level. For example, iPSC differentiated neurons do not form the complex anatomical circuits 
equivalent to what is seen in the brain in vivo.  In spite of these limitations, in the case of WS 
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these studies have provided further insight into genes such as FZD9, BAZ1B, and GTF2I, and 
suggest that they all contribute to neuronal phenotypes.  
1.2.3  Human general population association studies 
Another strategy that employs human genetics to identify genotype-phenotype 
correlations of genes in the WSCR, is to test variation in these genes for association with traits in 
the general population, both in samples of individuals with WS and in case-control designs. The 
duplication of the WSCR was found to be significantly associated with autism spectrum disorder 
(ASD) diagnosis in a case-control study design (26). Association analyses have further 
implicated the general transcription factor 2i family of genes in social and cognitive phenotypes 
(50–53). The advent of next generation sequencing technology offers new potential to implicate 
not only common variants, but also rare variants in the pathogenesis of WS (54).  
Candidate gene associations have implicated two single nucleotide polymorphisms 
(SNPs) in the GTF2I in ASD as well as in neural phenotypes related to social cognition (50, 51). 
While these studies were not unbiased screens of the whole genome, the authors reasoned that 
the WSCR contains loci that affect social behavior. When variants in STX1A, CLIP2, and GTF2I 
were tested for association with ASD diagnosis in families with at least one affected child, only 
two SNPs in GTF2I, rs4717907 and rs13227433, were found to be over transmitted in the 
probands (50). Using this previous finding, these two SNPs were further associated with a metric 
that captures the low social anxiety and reduced social communicative skills of individuals with 
WS in a sample of 488 individuals attending university (53). The imputed rs13227433 genotype 
was also found to be associated with reduced amygdala reactivity to threatening stimuli, a neural 
phenotype that has been documented in WS (51) in a sample of 808 university students. Finally 
the SNP, rs2267824, located within the GTF2IRD1 gene, was associated with a metric that 
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captures the neuroanatomical gestalt of the WS brain in a sample of 1,863 people from the 
general population, suggesting that it contributes to brain anatomy that is specifically observed in 
individuals with WS (52). These candidate gene focused studies corroborate the role of both 
GTF2I and GTF2IRD1 in behavior and brain development related to WS.		
Association studies are valid study designs to identify genomic loci that correlate with a 
trait of interest, but they have several limitations. The detection of a significantly associated 
variant does not mean the causal variant has been detected. Rather, in most cases an association 
elucidates a region in the genome that contains the causal variant. In addition, association studies 
based on genotyping with SNP-chips are only able to test common SNPs, which are expected to 
have small effect sizes, so in order to detect these effects large sample sizes are required. To 
overcome this, next generation sequencing technologies can be used to query the role of rare 
variants in modifying the phenotypes of WS. Since WS is caused by the contiguous deletion of 
1.5-1.8Mbp on chromosome seven, individuals with WS only have one remaining copy of the 
region, which could unmask the effects of recessive alleles (55). This hypothesis was tested for 
the cardiovascular phenotype, looking specifically at variants in the ELN. With a sample size of 
55 individuals, no one specific variant associated with severity of the cardiovascular disease 
(56). This approach could be applied to other genes in the WSCR as well as other phenotypes in 
the region to understand how the genetic variation associates with different aspect of the 
disorder.  
The human approaches taken to study the genotype-phenotype correlations within WS 
has, so-far, have highlighted the variability of the phenotypes and a complex relationship with 
the genes in the region. My work has focused on describing how genetic variation within the 
WSCR and in the whole exome can modify the social phenotype of WS. I analyzed the whole 
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exome sequencing data of 85 individuals with WS to associate genetic variants with the social 
phenotype. I can use the variation across individuals with WS that have received the same 
standardized social questionnaire to ask how much does genetic variation contribute to the social 
phenotype. This allowed me, in an unbiased, way to test for genes in the WSCR and the whole 
exome that are important for modifying social behavior in WS, which could inform clinicians 
taking care of individuals with WS as well as inform genes involved social behavior in the 
general population.  
1.3 Introduction to the general transcription factor 2I family 
Performing gene associations in humans, while informative on what locations of the 
genome are important for different traits, are not conducive to conducting controlled experiments 
that could lead to a mechanistic understanding of how genes exert their effects on behavior. 
Along with the human studies I did, I leveraged the experimental advantages of the mouse model 
to focus on the interactions of two genes in the WSCR, Gtf2i and Gtf2ird1. I chose to investigate 
these genes to test the hypothesis that they contribute to the cognitive and behavior phenotypes 
as the human literature has suggested and to extend the current research by testing how they 
interact. This family is made up of three paralogous transcription factors that are located in the 
WSCR. GTF2I and GTF2IRD1 are deleted in the 1.5Mbp deletion, and GTF2IRD2 is deleted in 
the larger 1.8Mbp deletion. These transcription factors have been extensively studied in different 
model systems, including cell lines and mouse models, usually focusing either on GTF2I or 
GTF2IRD1. Since both seem to contribute to overlapping phenotypes and they share overlapping 
DNA binding targets, these transcription factors merit further investigation. 
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1.3.1  General background on the GTF2I family  
Different groups discovered the GTF2I family of genes independently. GTF2I was 
discovered in several contexts, including a target of Bruton’s tyrosine kinase in B-cells (BAP-
135) (57), a protein that stabilizes the serum response factor complex (SPIN) (58), and as a 
transcription factor in the WSCR that can bind to the E-box and Inr element (59), which were all 
shown to be the same GTF2I protein. GTF2IRD1 has a similar history in which it was discovered 
many independent times as a gene expressed in the muscle (MusTRD1) (60) as well as a 
transcription factor in the WSCR (WBSCR11) (61, 62).  
All three are multiexonic genes that are subject to extensive alternative splicing. GTF2I is 
made up 35 exons, GTF2IRD1 contains 27 (63), and GTF2IRD2 has only 16 exons due to the 
replacement of the 3’prime end of the gene with a CHARLIE8 transposon (64).  The sequence 
features that distinguish these genes as a family are the I repeats, of which GTF2I contains 6, 
GTF2IRD1 contains 5, and GTF2IRD2 has 2. These are helix-loop-helix domains that are 
thought to be important for protein-protein interactions and DNA binding (65). They also have a 
conserved N-terminal leucine zipper (66, 67), that is involved in homo and heterodimeriziation 
that can affect DNA binding function. The evolutionary history of these genes points to 
GTF2IRD1 as the ancestral gene that was duplicated to produce GTF2I. These two genes are 
present in all land mammals with the duplication and inversion of GTF2I giving rise to 
GTF2IRD2, which is present in all placental mammals (68). This conserved evolutionary history 
in mammals makes studying these genes tractable in mouse models. The mouse Gtf2ird1 and 
human GTF2IRD1 share 87.9% amino acid identity and the mouse Gtf2i and human GTF2I 
share 97.3% amino acid identity (69). Given the similar evolutionary history of these genes, it is 
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important to understand to what extent these genes share overlapping function, as well as how 
they differ.  
 GTF2I was the first gene discovered and has been the best studied, probably due to its 
higher abundance in many different tissues and due to the availability of effective antibodies. 
The expression of GTF2I is described as ubiquitous, with higher expression early in 
development. In the mouse, Gtf2i mRNA is maternally deposited by the mother in the fertilized 
egg and is highly expressed in the inner cell mass, and continues to be highly expressed 
throughout development (70, 71). In situ hybridization experiments in the mouse brain showed 
uniform expression of Gtf2i from embryonic day 18.5 to postnatal day seven, with enhanced 
expression of the mRNA in Purkinje cells, the hippocampus, and cerebral cortex in the adult 
brain, all of which was described as neuronal. The protein showed a similar expression pattern, 
with protein detected in both the nucleus and the cytoplasm, with enrichment in the hippocampus 
and cerebellum (72). The presence of GTF2I in both the nucleus and the cytoplasm suggests that 
this transcription factor has functions beyond regulating nuclear transcription.  
 Along with its roles as a basal transcription factor, GTF2I plays a role in the cytoplasm 
that allows it to convey cellular information to the nucleus. GTF2I was first discovered due to its 
ability to bind the Inr element at transcription start sites but also at upstream enhancers (73). It 
was shown that some of its transcriptional activity was due to tyrosine phosphorylation by SRC 
that allowed cytoplasmic GTF2I to translocate to the nucleus, suggesting that GTF2I can induce 
transcriptional changes based on signal transduction pathways (74). Interestingly Src knockout 
mouse models show phenotypes such as hyperactivity and hypersociability, suggesting that 
disruption of this gene and its downstream pathways can recapitulate some features of Gtf2i 
knockout models (75). Another effect that phosphorylation of GTF2I by SRC has is to inhibit 
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agonist induced calcium entry (76). The cytoplasmic phosphorylated GTF2I competes with 
TRPC3 protein, a calcium channel, to bind PLC-γ, which prevents the localization of TRPC3 to 
the membrane and inhibits calcium entry into the cell. This was shown to affect neuron 
morphology and calcium electrophysiology in neurons that are missing one copy of Gtf2i. The 
neurons with less Gtf2i had more complex axons and increased calcium entry (77). These studies 
have elaborated the complex cellular role that GTF2I plays in both transcription and signal 
transduction and how it can affect neural phenotypes, which may contribute to phenotypes in 
WS. No studies have been done that show what happens to transcription genome-wide in the 
brain when Gtf2i is increased or decreased, which the work I present in chapter three describes. 
Also, given the dual role of this transcription factor the paucity of data concerning its effect on 
transcription makes it difficult to disentangle which functionality of Gtf2i is contributing to 
affect behavior.  
 In contrast to the extensive transcriptional roles and signal transduction function of 
GTF2I, GTF2IRD1 has mostly been characterized as having a role in transcriptional regulation. 
The expression of this gene was described using a lacZ reporter in the mouse. Ubiquitous 
expression was seen at embryonic day 7.5 with more localized expression occurring after 
organogenesis. In the developing brain it is expressed most highly in the pituitary, developing 
hypothalamus and thalamus, and hindbrain with little expression in the telencephalon. The gene 
is expressed less in adulthood across all tissues, and within the brain it is the most highly 
expressed in the olfactory bulbs, Purkinje neurons, and neurons of the piriform cortex. It is 
highly expressed in adult brown adipose tissue (78).  The low expression of this gene in vivo 
along with poor antibodies has made this protein difficult to study in vivo. However, work in 
cells that highly express this gene show that is mostly localized to the nucleus in a punctate 
 
 
20 
pattern and in close proximity to other chromatin regulators such as SP1 and H3K27Me2/3 and 
H3K4Me3 marks. A yeast 2 hybrid screen further suggested that GTF2IRD1 interacts with 
chromatin modifiers such as ZMYM2 and ZMYM3 along with proteins involved in ubiquitin 
pathways such as USP20 and USP33 (79). These data suggest that it plays a role in 
transcriptional regulation.  
Other studies have shown that GTF2IRD1 binds to specific genomic regions to affect 
transcription and the Gtf2ird1 genes is under tight transcriptional and posttranslational 
regulation.  In the mouse retina Gtf2ird1 binds to the LCR enhancer and promoter regions of 
opsin genes to promote transcription (80). Hasegawa et al. showed that Gtf2ird1 expression is 
induced in mouse brown adipose tissue in cold conditions and associates with the PRDM16 
complex to repress fibrotic gene transcription (81).  In addition, GTF2IRD1 has been shown to 
negatively autoregulate its own transcription. The N-terminal leucine zipper was proposed to 
increase binding to its own upstream regulatory element and mutating the leucine zipper resulted 
in a difference in bind affinity to the sequence (66). Finally, GTF2IRD1 is post translationaly 
modified by the addition of a SUMO group that alters its protein-protein interactions and targets 
the protein for degradation (82). The extensive roles of Gtf2ird1 in transcriptional regulation and 
its tightly regulated mRNA and protein expression suggest that this gene plays an important 
biological role that could contribute to the phenotypes of WS.    
The DNA binding of these two transcription factors has been studied genome-wide in 
different model systems. The core binding motifs for the fourth I repeat of GTF2I and 
GTF2IRD1 was identified as RGATTR using the SELEX method (83). In a similar experiment 
the binding site of the full length GTF2IRD1 was determined to be 
GGGRSCWGCGAYAGCCSSH (65).  Chip-Chip experiments in mouse embryonic stem cells 
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revealed 5,744 binding peaks for Gtf2i and 625 binding peaks for Gtf2ird1, most of which were 
located in promoters of genes. When binding was investigated in embryonic craniofacial tissue 
they identified 1,181 Gtf2i binding peaks and 1,520 Gtf2ird1 binding peaks, again most were 
located in promoter regions. They showed examples of sites where both proteins were located at 
the same promoter regions suggesting they can overlap in the genes they regulate. Most of the 
binding sites were located in areas of bivalent chromatin marks (84). GTF2I binding has been 
assessed in human iPSC cells using ChIP-seq and was found to bind 1,554 genes at their 
promoters. About half of these binding sites were also targets of the LSD1 histone demethylase 
(44). Gtf2i has also been shown to help target CTCF to promoter regions.  Genome-wide binding 
analysis of Gtf2i and Gtf2ird1 show that they have overlapping targets and cooperate with other 
chromatin regulators. Further study of the binding patterns of these proteins in vivo in other 
relevant tissues will continue to elucidate the role these genes play in transcription regulation and 
downstream affected pathways.  
 Given that both GTF2I and GTF2IRD1 are transcription factors and they bind many 
genes in the genome, their affects on transcription genome wide have been minimally described 
and with contrasting results. Gtf2ird1 overexpression in mouse embryonic fibroblasts led to 
around 1,000 upregulated genes and 1,000 downregulated genes covering pathways such as 
ubiquitin cycle, RNA binding, and cell cycle (85).  In contrast, Gtf2i overexpression in mouse 
embryonic fibrobalsts led to fewer changes with only 90 genes upregulated and 68 genes 
downregulated. These genes made up categories such as transcription regulation, immune 
response, and apoptosis (86). The effects of knocking out each transcription factor was assessed 
in embryonic day 9.5 mouse models. In the Gtf2i null embryos there were 217 upregulated and 
2,356 downregulated genes spanning categories such as cytoskeleton remodeling, cell cycle, 
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transcription, and the ubiquitin cycle. However, Gtf2ird1 null embyros showed only 38 
upregulated genes and 498 downregulated genes that did not show any enrichment for specific 
GO categories (87). These findings somewhat mirror the overexpression data. 
Another Gtf2ird1 mouse model profiled the transcriptomes of the developing brain at 
embryonic day 15.5 and postnatal day 0 and showed no significantly differentially expressed 
genes (88). Yet another Gtf2ird1 model that showed overgrown lip epidermal tissue revealed 
1,165 upregulated genes and 1,073 down regulated genes. Gene set enrichment analysis on the 
upregulated genes highlighted pathways such as cell cycle, the ribosome, proteasome, and 
ubiquitin mediated proteolysis. Down regulated genes showed enrichment in calcium signaling, 
oxidative phosphorylation, and cardiac muscle contraction (89). Finally, transcriptome profiling 
of the hippocampus in a mouse model that has the entire syntenic WSCR deleted showed down 
regulation of genes in the Pik3 kinase pathway as well as Bdnf (90, 91). 
 Overall, transcriptional studies of Gtf2i and Gtf2ird1 seem to be dependent on many 
factors that include tissue type, stage in development, how the genes are mutated, and mouse 
strain. The transcriptome data generated in the E9.5 embryos should be cautiously interpreted 
since both the Gtf2i and Gt2ird1 null mutants described were embryonic lethal and showed 
neural tube closure defects as well as vascular defects. Comparing these very severe embryos to 
the WT embryos show that many of the transcriptional changes detected are probably 
consequences of the disrupted development of the embryo, which make teasing out the direct and 
indirect effects of reducing the expression of Gtf2i and Gtf2ird1 difficult. The discrepancy 
between the transcriptome findings of the brain and the lip tissue could arise for several reasons. 
Different mutants were used and in vivo analysis of the Gt2ird1 protein was lacking in both 
studies. It would be beneficial to know how the mutations are affecting the protein levels as well 
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as the normal WT levels of protein expression between these two tissue types. The lip tissue also 
showed a clear morphological phenotype that specifically affected the epidermal tissue and not 
the dermal tissue, cartilage, or underlying muscle. The striking difference between genotypes in 
the lip tissue could be driven by a clear disruption of a specific cell type (92), while in the brain 
there could be more subtle effects in different cell types diluting the signal. Incorporating 
multiple levels of information such as ChIP-seq, RNA-seq, and tissue specific expression of 
these genes will aid in constructing a more complete understanding the role of these transcription 
factors.  
1.3.2  Mouse models of Gtf2i and Gtf2ird1 
Along with understanding what the molecular functions of these two transcription factors 
are, in order to provide useful insight into the etiology of WS, the affect these two transcription 
factors have on behavior should also be studied. Previously, I have described the evidence that 
supports the functioning of these genes in behavior, cognition, and physical attributes that we 
have gleaned from human studies. As mentioned, human studies come with their own 
limitations: in rare partial deletions one is making inferences based on single individuals. 
Likewise, one is unable to model behavioral consequences in iPSCs. Model organisms, 
specifically the mouse, have been instrumental in understanding both the functional roles of 
genes as described in the previous section and the consequences of dosage changes of genes on 
behavior. The mouse is an attractive model in which to model WS for several reasons: 1) a 
region of chromosome five in the mouse is syntenic to the WSCR in humans, 2) geneticists have 
a large tool kit in which to accurately modify the mouse genome to test specific mutations or sets 
of mutations, 3) mice are able to be bred so that the same mutation can be studied in a large, 
controlled sample allowing for statistical inferences, and 4) mice are social animals that display 
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behaviors in domains that are disrupted in WS. Many different mouse models have been used to 
try and understand the behavioral consequences of genes in the WSCR, with varying degrees of 
face validity to WS. The strain of mouse and how the mutations were generated play a large role 
in the manifestation of phenotypes in mouse models. This makes synthesizing the data from 
different labs and experiments difficult, but consistent phenotypes across many different models 
can provide strong corroborative evidence for genotype-phenotype correlations.  
Large deletion mouse models 
The mouse model with the highest construct validity is a hemizygous deletion of the 
syntenic WSCR on the mouse chromosome five and is termed the complete deletion (CD) mouse 
(93). The mouse was generated using the cre-lox system with a loxP site situated in exon two of 
Gtf2i and the other loxP site in intron five of Fkbp6 on the C57BL/6J background. This mouse 
model showed phenotypes that are consistent with most of the phenotypes of WS that can be 
tested in the mouse. The physical features include mild cardiovascular phenotypes, smaller 
skulls, reduced brain size, decreased volume of hippocampus, and more immature neurons in the 
dentate gyrus as determined by doublecortin immunostaining. A battery of behavior tests in the 
CD mice showed deficits in motor coordination, decreased motor tonicity strength, increased 
startle response to stimulus noise, and a decreased habituation to a social stimulus (93). Another 
study of the CD mice showed deficits in working memory as tested by the spontaneous 
alternating T-maze and novel object recognition, which was reported as normal in a previous 
study. The social phenotype was replicated as well as a decrease in the number of marbles buried 
in the marble burying task (91). Finally, the role of Gtf2i in the manifestation of the behavioral 
phenotypes in the CD animal was tested by delivering adeno-associated virus 9 (AAV9) that 
carried the mouse Gtf2i cDNA into the cisterna magna of CD mice. The addition of Gtf2i cDNA 
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rescued the increased social phenotype, partially rescued the motor coordination, but did not 
affect the marble burying deficits (90). This mouse model showed deficits in motor coordination 
and increased startle to a stimulus noise. Humans with WS are known to have poor balance as 
well as hyperacusis. The mice also recapitulated the hypersocial phenotype of WS as tested in 
these behavioral tasks using only male mice. The CD model is a great tool to understand how the 
entire WSCR affects mouse behavior and the underlying mechanisms. However, the work done 
in the CD mouse should be expanded to include female mice to understand any sex or sex by 
genotype interactions. This would also inform how robust the phenotypes are. For instance the 
social phenotypes have only been tested in males using an unconventional method.  Including 
social tasks that probe different aspects of sociality would help pinpoint the specific pathways 
involved in manifesting the disorder.  
 There are two other large deletion models that attempt to localize which genes are 
involved in specific mouse behaviors by splitting the WSCR into two halves and deleting each 
half (94). These mice were generated using the cre-lox system on the C57BL/6J background. The 
proximal deletion mice (PD) are hemizygous for Gtf2i through Limk1. The distal deletion mice 
(DD) are hemizygous for Trim50 through Limk1. Breeding the PD and DD mice together results 
in four littermate genotypes, which include a mouse that is hemizygous for the whole region on 
two different chromosome and is homozygous null for Limk1, this is called the P/D mouse. The 
DD and P/D mice showed similar shortened skulls with more severe differences in the P/D mice. 
This indicates that genes on the distal half of the deletion contributing to the craniofacial 
phenotypes, but perhaps genes in the proximal half can exacerbate the phenotype. There were 
mixed results on a series of behavior tasks that probe social behavior. The partition task showed 
all three genotypes spent more time at a partition that held a social stimulus than WT littermates. 
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A direct social task showed only the PD mice spent more time investigating a conspecific 
compared to WT littermates. The three chamber social approach task showed a significant 
preference for the social stimulus in the PD and P/D mice but no such preference in the WT or 
DD animals. Finally in a test of social dominance the PD and P/D mice had a decrease win ratio 
suggesting reduced dominance behavior. The P/D mice showed decreased locomotor activity and 
poor balance, and the partial deletions had intermediate values. Altered response to sensory 
stimuli was tested using the acoustic startle response and pre-pulse inhibition. This was only 
altered in the PD mice with no phenotype in the P/D or DD genotypes. In a learning and memory 
task, the DD mice showed decreased freezing in contextual and cued fear memory. Studying the 
two half deletions can help further localize the genes involved in specific phenotypes. These 
studies suggest that the DD genes are involved in the craniofacial phenotypes and fear memory 
recall. The PD genes affect, in some tasks, social behavior and the response to sensory stimuli 
(94). Genes in both halves of the deletions may contribute to balance deficits, which is more 
affected when both halves are deleted. Overall, it seems like some phenotypes such as the 
balance and craniofacial differences are being influenced by multiple genes.  
Gtf2i and Gtf2ird1 mouse models 
The larger mouse models of WS test the affects of knocking out the entire region on 
mouse behavior. One of the advantages of mouse models is the wide range of tools geneticists 
have at their disposable to manipulate the genome, permitting the study of very specific 
mutations of single genes. Single gene knockout mice exist for several different genes in the 
WSCR, with many genes having multiple different mouse models (95). For Gtf2i there are two 
mouse models that decrease the expression of Gtf2i to varying degrees. One model has a gene 
trap cassette in intron 3 of Gtf2i  (Gtf2iGt(YTA365)Byg/β) that has been characterized in (29, 87, 96, 
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97) and results in a null allele. The second Gtf2i model has a targeted deletion of exon 2 
(Gtf2iΔex2), which contains the canonical translation start codon, and produces an N-terminally 
truncated protein that begins at a methionine in exon five and is described in (67, 90). The 
former model is embryonic lethal in the homozygous state (29, 87, 96) and the latter model 
produces viable homozygous animals at a lower than expected Mendelian ratio (67). There are 
four different mouse models of Gtf2ird1 that have been described in the literature: 1) the 
Gtf2ird1XE465 model has a gene trap lacZ cassette located in intron 22 (87), which makes a fusion 
protein, 2) the Gtf2ird1 Tg(Alb1-Myc)166.8 model has a myc transgene that randomly integrated 
into the locus replacing the transcription start site and the first exon of Gtf2ird1(39, 98–100), 
which has no detectable expression, 3) the Gtf2ird1tm1Hrd model was made by homologous 
recombination removing exon 2, which contains the canonical translation start codon, and has 
increased expression of Gtf2ird1 transcript but produces an N-terminally truncated protein at 3% 
of WT levels (66, 78, 92), and 4) the Gtf2ird1tm1LR model was made by homologous 
recombination removing exons 2,3,4 and part of 5, which still makes an aberrant Gtf2ird1 
transcript but protein analysis was not done (101). All of the Gtf2ird1 models can produce viable 
homozygous animals except for Gtf2ird1XE465, which expire embryonically. This more severe 
phenotype has been attributed to the production of a fusion protein whose function is unknown 
(88). While there are many mouse models of both of these genes that have been tested on 
different mouse backgrounds and on different behavioral tasks, synthesizing the data across all 
the experiments can provide strong evidence of the roles of these genes on behaviors.  
 The two mouse models of Gtf2i have shown hypersocial phenotypes (90, 96, 97). The 
specific social phenotypes queried by the specific tasks differ. In two experiments the Gtf2i 
heterozygous mutants display a lack of habituation to a social stimulus that is normally observed 
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in WT littermates (96). Another experiment using the N-terminally truncated protein, and 
showed that heterozygous and homozygous mutants investigate a social stimulus for more time 
compared to WT littermates (90). The most convincing experiment employed a social operant 
learning paradigm, in which the heterozygous mutants will work harder for more social rewards 
(97).  Besides the social phenotypes other behaviors have been documented such as impaired 
novel object recognition, increased anxiety, motor coordination marble burying in homozygous 
animals, and smaller craniums (67, 90, 96). The work done in single Gtf2i mutants supports its 
role in the social aspect of WS, and potentially in anxiety, motor ability, and the craniofacial 
features.  
 The several Gtf2ird1 mutant mouse models show many behavioral and physical deficits, 
but in some models exhibited findings that contrast other models. Furthermore, some of the 
phenotypes are only seen in the homozygous knockouts, which don’t reflect the gene dosage 
effects that are expected to be seen in humans with WS. One consistent phenotype seen in two 
models of Gtf2ird1 is a motor coordination deficit, which was also seen in the larger deletions of 
the WSCR and in one Gtf2i model (92, 100). Other phenotypes such as activity levels and 
anxiety-like behaviors are discrepant across models. Some models report increased activity and 
decreased anxiety, while another reports the opposite (92, 100, 101). Social behavior has only 
been tested in one Gtf2ird1 mouse model, using the resident intruder paradigm, which showed 
decreased aggression, but an increase is social investigation by the Gtf2ird1 heterozygous and 
homozygous mutants (101).  Two models have reported facial dysmorphisms in the mice, one 
which affects the cranium and the other affects the soft tissue of the face (39, 92). The 
contrasting evidence in these mouse models could be due to the mouse background on which 
each model was made or how the gene itself is disrupted. The evidence shows that this gene may 
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also contribute to motor deficits, the social phenotype, and the craniofacial phenotype that is 
observed in WS.  
 Overall, single gene knock out models of both Gtf2i and Gtf2ird1 show overlapping 
behavior phenotypes, specifically in social and motor deficits. However, these genes have not 
been studied in combination, which is what is expected in the deletion of WS. This leaves open 
the question if this two paralogous transcription factors can interact with each other to 
synergistically affect behavior? Understanding how these genes function together will give a 
more complete understanding of how genes in the WSCR interact to produce the full phenotypic 
spectrum of WS. These hypotheses are addressed in chapters three and four of this thesis.  
1.4 Conclusions 
Both human and mouse genetic experiments have demonstrated that the WSCR is an 
important genomic region for a variety of traits, such as craniofacial development, cardiovascular 
health, cognition, anxiety, and social behaviors. The field has employed many different strategies 
to further understand the genes responsible for causing the phenotypes of WS and thus providing 
insight on the biological mechanisms of different human characteristics. Still the only strong 
monogenetic contribution of a gene in the WSCR to a specific phenotype of WS is the role ELN 
plays in the cardiovascular disease. Even this monogenic contribution can be modified by 
another gene in the region NCF1. There is evidence for the role of several genes contributing to 
several different phenotypes. This oligogenic hypothesis may help the field further understand 
how the genes in the WSCR work together to produce the WS phenotypes, as has been shown for 
other copy number variation disorders (102, 103). The work I describe in this thesis uses both 
human genetics and mouse models to expand the knowledge of how genes in the WSCR affect 
behavior. I use whole-exome sequencing to analyze the largest genetic dataset of individuals 
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with WS, to test the hypothesis that variation in the remaining WSCR allele and exome-wide can 
modify the social phenotype. I then use newly generated mouse models to understand where 
Gtf2i and Gtf2ird1 bind genome-wide in the developing brain and what are the transcriptional 
and behavioral consequences on mutating these genes. I am able to test the hypothesis that these 
genes both affect the same phenotypes, testing the oligogenic contribution of these genes on 
behavior. Finally, I use mouse models to directly compare the affects of both Gtf2i and Gtf2ird1 
to the affects of the entire WSCR to test if these two genes, which have been highly speculated in 
the literature as driving the phenotypes of WS, are sufficient to replicate the phenotypes 
produced by all the genes in the WSCR. My data suggest that these genes do contribute to 
behavior, but other genes in the region or the effect of deleting the entire WSCR has more 
striking behavioral consequences. This leads me to conclude that the complex phenotypes that 
are disrupted in WS are caused by complex genetic interactions of genes in the region and 
require more than loss of just these two genes.  Further testing of the oligogenic relationship of 
genes will highlight the complex biology of human traits and the pathobiology of WS.  
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Chapter 2: Exome sequencing of 85 Williams 
Beuren syndrome cases rules out coding 
variation as a major contributor to 
remaining variance in social behavior 
 
Nathan D. Kopp, Phoebe C. R. Parrish, Michael Lugo, Joseph Dougherty, and Beth A. Kozel 
From:  
Exome sequencing of 85 Williams Beuren syndrome cases rules out coding variation as a major 
contributor to remaining variance in social behavior. 
Kopp, Nathan D., Phoebe CR. Parrish, Michael Lugo, Joseph D. Dougherty, and Beth A. Kozel. 
“Exome sequencing of 85 Williams-Beuren syndrome cases rules out coding variation as a major 
contributor to remaining variance in social behavior”. Molecular Genetics and Genomic 
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2.1 Abstract 
Large, multigenic deletions at chromosome 7q11.23 result in a highly penetrant constellation of 
physical and behavioral symptoms known as Williams Beuren syndrome (WS).  Of particular 
interest is the unusual social-cognitive profile evidenced by deficits in social cognition and 
communication reminiscent of autism spectrum disorders (ASD) that are juxtaposed with normal 
or even relatively enhanced social motivation.   Interestingly, duplications in the same region 
also result in ASD-like phenotypes as well as social phobias.  Thus, the region clearly regulates 
human social motivation and behavior, yet the relevant gene(s) have not been definitively 
identified. Here, we deeply phenotyped 85 individuals with WS and used exome sequencing to 
analyze common and rare variation for association with the remaining variance in social 
behavior as assessed by the Social Responsiveness Scale.  We replicated the previously reported 
unusual juxtaposition of behavioral symptoms in this new patient collection, but we did not find 
any new alleles of large effect in the targeted analysis of the remaining copy of genes in the 
Williams syndrome critical region. However, we report on two nominally significant SNPs in 
two genes that have been implicated in the cognitive and social phenotypes of Williams 
syndrome, BAZ1B and GTF2IRD1. Secondary discovery driven explorations focusing on known 
ASD genes and an exome wide scan do not highlight any variants of a large effect. Whole exome 
sequencing of 85 individuals with WS did not support the hypothesis that there are variants of 
large effect within the remaining Williams syndrome critical region that contribute to the social 
phenotype. This deeply phenotyped and genotyped patient cohort with a defined mutation 
provides the opportunity for similar analyses focusing on noncoding variation and/or other 
phenotypic domains.   
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2.2 Introduction 
 Williams Beuren syndrome (WS) (OMIM #194050) is a neurodevelopmental disorder 
caused by a 1.5 to 1.8 Mbp deletion on chromosome 7q11.23. The deletion causes a constellation 
of symptoms that include cardiovascular pathology, craniofacial dysmorphology, and a unique 
cognitive and personality profile(4,	14,	17).  The well-defined genetic lesion that causes WS is 
an opportunity to assess genotype-phenotype correlations. To date, only the cardiovascular 
phenotype has been convincingly linked to the haploinsufficiency of a single gene - the ELN 
gene(6, 104). Studying rare events that result in atypical deletions sparing different genes in the 
Williams syndrome critical region (WSCR), as well as single gene knock out studies in mouse 
models, have suggested that GTF2IRD1 and BAZ1B play a role in the craniofacial 
abnormalities(39, 105).  Likewise, the genes STX1A, LIMK1, CYLN2, BAZ1B, GTF2IRD1, and 
GTF2I (31, 38, 49, 96, 99, 106–109) have been implicated in the cognitive and behavioral 
phenotypes.  
 Understanding contributions to social phenotypes in particular for WS may define genes 
that regulate human social behavior, providing insight not only into WS, but also in other 
disorders as well as possible modifiers of social behavior in the general population. Deleting one 
copy of the genes in the WSCR produces the personality profile observed in WS, which consists 
of prosocial behaviors such as gregariousness, empathy, retained expressive language skills, and 
low levels of social anxiety, in spite of high anxiety in other domains(14, 19, 110–112). Despite 
the high social motivation of individuals with WS, they exhibit deficits in social cognition and 
communication(20, 113, 114). The Williams syndrome critical region duplication, 7q11.23 
duplication syndrome (Dup7) (OMIM#609757), conversely, is characterized by diametric social 
behaviors to those seen in WS, including separation anxiety, poor eye contact, and language 
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impairment, as well as overlapping phenotypes such as restricted and repetitive behavior and 
poor social communication (27).  It has also been shown that the prevalence of ASD in WS and 
Dup7 is higher than in the general population and the male sex bias for ASD diagnosis is present 
among individuals with Dup7(27, 115).  The similarities and differences in the social 
communication domains of WS and ASD have been described, and suggest that while both 
disorders show deficits in social communication, the WS group was not as impaired as the ASD 
group (113, 114). Unlike ASD, there is no sex bias in the frequency of WS and severity of social 
and cognitive phenotypes are similar across both sexes (21, 116). 
As in many diseases of haploinsufficiency, within WS there remains considerable 
variability in expressivity of the phenotypes, despite the very homogeneous genetic cause. It is 
thought that both genetic background and the environment introduce variation in the expression 
of a phenotype. The fact that individuals with WS are hemizygous for 26-28 genes has led to the 
assertion that variation in the remaining allele could contribute to the severity of symptoms in 
WS(13, 56). The presence of only one copy of genes in the WSCR could unmask the effects of 
recessive alleles in the region that are more difficult to detect in a diploid setting. Indeed, this 
logic has been applied to investigate the variability in the cardiovascular phenotype. Delio et al. 
2013 sequenced the exons that make up the ELN gene in a sample of 55 individuals with WS, but 
found no clear link between severity of phenotype and remaining genetic variation.  However, no 
similar studies have investigated the social profile of WS, in spite of the fact that there is some 
evidence that common variation in the region can influence social behavior in the general 
population.  For example, variation in the GTF2I gene has been associated with the WS 
cognitive profile, autism, oxytocin reactivity, amygdala activity, and social anxiety(53, 117, 117, 
118). Furthermore, genes outside of the WSCR are also likely to affect aspects of social 
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behavior. In particular genes that are associated with ASD have a profound effect on social 
interaction and could harbor variants that modify the phenotype of individuals with WS.  
Here, we employ whole exome sequencing to understand how genetic variation within 
the WSCR, and other protein coding genes, impacts the severity of the WS social phenotype. We 
generate a rich catalogue of genetic variants identified from 85 individuals with the typical WS 
deletions; each individual has also been assessed with the Social Responsiveness Scale-2 (SRS) 
questionnaire, a quantitative measure of reciprocal social behavior. The SRS was first developed 
to quantify autistic traits in both the general and clinical populations(119, 120). SRS scores have 
also been used to describe different aspects of the social phenotype in WS (20). We then employ 
a three-tiered approach to screen for the existence of alleles that contribute to SRS scores in the 
context of a potentially sensitizing WSCR deletion, ordering the analyses to conserve statistical 
power.  First, we describe the genetic variants observed in the remaining WSCR and test if they 
can explain the variance in the SRS scores. We find little evidence that these common or rare 
variants in the region are associated with SRS scores. Next, we go beyond the WSCR and test 
variants in 71 genes known to be associated with ASD (121), reasoning variation that contributes 
to autistic features in non-WS children may modify autistic features in the WS cohort as well. 
Finally, we test variants throughout the whole exome. We find no genetic variants of sufficient 
effect size to support the hypothesis that they contribute to the social phenotype in this sample of 
individuals with WS. However, we have more thoroughly described the variation in the WSCR 
region as it relates to social behavior and provide the largest genetic dataset to date of individuals 
with typical WS deletions for future analyses of other phenotypic domains.  
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2.3 Results 
2.3.1 SRS variability in Williams syndrome 
The unique social profile of Williams syndrome includes increased social motivation 
(e.g. indiscriminate approach to strangers), strong eye contact, use of affective language, 
emotional sensitivity as well as poor social judgment and restricted interests(19, 110–113, 122). 
Many comorbidities, such as specific phobias, ADHD, and anxiety, have been commonly 
reported in WS as well(21, 22, 123–125).  To quantify social features in our WS cohort, we used 
a standard instrument for assessing social reciprocity, parent-reported SRS scores from 85 
individuals with WS.  
We examined the SRS and its subscores in depth. In our sample, the SRS T-scores are 
continuously distributed in the WS population with a male mean T-score±SD of 64.58±12.28 
(mean male raw score±SD 74.53±32.03) and female mean T-score±SD of 62.94±11.04	(mean 
female raw score±SD 67.08±26.04)  (Figure 1). There is no significant difference in SRS T-
scores (t70.76=0.6365, p=0.52) or raw scores (t65.907=1.1445, p=0.257) between sexes. To 
benchmark the WS values, Constantino and Todd, 2003 measured raw SRS scores in 788 twin 
pairs from the general population ranging in ages between 7 and 15 and estimated the mean male 
raw score±SD as 35.3±22.0	 and	 the	 female	 mean	 raw	 score±SD as 27.5±18.4;	 males	 and	females	were	significantly	different.	In	our	analysis,	we	show	that	individuals	with	WS	have	SRS	scores	that	are	shifted	towards	the	more	impaired	end	of	the	spectrum,	and	we	do	not	detect	 any	 significant	 sex	 differences	 in	 WS,	 which	 has	 been	 observed	 in	 the	 general	population.		
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Our	results	largely	replicate	the	results	seen	in	Klein-Tasman	et	al.	2010.	The	overall	T-score	distribution	reveals	 that	40%	of	our	samples	 fall	 into	 the	no	clinically	significant	impairment	 range,	 followed	 by	 41.1%	 with	 mild	 to	 moderate	 deficits,	 and	 18.9%	 with	severe	deficits.	The	number	of	individuals	showing	no	clinical	signs	in	our	sample	is	higher	than	the	13.4%	observed	when	the	parents	completed	the	SRS	in	Klein-Tasman	et	al.	2010,	but	more	 similar	 to	 the	 teacher	 reported	 results	 of	 38.8%.	 The	 sub	 scores	 also	 follow	 a	similar	pattern	to	what	has	been	reported	previously	(20).	There	 is	a	significant	effect	of	sub	 scale	 on	 the	 T-scores	 (F4,420	 =	 24.759,	 p	 <	 0.001)(Figure	 1B).	 Post	 hoc	 Tukey	 all-pairwise	comparisons	show	that	social	motivation	has	significantly	better	T-scores	than	all	other	 sub	 scales,	 consistent	 with	 Klein-Tasman	 et	 al.	 2010.	 The	 social	 awareness	 and	communication	 scales	 are	 not	 different	 from	 each	 other,	 but	 both	 show	 less	 impairment	than	 social	 cognition	 and	 restricted	 and	 repetitive	 behaviors.	 	 Social	 cognition	 and	restricted	 and	 repetitive	 behaviors	 were	 significantly	 more	 impaired	 than	 all	 other	 sub	scales,	but	not	each	other.		
The	distribution	 of	 SRS	 scores	 in	WS	point	 to	 the	 possibility	 of	 additional	 genetic	variants	that	modify	the	social	phenotype.	First,	we	see	a	larger	standard	deviation	in	the	SRS	data	in	our	sample	compared	to	that	of	the	norming	population	from	Constantino	and	Todd	2003.	The	extra	variance	suggests	individuals	with	WS	are	more	sensitive	to	genetic	or	environmental	factors	that	modify	social	behavior.		Second,	in	our	sample	there	are	only	two	individuals	that	show	severe	social	motivation	deficits,	and	these	individuals	also	show	severe	deficits	in	the	total	SRS	T-score	as	well	as	all	other	sub	scales.	 	These	outliers	also	suggest	some	individuals	may	harbor	additional	rare	variants	of	large	effect	size	resulting	
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in	a	phenotype	 that	 is	more	 frankly	autistic.	To	 test	 these	 two	hypotheses,	we	generated	and	analyzed	exome	sequence	from	this	cohort	of	WS	patients.		
2.3.2	Identification of variants in the Williams syndrome critical region	
Williams syndrome individuals are hemizygous for 1.5-1.8Mbp on chromosome 7q11.23. 
Since they only have one remaining allele, our primary hypothesis was that second hits in genes 
believed to impact social phenotypes within the WSCR would produce more extreme social 
phenotypes. We performed whole exome sequencing on 85 individuals, all of whom have an 
SRS score. We called 120 variants in the remaining WSCR and annotated them with the allele 
frequency in our sample, ExAC allele frequency, mutation consequence, clinical significance as 
assessed by ClinVar, and scores that assess deleteriousness of missense variants catalogued in 
dbNSFP.  (Supplemental Table S1). Table I shows the 55 exonic variants discovered in the 
region.  For display purposes we have only included the CADD PHRED score and the MetaLR 
score, which is a composite score that incorporates information from nine other measures  of 
deleteriousness and has been shown to have more predictive power than the individual 
component scores(126).  
We first examined this set of variants to determine if any loss-of-function variants might 
be present in individuals with particularly severe SRS scores in our sample.  Upon inspection of 
the exonic variants, we notice no severe likely protein truncating variants. As homozygous nulls 
for at least two genes in this region(ELN and GTF2I) are expected to be lethal(96, 127), we also 
assessed missense mutations in these genes that might alter function. Based upon the predictions 
of MetaLR all the missense mutations called are expected to be tolerated. None of the variants 
were reported as pathogenic in ClinVar. The highest CADD scores observed are a novel variant 
and SNP rs35607697, both located in the TBL2 gene. Another novel variant was identified as a 
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synonymous change in the BAZ1B gene. Similar results are found for non-exonic variants in the 
region (Supplemental Table S1). This suggests that beyond the reduced copy number of the 
entire WSCR, neither a second rare deleterious coding variant nor any common missense 
mutations in the WSCR explain individuals with outlier SRS scores.  It should be noted that we 
did not identify any variants in GTF2I, one of the primary candidates for mediating the social 
cognitive profile.  
2.3.3 Association analyses 
 To test the hypothesis that individual variants in the WSCR can explain the variance in 
the SRS scores in our sample, we perform classic quantitative trait loci associations. Rare disease 
populations by definition will have small sample sizes such as in this study. We calculated the 
power of our current study to be able to detect variants with different effect sizes and also 
calculated the number of samples that would be needed to reach a certain power given an effect 
size (Figure 2). We calculated the power for analyzing variants in the WSCR, variants in 71 
ASD genes, and the remaining variants identified throughout the exome. Since we are 
conducting fewer tests in the WSCR, we have the most power in this analysis, however we are 
still only powered to detect very large effect sizes that might be unmasked by the hemizygosity 
of the region, such variants would need to explain more than 10% of the heritability of the trait to 
achieve 80% power. Most effect sizes for common variants in diploid regions of the genome 
typically assessed by GWAS for complex traits explain around 1% of the heritability of the 
trait(128). In order to be able to detect variants that explain 5% of the variance of the trait with 
80% power using only variants in the WSCR would require 312 individuals (Figure 2B).  
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We then performed a quantitative trait association analysis of common variants in the 
WSCR on the SRS T-scores from the whole cohort. We used PLINK to test for an association on 
each of the 34 common variants in the WSCR, defined as MAF > 0.05, which corresponds to an 
allele count of at least four in the WSCR due to the hemizygosity of the region. We adjusted for 
age, sex, and ancestry. We found no association between any SNP and SRS that survived 
multiple comparison corrections (Figure 3A). The top five SNPs are displayed in Table II. 
Interestingly, the most significant SNP, rs2074754, is located in the BAZ1B gene, which has been 
previously implicated in contributing to the cognitive phenotypes in WS (49). Furthermore, the 
next most nominally significant SNP is rs61438591, an intronic variant in the GTIF2RD1 gene, 
another gene highly implicated in the cognitive and social phenotypes seen in WS(92, 99–101).  
Since the common variants in WSCR showed no association, we wanted to test for the 
possibility that rare variants could contribute to the variability in SRS T-scores. To test this, we 
used SKAT-O, which tests all variants in the region at once and weights each variant by its 
minor allele frequency. Similarly, we included age, sex, and ancestry as covariates. We tested 
each gene in the WSCR independently, because we hypothesized only certain genes in the 
region, such as STX1A, LIMK1, CYLN2, BAZ1B, GTF2IRD1 (31, 38, 49, 96, 99, 106–109) that 
have been implicated in the cognitive phenotypes would contribute to the social phenotype rather 
than the entire region. While no gene p-value survives multiple testing corrections, the ELN gene 
has the most nominally significant p-value of 0.013   
The results of our analysis of variation in the WSCR suggest that common and rare 
variants in the remaining allele do not strongly influence social behavior in WS. This does not 
exclude the possibility that a second deleterious hit or common variation in other genes outside 
the region contributes to the variation in the SRS T-scores. To test this, we next examined 
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variation in 71 genes known to be associated with autism spectrum disorders(121). These genes 
should be enriched for loci that affect social behavior and genetic variation in these genes could 
contribute to variability seen in WS. We called 1,367 variants in the 71 genes (Supplemental 
Table S2). We annotated the variants as above, with clinical significance and measures of 
deleteriousness compiled in dbNSFP. There are 313 (22.9%) variants that had at least one 
submission to ClinVar. None of these variants had previous evidence to support pathogenicity. 
There are 33 missense variants predicted to be deleterious by MetaLR that are seen in 36 
individuals in our sample. Despite having a putatively deleterious variant the distribution of SRS 
T-scores is similar between individuals either carrying or lacking deleterious variants in these 
genes (t82.999=0.6878, p-value=0.4935). There are seven variants that should result in a truncated 
protein, one stop gain in the USP45 gene and six frameshift mutations. Only one sample 
harboring one of these mutations has a severe SRS T-score of 77. All of these protein-truncating 
mutations are also observed in the ExAC cohort.  
We next tested for associations of each of the 381 common variants (MAF> 0.05) in 
these genes. No SNP was significant after multiple testing corrections (Figure 3B). The top five 
SNPs are located in Table II. Since each of these genes has been associated with ASD, we 
hypothesized that rare and common variants in each of the genes could contribute to SRS. We 
performed SKAT-O on the variants located in the autosomal ASD genes altogether, which also 
showed that there is little evidence to support variants in these 68 ASD genes have a strong 
effect on SRS T-scores, p=0.431 
While it would be underpowered for any but the largest effect sizes (Figure 2A), for 
thoroughness we did an unbiased scan of the whole exome. We also examined the polygenic 
contribution of common variants to the SRS. The common variant analysis was performed on 
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66,620 variants (Figure 3C). The most nominally significant single SNP is rs527221 located in 
the DMPK gene, which is responsible for causing type 1 myotonic dystrophy (129) (Table II). 
While there is suggestive evidence for single variants such as rs527221, we calculated the 
polygenic risk scores (PRS) for each of the individuals in our sample to test if exome wide there 
are many SNPs of small effect that contribute to the social phenotype in WS. We used the 
summary statistics from the most recent PGC GWAS on autism spectrum disorders to calculate 
the PRS for our sample(130). We reasoned the polygenic risk of autism would be correlated with 
the SRS because this is a questionnaire used to assess behaviors that are affected by autism. 
Variants from the PGC GWAS were included if the p-value for the variant was under the 
threshold determined by the high resolution screen in the PRSice software(131). Interestingly, 
only the PRS for the motivation sub score was nominally significant (p=0.033), but after 
permutation to determine an empirical p-value it was not significant (p=0.308). The correlations 
of the PRS for each of the samples and the sub score as well as total SRS are shown in 
supplemental figure 1. Counterintuitively, there is a negative correlation between the PRS and 
motivation sub score. While this is the largest correlation between the PGS and sub scores it 
implies that more genetic risk for autism leads to a lower and less impaired social motivation T-
score. However, given the small sample size and small number of SNPs available from whole 
exome sequencing compared to whole genome genotyping we are wary of making strong 
conclusions from this analysis.  
We and others (20) have shown that individual sub scores of the SRS  are affected 
differently by the deletion of the WSCR. Therefore, we wanted to rule out the possibility that 
variants are indeed affecting specific sub scales of social behavior, but that testing the total SRS 
score is masking those effects. Thus, in an exploratory manner, we repeated the quantitative trait 
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loci associations for each of the sub scores of the SRS using the variants in the WSCR, 71 ASD 
genes, and the remaining whole exome variants. Since the sample size is small we conducted 
these associations for exploratory and hypothesis generating purposes. The top five SNPs from 
each association are reported in supplemental tables 3-5. For each of the analyses we see similar 
variants showing the highest association as were associated with the total SRS, likely due to the 
high correlation between the SRS and the sub scores (Supplemental Figure 2). Thus, an 
analysis of the total SRS was not masking independent genetic effects on each sub scale. 
2.4 Discussion 
 Phenotypic variability has been appreciated in many of the symptom domains of WS 
including the cardiovascular phenotypes, the unique cognitive profile, and in social 
behavior(132–134). Here, we have described the variability of reciprocal social behavior in a 
sample of 85 individuals with the typical WS deletion using the SRS-2. Our results replicate the 
findings of Klein-Tasman et al. 2010, revealing that overall individuals with WS have SRS 
scores that are shifted to the more socially impaired end of the distribution, with most problems 
relating to the social cognition and restricted and repetitive behavior sub scales of the SRS while 
social motivation is spared. 
 We also note that sex differences in the general population have been reported 
previously in the literature for SRS. These sex differences were not consistent with different 
genetic factors contributing to the SRS in boy and girls, but due to discrepant effects of common 
genetic and environmental factors on SRS, such as differences in sensitivity to environmental 
factors or the X-inactivation phenomenon (119). However, we do not see evidence of sex effects 
in our sample of individuals with WS. The magnitude of the difference between males and 
females in our sample is similar to what was reported in the general population, so our lack of a 
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significant finding could be due to our small sample size. The standard deviation of the SRS is 
large in both the general population and still larger in the WS population, so it may also be that 
larger sample sizes are needed to overcome the considerable variance in the data. The fact that 
the WS population has a larger standard deviation could also suggest that individuals with the 
deletion are sensitized to other factors that contribute to variation in the SRS such as background 
genetic variation or environmental factors.  
We performed whole exome sequencing on our sample of 85 individuals to test for 
additional genetic contributions to the variability seen in social behavior in individuals with WS. 
We used the identified variants to test the hypothesis that genetic variation in the remaining 
WSCR allele can explain some of the variability in SRS T-scores. Genes in this region have a 
dosage sensitive effect on social behavior evidenced from the contrasting social phenotypes of 
the WS deletion and the reciprocal duplication, suggesting that variants in the remaining WSCR 
allele that affect expression or function of the genes could further contribute to the social 
phenotype(13). We called 120 variants in the WSCR with 55 variants being exonic. We used 
evidence such as the amino acid change, clinical significance suggested by the ClinVar database, 
and multiple algorithms to predict the consequences of the variants. Within the WSCR we do not 
find any variants that cause protein truncation. None of the missense variants are predicted to be 
deleterious based on the MetaLR composite score. Of the nine variants that have been submitted 
to ClinVar, all were described as benign or likely benign. A quantitative trait association analysis 
using the common variants in the region resulted in no SNP that survived multiple testing 
corrections. The most significant SNP, rs2074754, is a synonymous SNP in the BAZ1B gene. 
This gene encodes for a protein product in the bromodomain protein family that modifies 
chromatin to affect transcription and has been implicated in the cognitive phenotypes in WS. 
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Knocking down this gene in human derived induced pluripotent stem cells upregulates genes 
involved in mitosis as well as downregulating genes that are involved in the development of the 
nervous system(49) The second most nominally significant SNP, rs61438591, is an intronic 
variant in GTF2IRD1, which encodes for a transcription factor that has been suggested to 
contribute to the cognitive and social behavior deficits (38, 39, 49, 92, 100, 101).  If future 
studies with increased power replicate this association, it would suggest that noncoding variation, 
perhaps controlling the expression of this gene, might contribute to variation is social behavior.  
We also tested the association of all variants in the WSCR using SKAT-O. This test indicated no 
variants with sufficient effect size were detected in the WSCR.  
While we have not shown evidence that variants in the remaining WSCR contribute to 
the social phenotype in WS, we cannot conclusively discard this hypothesis. However, our study 
does clearly indicate that the alleles genotyped here are either not causative or exert too small an 
effect size on SRS for our current power (Figure 2), but it does not rule out variants of small 
effect on social behavior in the region. Research on other copy number variants associated with 
ASDs showed that larger CNVs tended to have genes of smaller individual effect size and 
suggests the phenotype of the overall CNV is due to the cumulative effect of each of those 
genes(121). Further we did not detect any variants in the gene GTF2I, which has been highly 
suspected of contributing to the social behaviors in WS(31, 38, 53, 90, 96). The lack of variant 
calls in our sample could be due to the fact that GTF2I is under stringent purifying selection. 
Indeed, looking at the ExAC data covering this gene, they show that there are fewer missense 
variants than expected by chance. ExAC discovered 62 synonymous and 56 missense mutations 
in 60,706 people(135). In our sample of 85 individuals we would expect to see variants in ExAC 
that have an allele frequency of greater than 0.0059, which is an allele count of one in our 
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sample. There are ten variants with an allele frequency greater than 0.0059 detected in ExAC, 
only three of which are exonic. Thus, we would need a much larger sample size to investigate 
coding variants in GTF2I. The two linked variants in GTF2I that have previously been associated 
with oxytocin responsiveness and amygdala reactivity, rs1322743 and rs4717907, are intronic 
and were not covered in our sequencing(51, 118).  
  We further used the genetic data to investigate the role of variation in 71 genes that have 
been associated with ASD. WS and ASD do show phenotypic overlap(114, 136), and we 
reasoned that these genes should be enriched for functional roles in social behaviors. Likewise, 
the presence of outlier scores on the SRS that indicated severe impairment, suggested there could 
be possible second deleterious hits on top of the WS deletion in our dataset. Second hits are 
expected to be rare but have been observed in WS to explain a case of a child with comorbid 
seizures(54).  Inspecting the 1,367 variants discovered in the ASD genes, 313 variants have been 
previously submitted to ClinVar, none of which show evidence for any pathogenicity. We 
observed seven protein-truncating mutations that do not associate with severe SRS T-scores. 
Several missense mutations were predicted to be deleterious, but there was no association 
between individuals that had a putative deleterious variant and a more impaired SRS score. 
Testing the common and rare variants in these genes showed no associations with the social 
phenotype.  Similar results were found when we performed the association analyses on all of the 
variants discovered in the cohort. The most significant SNP was rs527221, a nonsynonymous 
variant in the DMPK gene, which is responsible for causing type 1 myotonic dystrophy, severe 
childhood forms of which have been associated with ASD(137). We also tested if polygenic risk 
for increased ASD liability is associated with the SRS T-score and sub scores. This boosts our 
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ability to detect the impact of many loci with small effects. The largest correlation was between 
the PRS and the social motivation sub score, although this was not significant.  
WS seems to affect specific domains of social behavior as evidenced by significant 
differences between the sub scores of the SRS. This observation led us to an exploratory 
examination of associations with the sub scores of the SRS and test if different genetic variants 
contribute to each sub score. Overall using variants from the WSCR, ASD genes, or the whole 
exome identified the same variants as nominally significant. The SRS and the sub scores are very 
correlated, but the social motivation in the WS sample is the least correlated to all other scores. 
This reflects that fact that social motivation tends to be rated within the normal range in WS, 
while the other scores are often higher. Interestingly, the whole exome association on the 
motivation T score leads to the lowest FDR values compared to the other scores, suggesting that 
there may be more genetic signal when using this sub scale. Indeed, this decoupling of the social 
motivation subscale from other SRS items highlights the possibility that the social motivation 
subscale might provide useful clinical information going forward; individuals carrying the 
WSCR deletion yet not showing a spared social motivation might warrant a deeper examination 
for additional factors impacting their presentation. 
There are several limitations to our current study that should be addressed in future 
research. First the current study genotyped and assessed only the probands and not their parents. 
Having genetic information from trios would allow us to distinguish between variants that are 
inherited or de novo, which would aid in interpretation and prioritization of variants. Further, 
being able to compare the SRS score of the individual with WS to biparental SRS mean would 
let us control for effects of background genetic variation(120). Second, we are limited to 
investigating exonic variation. While interpretation of exonic variants is more straightforward 
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because they potentially disrupt coding sequences, and can aid in the detection of deleterious rare 
variants, we could be missing important regulatory information that is located in promoters or 
introns of genes. Third, we were not able to control for intellectual functioning of the individuals 
with WS. The SRS has been reported to not correlate with intellectual functioning(138), but 
Klein-Tasman et al. 2010 found significant negative correlations between intellectual functioning 
and the total SRS T-score when parents completed the report, but not when teachers completed 
the report. SRS values have been shown to be dependent on levels of expressive language, 
nonverbal IQ, and behavioral problems. A subset of SRS questions was selected to ameliorate 
these dependences(139). The short form of the SRS as well as other questionnaires that assess 
adaptive skills and social behaviors could be used in the future to provide supporting information 
about the social phenotype and underlying genetics in WS. Finally, while our study represents 
the largest single collection of WS samples reported to date, it is only powered to detect strong 
effects of common variants due to our small sample size. This is challenging to overcome due to 
the low prevalence of WS.  
In conclusion, we have tested the hypothesis that variation in the remaining WSCR allele 
affects the social phenotype of individuals with WS, by applying whole exome sequencing to a 
sample of 85 individuals with typical WS deletions. We show that common and rare variants in 
the region do not associate with SRS T-scores in our sample. Further, we show that variation 
outside of the region does not account for the social variability. This is not to say that genetic 
variation does not play a significant role in phenotypic variability in WS, but that it will require 
larger sample size to detect. In the future, applying whole genome sequencing to a sample of 
individuals with WS might elucidate the roles of genetic variation in the regulatory elements. 
Whole genome data could also allow for more accurate breakpoint determination. Redundant 
 
 
49 
sequences in the low copy number repeat areas at either end of the WS deletion prevent accurate 
end point detection by CMA.  This will be an interesting avenue to pursue in order to investigate 
how deletion size variation among individuals with typical 1.5 to 1.8 MB deletions contributes to 
social behavior.  For example, Porter et al. showed that those with larger (1.8Mb deletions) had 
decreased executive functions(41). It is also worth noting that the current genetic data set has 
additional clinical data available, which can be queried in the future for the presence of more 
substantial associations with other WS related phenotypes.  
2.5 Materials and Methods 
Ethical Compliance and samples 
This study was conducted with approval of the IRBs at Washington University School of 
Medicine and the National Institutes of Health.  Consent was obtained prior to inclusion in the 
study.  Once enrolled, participants provided a DNA sample by blood or saliva and their care-
givers filled out health related questionnaires.  The 85 individuals that make up our sample have 
ages that range from 2.5 to 65.5 years with a mean of 16.1 years. Caregivers provided a self-
reported ethnicity. The majority of the sample was reported as white (77 individuals). There are 
two individuals that are African American, three Chinese, and three others.  
Confirmation of diagnosis 
WS diagnosis and typical deletion size was confirmed using either chromosomal microarray or 
quantitative PCR.  In some cases, clinical microarray results were derived from the medical 
record.  Array type varied by individual.  For the remaining individuals, some received a 
research array (Cytoscan HD, Applied Biosystems) with analysis using the accompanying ChAS 
software.  Others underwent deletion size assessment using quantitative PCR for genes within 
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and outside of the Williams region using Taqman copy number probes (Thermo-Fisher, AUTS2: 
Hs04984177_cn, CALN1: Hs04946916_cn, FZD9: Hs03649975_cn, CLIP2: Hs00899301_cn, 
HIP1: Hs00052426_cn, POM121C: Hs07529820_cn).  Copy number analysis was done 
according to the manufacturer’s instructions and output data analyzed using their Copy Caller 
software.  All individuals were confirmed to have deletions that included the WSCR genes ELN, 
FZD9 and CLIP2, but did not include genes external to the typical deletion such as CALN, 
AUTS2, POM121C or HIP1 (data not shown).  
Social Responsiveness Scale 
The social responsiveness scale-2 (SRS) is a 65-item questionnaire that measures aspects of 
social interaction that make up the core symptoms of autism spectrum disorders. The output is a 
total raw score as well as a T-score that is adjusted for sex, age, and the relationship of the 
reporter to the proband. The total score is made up of the scores of five subcategories that are 
impaired in ASDs: social awareness (AWR), social cognition (COG), social motivation (MOT), 
social communication (COM), and behaviors typical of autism such as restricted interests and 
repetitive behaviors (RRB). The response to each question ranges from 1 (not true) to 4 (almost 
always true). The T-scores are binned into four groups: normal < 59, mild between 60 and 65, 
moderate between 66 and 75, and severe > 76. For this study, the age-specific (pre-school, 
school age, or adult) SRS-2 was completed by the participant’s caregiver and analyzed as a T-
score that is adjusted for sex, age, and the relationship of the reporter. We provide values from 
the general population that have been previously reported for comparison (119, 138). 
Sequencing and Variant calling 
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Whole exome sequencing and alignment was performed at Washington University in St. Louis 
by the McDonnell Genome Institute on 85 DNA samples from individuals with WS. Exomes 
were captured using Nimblegen SeqCap EZ Choice HGSC Library version 2.1, which targets 
45.1 Mbp covering 23,585 genes and 189,028 non-overlapping exons. Exomes were aligned to 
the GRCh37-lite genome using bwa  –mem v0.7.10(140) default settings, samtools v0.1.19(141) 
was used to assign mate pairings, sort, and index the bam files. Duplicates were marked using 
Picard MarkDuplicates v1.113.  
Variant calling was done following GATK best practices on the aligned exomes (142). Briefly, 
using GATK v3.6.0 indels were realigned and the base quality scores recalibrated. Variants were 
initially called per sample using the haplotype caller tool, followed by jointly calling variants. To 
improve variant calls, we recalibrated variants and used a truth sensitivity tranche of 97 for 
SNPs, and a truth sensitivity tranche of 94 for indels. These thresholds were chosen to maximize 
the number of known and novel variants while still being stringent enough to limit the number of 
false positive variant calls. To further filter the variants we used the VariantFiltration tool to 
filter variant sites that had lower than a 10x average coverage or an inbreeding coefficient less 
than -0.20 to remove sites with excess heterozygosity. Genotype calls were filtered and 
considered to be missing if they had a genotype quality score of less than 20, which refers to a 
99% probability that the call is correct. Finally, using vcftools v0.1.14(143), we removed sites 
that had a genotype missing rate of greater than 10%, as well as sites that no longer showed any 
variation. This produced a call set of 202,820 variant sites. The final call set has a Ti/Tv ratio of 
2.76 and a dbSNP rate of 88.5%. These metrics are consistent with quality variant calls and a low 
false positive rate.  
Variant annotation 
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The variant call set was split into three groups using vcftools: 1) variants in the Williams 
syndrome critical region (WSCR) defined by hg19 coordinates chr7:72,395,660-74,267,841 2) 
variants located in 71 genes associated with ASD(121), and 3) the remaining non-overlapping 
variants. All sets include exonic variants as well as variants located in introns that are pulled 
down by the capture reagents.  Bcftools v1.2(141) was used to split multiallelic sites into 
separate lines for each allele and left normalized so positions would be compatible with 
ANNOVAR annotation files version 2016-02-01(144). The ANNOVAR table_annovar.pl 
function was used to annotate all three variant call sets with the RefSeq gene annotation, variant 
consequence, ExAC allele frequency(135), sample specific allele frequency, dbsnp147 name, 
clinical significance assessed by ClinVar(145). Missense variants were also annotated with 
measures of deleteriousness compiled in dbNSFPv3.3a(146). We highlight the CADD PHRED 
score and MetaLR as two measures of variant deleteriousness. CADD scores are defined at each 
base in the genome and for every possible single nucleotide change(147). CADD scores compare 
65 annotations, including functional data as well as conservation scores, between fixed human 
derived alleles and simulated variants. Deleterious variants should be depleted in the observed 
fixed alleles and not in the simulated variants. CADD PHRED scores represent the relative rank 
of a CADD score compared to all other possible allele CADD scores; a CADD score of 10 
means this allele is ranked as the top 10% of all possible CADD scores. Larger CADD PHRED 
score indicates an increased predication of deleteriousness. MetaLR uses logistic regression to 
incorporate information from 9 other variant annotations that consider function as well as 
conservation(126). The model was trained on true deleterious variants and true neutral variants 
described in the Uniprot database. The composite MetaLR score was found to have greater 
predictive ability than any of the single scores that make up MetaLR.    
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Power Analysis  
We performed a power analysis to provide the limits of genetic effects that we would be able to 
detect given our cohort size. For future studies we also calculate the sample sizes that would be 
needed to detect different magnitudes of genetic effects. We used the Genetic Power Calculator 
(148). We calculated the predicted power of the current sample size n=85 using a p-value 
threshold corresponding to the Bonferroni corrected alpha for each set of analyses (WSCR 34 
variants, alpha=0.00147, ASD 381 variants, alpha=0.000131, WEX 66620 variants, 
alpha=7.5x10-7. Our main hypothesis is variants on the remaining WSCR allele affect the social 
phenotype; we wanted to calculate the sample sizes that would be required to detect different 
size genetic effects in the WSCR at different levels of power. We again used the alpha threshold 
based on the 34 common variants we identified in the exons of the WSCR and report the sample 
size required to achieve a specific power.  
Association analyses 
Common variant analysis 
The variant call files were converted to plink binary bed format using the GATK tool 
VariantToBinaryPed. We used PLINK v1.9(149) --linear option to conduct a quantitative trait 
association using the SRS T-score as the quantitative trait. Ancestry was controlled for by 
including the first four principle components, determined by the --pca function in PLINK, as 
covariates along with sex and age. We used alleles that had a minor allele frequency (MAF) of 
0.05 or greater. We performed the association analyses on the three separate groups of variants 
described in the previous section. It should be noted that allele frequency in the Williams 
syndrome critical region is inflated because of the hemizygous state of the region in individuals 
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with WS. A MAF of 0.05 in this region corresponds to an allele count of four. In all cases we 
report the effect size of a variant under an additive model. Though the small sample size of this 
study limits power, in an exploratory fashion we also performed the same quantitative trait 
analysis on each of the sub scores of the SRS using variants in the WSCR, ASD genes, and the 
whole exome.  
SKAT-O 
SKAT-O (150)was implemented in the R v3.1.3 environment. SKAT-O fits a multiple linear 
regression of all SNPs located in a user provided region. The framework in SKAT-O allows for 
correlation between SNPs in a region, where if all SNPs are perfectly correlated this would 
become a burden test, but also allows SNPs in the same region to have effects in opposite 
directions. Significance is assessed by region rather than by SNP. We considered each gene that 
harbors a variant in the WSCR as a separate region for a total of 26 regions. To test for an overall 
effect of variants in the ASD genes we collapsed the 61 autosomal genes into one region.  We 
used the beta function shape parameters (1,50) to put more weight on SNPs that have lower 
minor allele frequency, reasoning that rare causal alleles potentially have a greater effect size. 
We again controlled for age, sex, and the first four principal components.  
Polygenic Risk Score 
Polygenic Risk Scores (PRS) can be used to test if there is a contribution of many loci of small 
effect on the phenotype of interest by summing the effects of variants that may have not reached 
genome-wide significance. For a discovery set, we used the publically available summary 
statistics from the most recent Psychiatric Genome Consortium genome wide association study 
(GWAS) of autism spectrum disorder (130), reasoning that genetic risk for autism would 
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contribute to SRS scores. The best-fit PRS was determined using the high-resolution 
functionality in the PRSice software(131). All of the variants identified throughout the exome 
with a MAF >0.05 and that are also present the in the discovery set were used to calculate the 
PRS. Sex, age, and the first four PCs were included as covariates. After clumping there were a 
total of 23,191 variants used to calculate the PRS.  PRSice was used to calculate the significance 
of the PRS at the best-fit p-value threshold using 10000 permutation to determine an empirical p-
value. PRS for each of the samples was calculated for the total SRS T-score as well as the sub 
scores.  
Other statistical analyses 
All remaining statistical tests were done in the R v3.1.3 environment. Two sample t-tests were 
used to compare the means of two groups. ANOVA was used to test differences in mean of sub 
scales of SRS. TukeyHSD post hoc comparison was performed using the multcomp package. 
The qqman(151) package was used to generate manhattan and qq plots.  
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2.7 Figures 
  
Figure 1: Distribution of Social Responsiveness in 85 individuals with typical WS deletion. A Distribution of 
the raw SRS scores B Severity bins of SRS and subcategory scores.  
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Figure 2: Power analysis. AThe power to detect variants of different effect sizes for the current study. The alpha 
for the three different sets of analyses was determined by using the Bonferroni correction based on the number of 
SNPs tested in each analysis. (WSCR: variants in the WSCR, ASD: variants in the 71 ASD genes, WEX: all 
remaining variants exome wide). B The predicted sample sizes that would be required to achieve different levels of 
power for detecting variants of different effect sizes. The sample size predictions were only done using the alpha for 
the number of SNPs tested in the WSCR. The horizontal dashed line indicates the sample size of the current study.  
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Figure 3: Variants in the WSCR, ASD genes, or whole exome do not contribute to SRS variability in a sample 
of WS with typical deletions. A qq plot showing distribution of p-values for common variants in the WSCR. Locus 
zoom plot showing the SNPs tested in the WSCR, highlighting the most nominally significant SNP in BAZ1B. B qq 
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and manhattan plot for variants called in 71 genes associate with ASD from Sanders et al. 2015. C qq and manhattan 
plot for variants exome wide. Blue line demarcates a suggestive p value threshold of 1x10-5. 
 
 
 
60 
 
Supplemental Figure 1: Polygenic Risk Score correlation with SRS and SRS subscores. A-F Panels show the 
correlation between the polygenic risk score (PRS) for the sub scores of the SRS calculated using variants from the 
PGC ASD GWAS that fall below the p-value threshold calculated from the best-fit PRS. Pearson correlation values 
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between the samples PRS and the SRS subscore shown as the inset. 
 
Supplemental Figure 2: SRS and sub scales are correlated. Heatmap display of the Pearson correlation values of 
the SRS and sub scale T-scores in 85 individuals with WS. Values of the correlation are labeled in the plot.  
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Table 1: Annotation of 55 exonic variants discovered in the WSCR 
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Table 2: Top five SNPs from quantitative trait locus associations  
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Supplemental Table S1: Annotation of 120 variants discovered in the Williams syndrome critical region 
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Supplemental Table S2: Genetic variants in 71 genes associated with autism spectrum 
disorder
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 Supplemental Table S3: Top 5 SNPs for each SRS subscore for variants in the Williams syndrome Critical 
Region
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Supplemental Table S4: Top 5 SNPs for each SRS subscore for variants in 71 genes associated with Autism 
spectrum disorder 
 
 
 
Supplemental Table S5: Top 5 SNPs for each SRS subscore for variants discovered across the whole exome 
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Chapter 3: The effects of Gtf2ird1 and Gtf2i 
DNA binding on transcription and behavior 
supports the important function of the N-
terminal end of Gtf2ird1.  
 
Nathan Kopp, Katherine McCullough, Susan E. Maloney, Joseph Dougherty 
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3.1 Abstract  
The two transcription factors Gtf2i and Gtf2ird1 have been thought to play a role in the 
craniofacial, cognitive, and behavioral phenotypic domains of WS. There exist many mouse 
models of each of these transcription factors that show behavioral phenotypes. Further, some 
phenotypes such as balance, anxiety, and social behavior, mouse models of both transcription 
factors show deficits in the same direction, however the affect of these genes on behavior have 
not been studied in combination. To examine how these genes could mediate behavioral 
consequences we described the genomic binding sites of these transcription factors in the 
developing brain. We then characterized two new mouse models generated using the 
CRISPR/Cas9 system to test how mutating both Gtf2i and Gtf2ird1 can modify the 
transcriptional and behavioral phenotype observed in a single Gtf2ird1 mutant.  The Gtf2ird1 
mutant was shown to make a N-truncated protein that has decreased capacity to bind the 
promoter of Gtf2ird1 but still can bind genome-wide. Despite little differences in DNA-binding 
and transcriptome-wide expression, the mutation still caused balance, marble burying, and 
activity phenotypes, supporting a functional role for the N-terminus of Gtf2ird1. Mutating both 
Gtf2i and Gtf2ird1 did not modify the transcriptomic or behavioral phenotypes, suggesting that 
Gtf2ird1 mutation largely drives the behavioral phenotypes observed. 
3.2 Introduction 
The Williams syndrome critical region (WSCR) contains 26 genes that are typically 
deleted in Williams syndrome (WS) (OMIM#194050). The genes in this region are of interest for 
their potential to contribute to the unique physical, cognitive, and behavioral phenotypes of WS, 
which include craniofacial dysmorphology, mild to severe intellectual disability, poor visual 
spatial cognition, balance and coordination problems, and a characteristic hypersocial personality 
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(2,	13,	15).  Single gene knock out mouse models exist for many of the genes in the region, with 
differing degrees of face validity to the phenotypes of WS (92–96, 101). Two genes have been 
highlighted in the human and mouse literature as playing a large role in the social and cognitive 
tasks, Gtf2i and Gtf2ird1. Mouse models of each gene have shown social phenotypes as well as 
balance and anxiety phenotypes (92,	96,	97,	101,	152,	153). Since there is evidence that each 
gene affects similar behaviors, we set out to test the hypothesis that that knocking down both 
genes simultaneously would lead to more severe phenotypes, suggesting that multiple genes in 
the WSCR locus affect similar behaviors. Investigating both genes together, rather than 
individually could provide a more complete understanding of how the genes in the WSCR 
contribute to the phenotypes of WS.  
 Gtf2i and Gtf2ird1 are part of the General transcription factor 2i family of genes. A third 
member Gtf2ird2 is located in the WSCR that is variably deleted in patients with WS that have 
larger deletions(41). This gene family has arisen from gene duplication events, which resulted in 
high sequence homology between the genes (68). The defining feature of this gene family is the 
presence of the helix-loop-helix I repeats, which are involved in DNA and protein binding (154). 
Gtf2i has roles that include regulating transcriptional activity in the nucleus, but this 
multifunctional transcription factor also resides in the cytoplasm where it conveys messages 
from extracellular stimuli and regulates calcium entry into the cell (74, 76). So far, Gtf2ird1 has 
only been described in the nucleus of cells and is thought to regulate transcription and associate 
with chromatin modifiers (79). The DNA binding of these two transcription factors has been 
studied in ES cells and embryonic craniofacial tissue. They recognize similar and disparate 
genomic loci, suggesting that both genes interact to regulate specific regions of the genome (84, 
155). However, the DNA binding of these genes has not been studied in the developing brain, 
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which could provide insight on how the general transcription factor 2i family contributes to 
cognitive and behavioral phenotypes. 
We performed ChIP-seq on Gtf2i and Gtf2ird1 in the developing mouse brain to define 
where these genes bind and also to test the downstream consequences of disrupting the binding. 
We used the CRISPR/Cas9 system to make a mouse model with a mutation in just Gtf2ird1 and 
a mouse model with mutations in both Gtf2i and Gtf2ird1 to test how adding a Gtf2i mutation 
modifies the affects of Gtf2ird1 mutation. We showed that the mutation in Gtf2ird1 resulted in 
the production of an N-truncated protein that disrupts the binding of Gtf2ird1 at the Gtf2ird1 
promoter and deregulates the transcription of Gtf2ird1. While there are mild consequences of the 
mutation on transcription genome-wide the mutant mouse exhibited clear balance and marble 
burying deficits, as well as increased activity. Comparing the single gene mutant to the double 
mutant did not reveal more severe transcriptional changes or behavioral phenotypes. This 
suggests that Gtf2ird1 drives the majority of the phenotypes observed in the current studies, and 
the N-terminal end of this protein has functional consequences on DNA-binding and behavior.  
3.3 Results 
3.3.1 Gtf2i and Gtf2ird1 bind at active promoters and 
conserved sites 
The paralogous transcription factors, Gtf2i and Gtf2ird1, have been implicated in the 
craniofacial and behavioral phenotypes seen in humans with WS as well as mouse models (38, 
96, 97, 100, 101, 153). However, the underlying mechanisms by which the general transcription 
factor 2i family acts are not well understood. One approach to begin to identify how these 
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transcription factors can regulate phenotypes is by identifying where they bind in the genome. 
This has been done in ES cells and embryonic facial tissue and revealed that both of these 
transcription factors bind to genes involved in craniofacial development (84). However, these are 
not relevant tissues that could explain their affects on brain development and subsequent 
behavior. To overcome this we performed ChIP-seq for Gtf2ird1 and Gtf2i in the developing 
embryonic day 13.5 (E13.5) brain, a time point when both of these proteins are highly expressed.  
We identified 1,410 peaks that were enriched in the Gtf2ird1 IP samples compared to the 
input. The Gtf2ird1 bound regions were strikingly enriched in the promoter of genes and along 
the gene body, more so than would be expected by randomly sampling the genome (Figure 1A) 
(χ2 = 1537.8, d.f. =7, p < 2.2x10-16). The bound peaks were found mostly in H3K4me3 bound 
regions (Fisher’s exact test, p<2.2x10-16), suggesting that they are in active sites in the genome. 
While the Gtf2ird1 bound regions were also enriched in repressed regions of the genome as 
defined by H3K27me3 marks (Fisher’s exact test, p< 2.2x10-16), 94% of the peaks were in 
H3K4me3 regions opposed to the 11% of Gtf2ird1 peaks found in H3K27me3 regions (Figure 
1B), suggesting the Gtf2ird1 may have more of a role in activation than repression. 
 To understand the common function of the genes that have Gtf2ird1 bound at the 
promoter we performed GO analysis. The top ten results were consistent with the functions 
previously described for Gtf2ird1, specifically regulation of transcription and chromatin 
organization, and we highlighted new categories, such as protein ubiquination (Figure 1C). To 
further test if these regions have functional consequences we compared the conservation of the 
Gtf2ird1 peaks to a random sample of the genome and found that the Gtf2ird1 peaks are more 
conserved (t=18.131,d.f.=2403, p < 2x10-16) (Figure 1D). We conducted motif enrichment 
analysis using HOMER to identify other factors that share binding sites with Gtf2ird1 (Figure 
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1E). The GSC motif, which is similar to the core RGATTR motif for Gtf2i and Gtf2ird1, was 
identified in 4.64% of the targets (65). Interestingly, the CTCF motif was found at 11% of the 
Gtf2ird1 targets, further supporting its role in chromatin organization.   
 Gtf2i Chip-seq showed similar results to that of Gtf2ird1. We identified 1,755 WT Gtf2i 
peaks that had significantly higher coverage in the WT IP compared to the KO IP 
(Supplemental Figure 1A). These peaks were significantly enriched for promoter regions as 
well as the gene body when compared to random genomic targets (Figure 2A)(χ2 = 911.63, 
d.f.=7, p < 2.2x10-16). Similar to Gtf2ird1, the majority of the Gtf2i peaks  (78.7%) overlapped 
H3K4me3 peaks (Fisher’s exact test, p< 2.2x10-16), with a smaller subset of peaks (20.7%) 
overlapping with the H3K27me3 mark (Fisher’s exact test p<2.2x10-16). This suggests that these 
peaks are located mainly in active regions of the genome (Figure 2B). Summarizing the 
common functions of these target genes by GO analysis, showed enrichment for biological 
processes such as intracellular signal transduction and phosphorylation (Figure 2C).  For 
example, Gtf2i binds within the gene body of the Src gene (Figure 2D), which has been shown 
to phosphorylate Gtf2i itself to activate its transcriptional activity as well as regulate calcium 
entry into the cell (74, 76). Along with binding to gene promoters, the Gtf2i binding sites are 
significantly more conserved than random sampling the genome, further suggesting important 
functional roles of these regions (Figure 2E). Motif enrichment of the Gtf2i peaks revealed GC 
rich binding motifs such as for the KLF/SP family of transcription factors. Interestingly, the Lhx 
family of transcription factors motif is enriched. Finally, we see an enrichment of the CTCF 
motif, which Gtf2i has been shown to help target CTCF to specific genomic regions (156) 
(Figure 2F).  
 
 
91 
3.3.2 Gtf2i and Gtf2ird1 binding sites have distinct features yet overlap at a 
subset of promoters  
One way in which Gtf2i and Gtf2ird1 can interact is by binding the same sites in the 
genome. We set out to determine how the binding regions of these two genes were similar or 
different, as well as directly scanning for shared targets. First, we compared the Gtf2i and 
Gtf2ird1 chip peaks and found that the proportion of annotations of the binding sites are 
significantly different (χ2 = 282.84, d.f.=7, p < 2.2x10-16) (Figure 3A). While both transcription 
factors mainly bind in promoters and the gene body, Gtf2ird1 has a higher proportion of peaks at 
the promoter compared to Gtf2i, whereas Gtf2i has more peaks that fall in intergenic regions 
when compared to Gtf2ird1. Interestingly, when we compared them directly to each other the 
Gtf2ird1 bound peaks were significantly more conserved than the Gtf2i bound peaks 
(t=7.81,d.f.=2736.5, p=8.2x10-15) (Figure 3B). Next, to identify common targets, we looked at 
the overlap of the genes that had either of the transcription factors at their promoter, and we 
identified a significant overlap of 148 genes (Fisher’s exact test p < 1x10-38) (Figure 3C). The 
GO functions of the overlapped genes highlight specific roles in synaptic functioning and signal 
transduction (Figure 3D). The Mapk14 gene is an example of a gene involved in signal 
transduction that has both Gtf2i and Gtf2ird1 bound at its promoter (Figure 3E). Interestingly, 
Mapk14 is known to phosphorylate Baz1b (157), another transcription factor in the WSCR. 
Shared targets such as this one suggest there are points of convergence where having both genes 
deleted, such as in WS, might result in synergistic downstream impacts, and further implicates 
another gene in the WSCR.  
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3.3.3 Frameshift mutation in Gtf2ird1 results in truncated protein and affects 
DNA binding at the Gtf2ird1 promoter 
To investigate the functional role of Gtf2ird1 and Gtf2i at these bound sites and 
understand how these two genes interact, we set out to make loss of function models of Gtf2ird1 
individually and a double mutant with mutations in both Gtf2i and Gtf2ird1. We designed two 
gRNAs, one for Gtf2ird1 and one for Gtf2i, and injected them simultaneously into FVB mouse 
embryos, to obtain single gene mutations, as well as double gene mutations. We first 
characterized the consequences of a one base pair adenine insertion in exon three of Gtf2ird1. 
This is an early constitutively expressed exon, and the frameshift mutation introduced a 
premature stop codon in exon three, which we expected to trigger nonsense-mediated decay 
(Figure 4A). We crossed heterozygous mutant animals to analyze Gtf2i and Gtf2ird1 transcript 
and protein abundance in heterozygous and homozygous mutants compared to WT littermates 
(Figure 4B).  The western blots and qPCR were performed using the whole brain at embryonic 
day 13.5 (E13.5). As expected, the Gtf2ird1 mutation did not affect the protein or transcript 
levels of Gtf2i (Figure 4C,D). Contrary to our prediction that the frameshift mutation would 
cause nonsense-mediated decay, we observed an ~0.8 CT increase in Gtf2ird1 transcript with 
each copy of the mutation and a 40% reduction of the protein in homozygous mutants compared 
to WT with no significant difference between the WT and heterozygous mutants (Figure 4E, F).  
This suggests that the mutation did have an effect on protein abundance and disrupted the normal 
transcriptional regulation of the gene.  
Similar results were reported in a mouse model that deleted exon two of Gtf2ird1, which 
showed reduced levels of an N-terminally truncated protein caused by a translation re-initiation 
event at methionine-65 (66). We noticed a slight shift in the homozygous mutant band, which 
may correspond to the loss of the N-terminal end of the protein. The N-terminal end codes for a 
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conserved leucine zipper, which participates in dimerization as well as DNA-binding (66, 158). 
Mutating the leucine zipper was shown to affect binding of the protein to the Gtf2ird1 upstream 
regulatory (GUR) element that is located at the promoter of Gtf2ird1 (Figure 4G). Given the 
previous findings that Gtf2ird1 negatively autoregulates its transcription and mutating the 
leucine zipper affects binding to the GUR, we hypothesized that the frameshift mutation 
diminished the ability of Gtf2ird1 to bind to its promoter resulting in increased transcript 
abundance. We tested this by performing ChIP-qPCR in the E13.5 brain in WT and Gtf2ird1-/- 
mutants. In the WT brain, Gtf2ird1 IP enriched for the GUR 13-20 times over off-target 
sequences, which was significantly higher than the Gtf2ird1 IP in the Gtf2ird1-/- brain (Figure 
1H,I). Taken together, nonsense transcripts of Gtf2ird1 with a stop codon in exon three can 
reinitiate at a lower level to produce an N-truncated protein with diminished binding capacity at 
the GUR element.  
3.3.4 Truncated Gtf2ird1 does not affect binding genome wide 
Given that the one base pair insertion did not result in a full knock out of the protein, but 
did affect its DNA binding capacity at the GUR of Gtf2ird1, we tested whether the mutant was a 
loss of function for all DNA binding. We performed ChIP-seq in the E13.5 Gtf2ird1-/- mutants 
and compared it to the WT Chip-seq data to test the consequences of the mutation on DNA 
binding genome-wide. The ChIP-seq data confirmed the decrease in binding at the TSS of 
Gtf2ird, however, a small peak is still present at the TSS in the mutant animal, suggesting that 
the mutation has greatly decreased the binding at this locus (Figure 4J). We compared the 
coverage of the genomic regions identified in the WT ChIP-seq data as bound by Gtf2ird1 in the 
mutant and WT samples. Surprisingly, the only peak that was identified at an FDR < 0.1 as 
having differential coverage between the two genotypes was the peak at the TSS of Gtf2ird1 
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(Figure 4K). This suggests that this frameshift mutation has a very specific consequence on how 
the protein binds to its own promoter that does not affect its binding elsewhere in the genome. 
The Gtf2ird1 promoter has two instances of the R4 core motif in the sense direction and one 
instance of the motif in the antisense orientation. We searched the sequences under the identified 
peaks for similar orientations of the binding motif and found only three other peaks, of which 
none showed any difference in coverage between genotypes.  None of the three other peaks 
matched the exact spacing of the three motifs found in the Gtf2ird1 promoter. This suggests that 
the leucine zipper is important for a specific configuration of binding sites that is only present in 
this one instance in the mouse genome.   
3.3.5 Gtf2ird1 frameshift mutation shows mild transcriptional differences  
 The N-truncated Gtf2ird1 clearly affected the expression levels of Gtf2ird1 and affected 
its binding at the promoter of Gtfi2rd1. Although we didn’t see binding genome-wide perturbed, 
, it is possible losing the N terminal altered the proteins ability to recruit other transcriptional co-
regulators, and thus impact expression.  Therefore, we tested the effects of this mutation on 
transcription genome-wide in the E13.5 brain. We compared the whole brain transcriptome of 
WT littermates to either heterozygous or homozygous mutants.  
Strikingly similarly to the ChIP-seq data, the only transcript with an FDR < 0.1 is 
Gtf2ird1, which was in the same direction as we saw in the qPCR (Figure 4L and Supplemental 
Figure 2A). We leveraged the WT ChIP-seq data to see if the presence of Gtf2ird1 at a promoter 
correlates with gene expression. Binning the genes according to expression level showed that the 
distribution of Gtf2ird1 targets was different than expected by chance (χ2 = 48.83, d.f.=3 p < 
1.42x10-10), suggesting that highly expressed genes are more likely to have Gtf2ird1 bound at 
their promoters (Figure 4M). To see if there was a more subtle general effect below our 
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sensitivity for a single gene, we tested if the bound Gtf2ird1 targets that are expressed in the 
brain at E13.5 as a population had their expression shifted. However, we saw only a small trend 
towards significance between the bound genes and unbound genes, with a mean increase in 
expression of 0.014 log2 CPM fold change in Gtf2ird1 targets (Kolgmogorov-Smirnov test 
D=0.038, p=0.079).  While this is perhaps unsurprising, because the frameshift mutation did not 
disturb binding genome wide (Figure 4N), the homozygous mutant do have an overall decrease 
of ~ 50% protein levels which should mimic a WSCR deletion. Thus, transcriptional 
consequences of haploinsufficiency of this gene might be similarly small.   
3.3.6 Frameshift mutation in Gtf2ird1 is sufficient to affect behavior 
Although we observed small differences in DNA binding and overall brain transcription, 
another Gtf2ird1 model also reported no little effects of Gtf2ird1 on expression transcriptome 
wide in the brain, yet the model still showed behavioral phenotypes (88, 101). Therefore we 
tested if our mutation had downstream consequences on adult mouse behavior. There are many 
single gene knock out models of Gtf2ird1 and they each show distinct behavioral differences and 
in some instances the results are contradictory (39, 92, 100, 101). One consistent phenotype 
across models is motor coordination deficits, which is also an area of difficulty in individuals 
with WS. Similarly, we observed a significant effect of genotype (H2=7.88, p =0.01945), on how 
long the animals could balance on a ledge. Homozygous animals fell off the ledge sooner than 
WT littermates (p=0.021) (Figure 5A). Marble burying has not been reported in other Gtf2ird1 
models, but in larger WS models that either delete the entire syntenic WSCR or delete the 
proximal half of the region that contains Gtf2ird1 have shown decreased marble burying 
phenotypes (90, 93). We observed a similar significant effect of genotype on the number of 
marbles buried (F2,75=7.92, p =0.00076), with the Gtf2ird1-/- mutants burying fewer marbles than 
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WT (p=0.0176) and Gtf2ird1+/- littermates (p=0.00067) (Figure 5B). Reports of overall activity 
levels in Gtf2ird1 mouse models have been discrepant (92, 100). Here we showed that there was 
only a trend towards a significant main effect of genotype (F2,71=2.97, p=0.057) on total distance 
traveled in a one hour locomotor task, but there is a main effect of sex (F1,71=18.77, p=4.76x10-5) 
and a genotype by sex interaction (F2,71=4.98, p=0.0095) (Figure 5C). Activity levels were 
increased in the female Gtf2ird1-/- mutants at later time points compared to WT females, and to 
an intermediate extent in the Gtf2ird1+/- mutants (Supplemental Figure 3A). There were no 
differences in total distance traveled between the male genotypes (Supplemental Figure 3B). 
The time spent in the center of an open field is used as a measure of anxiety-like behavior in 
mice. Anxiety-like behaviors in Gtf2ird1 models have also been discrepant in the literature 
(101). Here we showed that there was only a trend for a main effect of genotype when we 
controlled for sex (F2,71=3.070, p=0.0526) (Figure 5D and Supplemental Figure3C, D).  
Finally, as individuals with WS also show high prevalence of phobias, as well as 
intellectual disability, we tested learning and memory using the conditioned fear task (2, 21). On 
day one the mice were trained to associated a tone with a footshock and we observed that the 
mice increased their freezing over time (F2,122=26.77, p=2.28x10-10), as expected, and there was a 
time by genotype interaction (F4,122=3.99, p=0.004) where the WT mice froze more during the 
last five minutes of the task compared to both the Gtf2ird1+/- (p=0.007) and the Gtf2ird1-/- 
mutants (p=0.002) (Figure 5E). On the second day, contextual fear memory was tested. We 
placed the mice in the same chamber in which they were delivered the footshock and measured 
their freezing behavior in the absence of the footshock and the tone. All genotypes exhibited a 
fear memory response as indicated by the significant effect of the context compared to baseline 
of day one (F1,61=31.83, p=4.63x10-7) but no main effect of genotype (F2,61=1.24, p=0.30). Each 
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genotype group froze more during the first two minutes of day two than on day one (WT: 
p=4.7x10-6, Gtf2ird1+/-: p=0.034, Gtf2ird1-/-: p=0.0061) (Supplemental Figure 3E). When we 
analyzed the entire time of the experiment of contextual fear we similarly saw no main effect of 
genotype (F2,61=2.36, p=0.010), but a significant effect of time (F7,427=4.43, p=9.14x10-5) and a 
time by genotype interaction (F14,427=2.19, p=0.0077), suggesting that the freezing behavior of 
the genotypes differ at certain time points during the task. Post hoc analysis showed that during 
minute two the WT animals are freezing significantly more than the Gtf2ird1+/- mutants 
(p=0.0008) suggesting a reduced contextual fear memory response (Figure 5F). On day three of 
the experiment, we tested cued fear by placing the animals in a different context but played the 
tone that was paired with the shock on day one. All genotypes had a similar response to the tone 
(F2,61=1.12, p=0.334) (Figure 5G). These differences could not be explained by differences in 
shock sensitivity (flinch: H2=3.34, p=0.19, escape: H2=2.98, p=0.23, vocalization: F2,56=4.24, 
p=0.12) (Supplemental Figure 3F).  
Overall, these behavior analyses show that the N-terminal truncation and/or the decreased 
total protein levels of the Gtf2ird1 mutant can still result in adult behavioral phenotypes, 
specifically in the domains such as balance, activity, and marble burying. The most severe 
phenotypes were observed in the homozygous mutants.  
3.3.7 Generation of Gtf2i and Gtf2ird1 double mutant 
 The evidence that this frameshift mutation in Gtf2ird1 has functional consequences on 
some of its DNA binding capacity as well as leads to behavioral phentoypes led us to 
characterize a double mutant that was generated during the dual gRNA CRISPR/Cas9 injection. 
This mutant allowed us to test the effects of knocking out Gtf2i along with mutating Gtf2ird1, as 
well as test the consistency of the previous Gtf2ird1 phenotypes across different mutations. The 
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double mutant described here has a two base pair deletion in exon five of Gtf2i and a 590 base 
pair deletion that encompasses most of exon three of Gtf2ird1 (Figure 6A). We carried out a 
heterozygous cross of the double mutants to similarly test the protein and transcript abundance of 
each gene in the heterozygous and homozygous state. The homozygous double mutant is 
embryonic lethal due to the lack of Gtf2i, which has been described in other Gtf2i mutants 
(Figure 6B) (87, 96). We were able to detect homozygous embryos up to E15.5. Thus we 
focused molecular analyses on E13.5 mice for the reasons mentioned above. The two base pair 
deletion in exon five of Gtf2i leads to a premature stop codon and is a full knock out of the 
protein, and decreases the transcript abundance consistent with the degradation of the mRNA due 
to nonsense-mediated decay (Figure 6C,D).  The 590 base pair deletion in Gtf2ird1 removes all 
of exon three except the first 14 base pairs. This mutation has a larger effect on protein levels 
compared to the one base pair insertion, but a small amount of a truncated protein is still made at 
about 10% of the level of WT protein. We observed the same increase in transcript abundance 
that was detected in the one base pair insertion mutation (Figure 6E,F).  
3.3.8 Knocking down both Gtf2i and Gtf2ird1 produces mild transcriptome 
changes  
To test if having both Gtf2i and Gtf2ird1 mutated had a larger effect on the transcriptome 
we performed whole brain RNA-seq analysis on WT E13.5 brains and compared them to Gtf2i+/-
/Gtf2ird1+/- littermates. There were only mild differences between the transcriptomes of the two 
genotypes similar to what was seen when we compared WT littermates to Gtf2ird1-/- mutants 
(Figure 6G). We also compared WT transcriptomes to the homozygous double mutants, which 
showed a greater difference between genotypes. However, this is probably due to the fact that the 
homozygous double mutants have a very severe phenotype, which includes neural tube closure 
defects. The GO terms suggested that overall nervous system development and glial cell 
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differentiation is disrupted (Supplemental Figure 4A,B). We also coupled the Gtf2i ChIP-seq 
data with the RNA-seq data. Unlike what we saw with Gtf2ird1 bound genes, there was 
association between the expression levels of genes and the presence of Gtf2i (χ2 = 6.58, d.f.=3 
p=0.086) (Figure 6H). This is consistent with a previous report of Gtf2i ChIP-seq data. There is 
a slight but significant shift to higher expression of genes of about 0.02 log2 CPM fold change 
that are bound to Gtf2i compared to genes that are not bound (Kolgmogorov-Smirnov test 
D=0.075, p=9.50x10-5) (Figure 6I).  
3.3.9 Double mutants show similar behavioral consequences similar to single 
Gtf2ird1 mutants 
To test the effects of mutating both Gtf2i and Gtf2ird1 we crossed the heterozygous 
double mutant to the single Gtf2ird1 heterozygous mouse (Figure 7A). This breeding strategy 
produced four littermate genotypes, WT, Gtf2ird1+/-, Gtf2i+/-/Gtf2ird1+/-, and Gtf2i+/-/Gtf2ird1-/- 
for direct and well-controlled comparisons. To test the effects of adding a Gtf2i mutation along 
with a Gtf2ird1 mutation we compared the Gtf2ird1+/- to their Gtf2i+/-/Gtf2ird1+/- littermates. The 
final genotype tested the effects of the heterozygous Gtf2i mutation in the presence of both the 
Gtf2ird1 mutations. To be thorough we tested the protein and transcript abundance of each gene 
in the four genotypes. As expected all genotypes with the Gtf2i mutation showed decreased 
protein and transcript levels. The Gtf2ird1 results reflected what was previously shown for each 
mutation, however, the Gtf2i+/-/Gtf2ird1-/- did not show any further detectable decrease in protein 
abundance compared to the Gtf2i+/-/Gtf2ird1+/- genotype (Supplemental Figure 5A-D).   
We repeated the same behaviors that were performed on the one base pair Gtf2ird1 
mutants. We saw a similar significant effect of genotype on balance (H3=10.68, p=0.014), with 
the Gtf2i+/-/Gtf2ird1-/- falling off sooner compared to WT littermates (p=0.025) (Figure 7B). 
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There was no significant difference between the Gtf2ird1+/- and Gtf2i+/-/Gtf2ird1+/- genotypes, 
suggesting that in the heterozygous state decreasing the dosage of Gtf2i does not strongly modify 
the Gtf2ird1+/- phenotype. These results were replicated in a subsequent cohort (Supplemental 
Figure 5E).  There was a significant effect of genotype on the number of marbles buried 
(F3,76=2.93, p=0.039). Post hoc analysis showed a significant difference between only the 
Gtf2ird1+/- and Gtf2i+/-/Gtf2ird1-/- littermates (p=0.050) (Figure 7C), with a trend in the same 
direction as was previously seen in the Gtf2ird1-/- mutants.  We saw a main effect of genotype on 
activity levels in the one hour locomotor task (F3,69=3.22, p=0.028), but we did not see the same 
main effect of sex (F1,69=2.29, p=0.14), or a sex by genotype interaction (F3,69=1.82, p=0.15); 
however we did see a three way sex by time by genotype interaction (F15,345=1.95, p=0.018). The 
combined sex data showed that the Gtf2i+/-/Gtf2ird1-/- travel more distance in the later time 
points than the WT and Gtf2ird1+/- at time point 40 (Figure 7D). When we looked at the data by 
sex we saw a larger effect in the females with the Gtf2ird1+/- and Gtf2i+/-/Gtf2ird1+/- intermediate 
to the Gtf2i+/-/Gtf2ird1-/- (Supplemental Figure 5F, G). There was also a main effect of 
genotype on the time spent in the center of the apparatus (F3,69=3.60, p=0.018). The Gtf2i+/-
/Gtf2ird1-/- spent less time in the center during the first ten minutes of the task compared to WT 
(p=0.0019) littermates with the Gtf2ird1+/- and Gtf2i+/-/Gtf2ird1+/- showing intermediate values 
(Figure 7E).  
Finally, we repeated the conditioned fear memory task using this breeding strategy. All 
genotypes increased their freezing after each foot shock on day one as expected. The WT 
animals exhibited higher freezing during minute one of baseline, but this difference diminished 
during minute two (Figure 7F). All animals showed a contextual fear memory response when 
they were re-introduced to the chamber on day two (F1,68=81.21, p=3.21x10-13) (Supplemental 
 
 
101 
Figure 5H) but there was no main effect of genotype (F3,68=1.61, p=0.19) (Figure 7G). On day 
three, when cued fear was tested, there was a significant effect of genotype on the freezing 
behavior (F3,68=3.17, p=0.030) and a time by genotype interaction (F21,476=1.63, p=0.040). 
During minute five of the task the Gtf2i+/-/Gtf2ird1-/- mutants froze significantly more than the 
WT (p=0.030) as did the Gtf2ird1+/- (p=0.024) (Figure 7H). The cued fear phenotype could not 
be explained by differences in sensitivity to the foot shock (Supplemental Figure 5I).  
By crossing these two mutant lines we tested the hypothesis that the double heterozygous 
mutant would be more severe than a mutation only affecting Gtf2ird1. Comparing the Gtf2ird1+/- 
and Gtf2i+/-/Gtf2ird1+/-, showed mild deficits compared to WT littermates that in some cases 
were intermediate to phenotypes of the Gtf2i+/-/Gtf2ird1-/-. There were no instances when either 
the Gtf2ird1+/- or Gtf2i+/-/Gtf2ird1+/- genotype was significantly different than the other, 
suggesting that in the behaviors that we have tested, Gtf2i mutation does not modify the effects 
of a Gtf2ird1 mutation. This unique cross also allowed us to characterize a new mouse line 
Gtf2i+/-/Gtf2ird1-/-, which had the largest impact on behaviors. The phenotypes of Gtf2i+/-
/Gtf2ird1-/- were always in the same direction as the phenotypes in the Gtf2ird1-/- mouse model, 
but we also saw a significant cued fear deficit when the Gtf2i mutation was added. This further 
supports that the behaviors tested here, such as activity levels, balance, anxiety-like behaviors, 
marble burying, and learning and memory are largely affected by homozygous mutations in 
Gtf2ird1.  
3.4 Discussion 
We have described the in vivo DNA binding sites of Gtf2ird1 and Gtf2i in the developing 
mouse brain. This is the first description of these two transcription factors in a tissue that is 
relevant for the behavioral phenotypes that are seen in mouse models of WS. Gtf2ird1 showed a 
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preference for active sites and promoter regions. The conservation of the Gtf2ird1 targets was 
higher on average than would be expected by chance, which provides evidence that these are 
functionally important regions of the genome.  The functions of genes that are bound by Gtf2ird1 
include transcriptional regulation as well as post translational regulation. A role for Gtf2ird1 in 
regulating genes involved in protein ubiquniation has not been described before. Genes involved 
in chromatin organization were also found to be bound by Gtf2ird1. This supports the role of 
Gtf2ird1 in regulating chromatin by transcriptionally controlling other chromatin modifiers. 
Along with its localization pattern in the nucleus and its direct interaction with other chromatin 
modifiers such as ZMYM5 (79, 82), this data suggests that Gtf2ird1 can exert its regulation of 
chromatin at several different levels of biological organization. The motif enrichment of Gtf2ird1 
peaks showed that CTCF may be present along with Gtf2ird1, further implicating the importance 
of Gtf2ird1 in chromatin biology. Interestingly, Gtf2i has been show to interact with and target 
CTCF to specific sites in the genome (156). It would be interesting to test if Gtf2ird1 has a 
similar relationship with CTCF and targets it to unique genomic loci.  
Overall, Gtf2i showed a similar preference for promoters and active regions, although it 
had more intergenic targets than Gtf2ird1, and the conservation of Gtf2i peaks was significantly 
lower than the Gtf2ird1 peaks. The genes bound by Gtf2i were enriched for signal transduction 
and phosphorylation. Interestingly, Gtf2i was bound to the gene body of the Src gene. Src is 
known to phosphorylate Gtf2i to induce its transcriptional activity (74). Phosphorylation of Gtf2i 
by Src also antagonizes calcium entry into the cell (76). While, knocking out Gtf2i did not affect 
the expression of Src, it would be interesting to understand the functional consequence of Gtf2i 
bound to Src, especially since knockout mice of Src exhibit similar behaviors as Gtf2i knock out 
mice (75).  
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The overlap of targets of Gtf2i and Gtf2ird1 was significant, and the genes that did 
overlap were enriched for synaptic activity and signal transduction. This was evidence that these 
genes could interact via their binding targets to produce cognitive and behavioral phenotypes. To 
test how mutating both Gtf2i and Gtf2ird1 would modify the phenotypes of just Gtf2ird1 we 
characterized two new mouse models. We used the CRISPR/Cas9 system to generate multiple 
mutations in the two genes individually as well as together from one embryo injection. The ease 
and combinatorial possibilities of this technology will be amenable to testing many unique 
combinations of genes in copy number variant regions, which will be important to fully 
understand the complex relationships of genes in these disorders.  
We saw that a frameshift mutation that we expected to trigger non-sense mediate decay in 
Gtf2ird1 did not and resulted in a mild reduction in protein levels in the homozygous mutant and 
an N-terminal truncation. Even making a larger 590bp deletion of exon three in Gtf2ird1 did not 
result in the degradation of the mRNA, but did have a larger effect on the protein, even though 
some protein product was still made. This phenomenon has been seen in at least two other mouse 
models of Gtf2ird1 (66, 101). These were made using classic homologous recombination 
removing either exon two or exon two through part of exon five. In both models Gtf2ird1 
transcript was still made, but no in vivo protein analysis was done due to poor quality antibodies 
and the low expression of the protein. The presence of an aberrant protein that can still bind the 
genome, as the mutant described here can, could explain the lack of transcriptome differences in 
the brain shown here as well as in (88). It could also be that the mutant protein can still interact 
with other binding partners and be trafficked to the appropriate genomic loci. This mutation did 
disrupt the binding of Gtf2ird1 to its own promoter, which resulted in an increase in transcript 
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levels. The property that specifies the Gtf2ird1 binding to its own promoter must be very unique, 
as DNA binding genome-wide was not perturbed in the mutant.  
Nonetheless, the mutated Gtf2ird1 protein was still sufficient to cause adult behavioral 
abnormalities. This supports the hypothesis that the N-terminal end of the protein has other 
important functions beyond DNA binding. Similarly, the N-truncation of Gtf2i did not affect 
DNA-binding, but still resulted in behavioral deficits (67). The single Gtf2ird1 homozygous 
mutant showed balance deficits, which is consistent across many mouse models of WS. We also 
observed decreased marble burying. This task is thought to be mediated by hippocampal 
function, suggesting a possible disruption of the hippocampus caused by this mutation (159). We 
saw an increase in overall activity levels in female Gtf2ird1 mutants. This could relate to the 
high prevalence of Attention Deficit/Hyperactivity Disorder seen in WS (22).  
Given the prior evidence that these two transcription factors are both involved in the 
cognitive and behavioral phenotypes of WS (34, 95), and the evidence that their shared binding 
targets regulate synaptic genes, we tested if having both Gtf2i and Gtf2ird1 mutated could 
modify the phenotype seen when just Gtf2ird1 was mutated. Contrary to our prediction, we did 
not see a large effect of adding a Gtf2i mutation to differences in transcriptome wide expression 
or behavioral phenotypes. This was also surprising given that we successfully reduced Gtf2i 
protein and it has been described in the literature as regulating transcription (58). It could be that 
by using the whole E13.5 brain we are diminishing the effects of transcriptional differences seen 
in a specific rare cell types. This potential confound could be overcome using single cell 
sequencing technologies in the future.  
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 When Gtf2i was knocked down it the presence of two Gtf2ird1 mutations, we saw 
phenotypes in the same direction as the homozygous one base pair insertion Gtf2ird1 mutant as 
well as significant results in the cued fear memory task. Thus, the behaviors tested in this study 
seem to be mainly driven by Gtf2ird1 homozygosity, which is consistent across the two different 
mutations. This does not exclude the possibility that Gtf2i can modify the phenotype of Gtf2ird1 
knockdown in other behavioral domains. For example, it would be interesting to see the effect of 
adding Gtf2i on top of a Gtf2ird1 mutation on social behaviors.   
Our study has provided the first description of the DNA-binding of both Gtf2i and 
Gtf2ird1 in the developing mouse brain and showed that they have unique and overlapping 
targets. These data will be used to inform downstream studies to understand how these two 
transcription factors interact with the genome. We generated two new mouse models that tested 
the importance of the N-terminal end of Gtf2ird1 and the affect of mutating both Gtf2i and 
Gtf2ird1. We provided evidence that despite either gene having little effect on transcription the 
Gtf2ird1 mutation affects balance, marble burying, activity levels, and cued fear memory.  
3.5 Materials and Methods 
Generating genome edited mice 
To generate unique combinations of gene knockouts we designed gRNAs targeting early 
constitutive exons of the mouse Gtf2i and Gtf2ird1 genes. The gRNAs were tested for cutting 
efficiency in cell culture by transfecting N2a cells with the pX330 Cas9 expression plasmids 
(Addgene) that had each gRNA cloned into it. The DNA was harvested from the cells and 
cutting was detected using the T7 endonuclease assay. The gRNAs were in vitro transcribed 
using the MEGAShortScript kit (Ambion) and the Cas9 mRNA was in vitro transcribed using the 
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mMessageMachine kit (Ambion). The two gRNAs and Cas9 mRNA were then injected into FVB 
mouse embryos and implanted into donor females. FVB mice were used for their large pronuclei 
and large litter sizes. The resulting offspring were genotyped for mutations by designing gene 
specific primers that had the illumina adapter sequences concatenated to their 3’ prime end to 
allow for deep sequencing of the amplicons surrounding the expected cut sites. The large 590 bp 
deletion was detected by amplifying 3.5kb that included exon two, exon three and part of intron 
three then using a Nextera library prep (Illumina) to deep sequence the amplicon. We described 
two founder mice obtained from these injections. Each founder line was bred to FVB/ANTJ mice 
to ensure the mutations detected were in the germline and on the same chromosomes in the case 
of founders with mutations in both genes. The mice were also crossed until the mutations were 
on a complete FVB/ANTJ background, which differs from the FVB background at two loci; 
Tyrc-ch, which gives the chinchilla coat color of FVB/ANTJ and 129P2/OlaHSd Pde6b allele, 
which the FVB/ANTJ are WT for and prevents them from becoming blind in adult hood. The 
coat color was genotyped by eye, and the Pde6b gene was genotyped using the primers provided 
by the Jackson Laboratory website.  
Western blotting 
Embryos were harvested on embryonic day 13.5 (E13.5) and the whole brain was 
dissected in cold PBS and flash frozen in liquid nitrogen. The frozen brains were stored at -80° C 
until they were to be lysed. The frozen brain was homogenized in 500ul of 1xRIPA buffer 
(10mM Tris HCl pH 7.5, 140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% DOC, 0.1% SDS, 
10mM Na3V04, 10mM NaF, 1x protease inhibitor (Roche)) along with 1:1000 dilution of 
RNAase inhibitors (RNasin (Promega) and SUPERase In (Thermo Fisher Scientific). The 
homogenate incubated on ice for 20 minutes and was then spun at 10,000g for 10 minutes at 4° C 
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to clear the lysate. The lysate was stored as two aliquots of 100ul in the -80° C for protein 
analysis and 250ul of the lysate was added to 750ul of Trizol LS and stored at -80° C for later 
RNA extraction and qPCR. Total protein was quantified using the BCA assay and 25-50ug of 
protein in 1x Lamelli Buffer with B-mercaptoethanol was loaded onto 4-15% TGX protean gels 
from Bio-Rad. The protein was transferred to a .2um PVDF membrane by wet transfer. The 
membrane was blocked with 5% milk in TBST for one hour at room temperature. The membrane 
was cut at the 75KDa protein marker and the bottom was probed with a Gapdh antibody as an 
endogenous loading control, and the top was probed with an antibody for either Gtf2i or 
Gtf2ird1. The primary incubation was performed overnight at 4° C. The membrane was then 
washed three times in TBST for five minutes then incubated with a secondary antibody HRP 
conjugated antibody diluted in 5% milk in TBST for one hour at room temperature. The blot was 
washed three times with TBST for five minutes then incubated with Clarity Western ECL 
substrate (Bio-Rad) for five minutes. The blot was imaged in a MyECL Imager (Thermo 
Scientific).  The relative protein abundance was quantified using Fiji (NIH) and normalized to 
Gapdh levels in a reference WT sample. The antibodies and dilutions used in this study were: 
Rabbit anti-GTF2IRD1 (1:500, Novus, NBP1-91973), Mouse anti-GTF2I (1:1000 BD 
Transduction Laboratories, BAP-135), and Mouse anti-Gapdh  (1:10,000, Sigma Aldrich, 
G8795), HRP-conjugated Goat anti Rabbit IgG (1:2000, Sigma Aldrich, AP307P) and HRP-
conjugated Goat anti Mouse IgG (1:2000, Bio Rad, 1706516).  
Transcript abundance using RT-qPCR 
RNA was extracted from Trizol LS using the Zymo Clean and Concentrator-5 kit with on 
column DNAase-I digestion following the manufacturer’s instructions. The RNA was eluted in 
30ul of RNAse free water and quantified using a Nanodrop 2000 (Thermo Scientific).  One ug of 
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RNA was transcribed into cDNA using the qScript cDNA synthesis kit (Quanta Biosciences). 
The cDNA was used in a 10ul PCR reaction with 500nM of target specific primer and the 
PowerUP Sybr green master mix (Applied Biosystems). The primers were designed to amplify 
exons that were constitutively expressed in both Gtf2i (exons 25 and 27) and Gtf2ird1 (exons 8 
and 9) and span an intron. The RT-qPCR was carried out in a QuantStudio6Flex machine 
(Applied Biosystems) using the following cycling conditions: 95° C 20 seconds, 95° C 1 second, 
60° C 20 seconds, repeat steps 2 through 3 40 times. Each target and sample was run in triplicate 
technical replicates, with three biological replicates for each genotype. The relative transcript 
abundance was determined using the delta CT method normalizing to Gapdh.  
ChIP 
Chromatin was prepared as described in (160). Briefly, frozen brains were homogenized 
in 10mL of cross-linking buffer (10mM HEPES pH7.5, 100mM NaCl, 1mM EDTA, 1mM 
EGTA, 1% Formaldehyde (Sigma)). The homogenate was spun down and resuspended in 5mL 
of 1x L1 buffer (50mM HEPES pH 7.5, 140 mM NaCl, 1mM EDTA, 1mM EGTA, 0.25% Triton 
X-100, 0.5% NP40, 10.0% glycerol, 1mM BGP (Sigma), 1x Na Butyrate (Millipore), 20mM 
NaF, 1x protease inhibitor (Roche)) to release the nuclei. The nuclei were spun down and 
resuspended in 5mL of L2 buffer (10mM Tris-HCl pH 8.0, 200mM NaCl, 1mM BGP, 1x Na 
Butyrate, 20mM NaF, 1x protease inhibitor) and rocked at room temperature for five minutes. 
The nuclei were spun down and resuspended in 950ul of buffer L3 (10mM Tris-HCl pH 8.0, 
1mM EDTA, 1mM EGTA, 0.3% SDS, 1mM BGP, 1x Na Butyrate, 20mM NaF, 1x protease 
inhibitor) and sonicated to a fragment size of 100-500bp in a Covaris E220 focused-
ultrasonicator with 5% duty factor, 140 PIP, and 200cbp. The sonicated chromatin was diluted in 
with 950ul of L3 buffer and 950ul of 3x covaris buffer (20mM Tris-HCl pH 8.0, 3.0% Triton X-
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100, 450mM NaCl, 3mM EDTA). The diluted chromatin was pre-cleared using 15ul of protein G 
coated streptavidin magnetic beads (ThermoFisher) for two hours at 4° C. For IP, 15ul of protein 
G coated streptavidin beads were conjugated to either 10ul of Gtf2ird1 antibody (Rb anti 
GTF2IRD1 NBP1-91973 LOT:R40410) or 10ul of Gtf2i antibody (Rb anti GTF2I Bethyl 
Laboratories) for one hour at room temperature. 80ul of the pre-cleared lysate was saved to be 
the input sample. 400ul of the pre-cleared lysate was added to the beads and incubated overnight 
at 4° C.  The IP was then washed two times with low salt wash buffer (10mM Tris-HCl pH 8.0, 
2mM EDTA, 150mM NaCl, 1.0% Triton X-100, 0.1% SDS), two times with a high salt buffer 
(10mM Trish-HCl pH 8.0, 2mM EDTA, 500mM NaCl, 1.0% Triton X-100, 0.1% SDS), two 
times with LiCl wash buffer (10mM Tris-HCl pH 8.0, 1mM EDTA, 250mM LiCl (Sigma), 0.5% 
NaDeoxycholate, 1.0% NP40), and one time with TE (10mM Tris-HCl pH 8.0, 1mM EDTA) 
buffer. The DNA was eluted off of the beads with 200ul of 1x TE and 1% SDS by incubating at 
65° C in an Eppendorf R thermomixer shaking at 1400rpm. The DNA was de-crosslinked by 
incubating at 65° C for 15 hours in a thermocycler. RNA was removed by incubating with 10ug 
of RNAse A (Invitrogen) at 37° C for 30 minutes and then treated with 140ug of Proteinase K 
(NEB) incubating at 55° C in a thermomixer mixing at 900rpm for two hours. The DNA was 
extracted with 200ul of phenol/chloroform/isoamyl alcohol (Ambion) and cleaned up using the 
Qiagen PCR purification kit and eluted in 60ul of elution buffer. Concentration was assessed 
using the highsensitivity DNA kit for qubit (Thermo Fisher Scientific). 
ChIP-qPCR 
Primers were designed to amplify the upstream regulatory element of Gtf2ird1. Two off 
target primers were designed that are 10kb upstream of the transcription start site of Bdnf and 
7kb upstream of the Pcbp3 transcription start site. The input sample was diluted 1:3, 1:30, and 
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1:300 to create a standard curve for each primer set and sample. Each standard, input, and IP 
sample for each primer set was performed in triplicate in 10ul reactions using the PowerUP Sybr 
green master mix (Applied Biosystems) and 250nM of forward and reverse primers.  The 
reactions were performed in a QuantStudio6Flex machine (Applied Biosystems) with the 
following cycling conditions: 50° C for 2 minutes, 95° C for 10 minutes, 95° C 15 seconds, 60° 
C for 1 minute, repeat steps 3 through 4 40 times. The relative concentration of the input and IP 
samples were determined from the standard curve for each primer set. Enrichment of the IP 
samples was determined by dividing the on target upstream regulatory element relative 
concentration by the off target relative concentration.  
ChIP-seq 
ChIP-seq libraries were prepared using the Swift Accel-NGS 2S plus DNA library prep 
kits with dual indexing (Swift Biosciences). The final libraries were enriched by thirteen cycles 
of PCR. The libraries were sequenced by the Genome Technology Access Center at Washington 
University School of Medicine on a HiSeq3000 producing 1x50 reads.  
Raw reads were trimmed of adapter sequences and bases with a quality score less than 25 
using the Trimmomatic Software (161). The trimmed reads were aligned to the mm10 genome 
using the default settings of bowtie2 (162). Reads that had a mapping quality of less than 10 
were removed. Picard tools was used to remove duplicates from the filtered reads 
(http://broadinstitute.github.io/picard). Macs2 was used to call peaks on the WT IP, Gtf2ird1-/- 
IP, and Gtf2i-/-/Gtf2ird1-/- IPs with the corresponding sample’s input as the control sample for 
each biological replicate (163). Macs2 used an FDR of 0.01 as the threshold to call a significant 
peak. High confidence peaks were those peaks that had some overlap within each biological 
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replicate for each genotype using bedtools intersect (164). The read coverage for the high 
confidence peaks identified in the WT IPs was determined using bedtools coverage for all 
genotypes. To identify peaks with differential coverage, we used EdgeR to compare the WT 
peaks coverage files to the corresponding mutant peak coverage and differential peaks were 
defined as having an FDR < 0.1 (165). The peaks with FDR < 0.1 and log2FC > 0 fine the Gtf2i 
high confidence peaks calls, since this mutation represents a full knockout of the protein. 
Annotations of peaks and motif analysis was performed using the HOMER software on the high 
confidence peaks (166). Peaks were annotated at the transcription start (TSS) of genes if the peak 
overlapped the +2.5kbp or -1kbp of the TSS using a custom R script. GO analysis on the ChIP 
target genes was performed using the goseq R package. We used E13.5 H3K4me3 and E13.5 
H3K27me3 forebrain narrow bed peak files from the mouse ENCODE project to overlap with 
our peak datasets (167). Deeptools was used to generate bigwig files normalized to the library 
size for each sample by splitting the genome into 50bp overlapping bins (168). Deeptools was 
used to visualize the ChIP-seq coverage within the H3K4me3 and H3K27me3 peak regions. 
PhyloP scores for the WT ChIP-seq peaks and random genomic regions of the same length were 
retrieved using the UCSC table browser 60 Vertebrate Conservation PhyloP table. The 
Epigenome browser was used to visualize the ChIP-seq data as tracks. 
RNA-seq 
1ug of E13.5 whole brain total RNA extracted from Trizol LS was used as input for 
rRNA depletion using the NEBNExt rRNA Depletion Kit (Human/Mouse/Rat). The rRNA 
depleted RNA was used as input for library construction using the NEBNext Ultra II RNA 
library prep kit for Illumina. The final libraries were indexed and enriched by PCR using the 
following thermocycler conditions: 98° C for 30 seconds, 98° C 10 seconds, 65° C 1 minute and 
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15 seconds, 65° C 5 minutes, hold at 4° C, repeat steps 2 through 3 6 times. The libraries were 
sequenced by the Genome Technology Access Center at Washington University School of 
Medicine on a HiSeq3000 producing 1x50 reads.  
RNA-seq analysis  
The raw RNA-seq reads were trimmed of Illumina adapters and bases with quality scores 
less than 25 using Trimmomatic Software. The trimmed reads were aligned to the mm10 mouse 
genome using the default parameters of STARv2.6.1b (169) . We used HTSeq-count to 
determine the read counts for features using the Ensembl GRCm38 version 93 gtf file (170). 
Differential gene expression analysis was done using EdgeR. We compared the expression of 
genes that are targets of either Gtf2ird1 or Gtf2i to non-bound genes by generating a cumulative 
distribution plot of the average log CPM of the genes between genotypes.  GO analysis was 
performed using the goseq R package.  
Behavioral tasks 
Animal statement 
All animal testing was done in accordance with the Washington University in St. Louis 
animal care committee regulations. Mice were group housed in same-sex, mixed-genotype cages 
with two to five mice in a cage in standard mouse cages with dimensions 28.5 x 17.5 x 12 cm 
with corn cob bedding. The mice had ad libitum access to food and water and followed a 12 hour 
light-dark cycle with the lights on from 6:00am-6:00pm. The rooms the animals were housed in 
were kept at 20-22° C and a relative humidity of 50%. All mice were maintained on the 
FVB/AntJ ((171)) background from Jackson Labs. All behaviors were done in adulthood 
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between ages P60-P130. A week prior to beginning behavior testing the mice were handled by 
the male experimenter. On days of testing the mice were moved to the testing room and allowed 
to habituate to the room and the male experimenter for 30 minutes before testing started. The 
number of mice and behaviors are listed in Table 1 and Table 2.  
Ledge 
To test balance, we timed how long a mouse could balance on a plexiglass ledge with a 
width of 0.5cm and a height of 38cm as described in (171). The mice were timed up to 60 
seconds. If the mouse fell off within the first five seconds the time was restarted and the mouse 
was given another attempt. If after the third attempt the mouse fell off within the first five 
seconds that time was recorded. We tested all mice on the ledge and then allowed for a 20 
minute rest time then repeated the testing on all the mice for a total of two trials for each mouse. 
The average of the two trials were used in the analysis.  
One hour locomotor activity 
We assessed activity levels in a one hour locomotor task, as previously described (171). 
Mice were placed in the center of a standard rat cage with dimensions 47.6 x 25.4 x 20.6cm. The 
rat cage was located inside of a sound-attenuating box with white light set to 24 lux. The mice 
could freely explore the cage for one hour. A plexiglass lid with air holes was placed on top of 
the rat cage to prevent the mice from jumping out of the cage. The position and horizontal 
movement of the mice was tracked using the ANY-maze software (Stoelting Co.: RRID: 
SCR_014289). The apparatus was divided into two zones, the edge zone was 5.5cm bordering 
the cage, and a 33 x 11cm center zone. The animal was considered in a particular zone if 80% of 
the mouse was detected in the zone. ANY-maze recorded the time, distance, and number of 
 
 
114 
entries into each zone. After the task, the mouse was returned to its home cage and the apparatus 
was thoroughly cleaned with 70% ethanol.  
Marble burying 
Marble burying is a species-specific task that measures the compulsive digging behavior 
of mice. Normal hippocampal is thought to be required for normal marble burying phenotypes. 
We tested marble burying as previously described (171). A rat cage was filled with aspen 
bedding to a depth of 3cm and placed in a sound-attenuating box with white light set at 24 lux. A 
5 x 4 grid of evenly spaces marbles was laid out on top of the bedding. The experimental mouse 
was placed in the center of the chamber and allowed to freely explore and dig in the chamber for 
30 minutes. A plexiglass lid with air holes was placed on top of the rat cage to prevent the mice 
from escaping. After 30 minutes the animal was returned to their home cage. Two scorers 
counted the number of marbles not buried. A marble was considered buried if two-thirds of the 
marble was covered with bedding. The number of marbles buried was then determined, and the 
average of the two scorers was used in the analysis. After the marbles were counted the bedding 
was disposed of and the rat cage and marbles were cleaned with 70% ethanol.  
Contextual and Cued Fear Conditioning  
Learning and memory were tested using the contextual and cued fear condition paradigm 
as previously described (172). Contextual fear memory is thought to be driven by hippocampal 
functioning whereas cued fear is thought to be driven by amygdala functioning. On day one of 
the experiment, animals were placed in a Plexiglas chamber (26cm x 18cm x 18cm; Med 
Associates Inc.) with a metal grid floor that had an unobtainable peppermint odor. A chamber 
light was on for the duration of the five-minute task. During the first two minutes, the animal 
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freely explored the apparatus, and this was considered the baseline. An 80dB white noise tone 
was played for 20 seconds at 100 seconds, 160 seconds, and 220 seconds during the five-minute 
task. During the last two seconds of the tone, the mice received a 1.0mA foot shock.  The tone is 
the conditioned stimulus (CS) and the foot shock is the unconditioned stimulus (UCS). The 
animal’s freezing behavior was monitored by the FreezeFrame (Actimetrics, Evanston, IL) 
software in 0.75s intervals. Freezing was defined as no movement besides respiration, and was 
used as a measure of the fear response of mice. After the five-minute task the mice were returned 
to their home cage. On day two, we tested contextual fear memory. The mice were placed in the 
same chamber as day with the unobtainable peppermint odor, and the freezing behavior was 
measured over the eight-minute task. The first two minutes of day two were compared to the first 
two minutes of day one to test for the acquisition of the fear memory. The mice were then 
returned to their home cage. On day three, to test cued fear, the mice were placed in a new black 
and white chamber that was partitioned into a triangle shape and had an unobtainable coconut 
scent. The mice were allowed to explore the chamber and the first two minutes were considered 
baseline. After minute two the 85 dB tone (CS) was played for the remaining eight minutes.   
Statistical Analysis 
All statistical analyses were performed in R v3.4.2. All statistical tests are reported in 
Supplemental Table 1. The ANOVA assumption of normality was assessed using the Shapiro-
Wilkes test and manual inspection of qqPlots, and the assumption of equal variances was 
assessed with Levene’s Test. When appropriate ANOVA was used to test for main effects and 
interaction terms. Post hoc analyses were done to compare between genotypes. If the data 
violated the assumptions of ANOVA non-parametric tests were performed. If the experiment 
was performed over time, linear mixed models were used to account for the repeated measures of 
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an animal using the lme4 R package. Post hoc analyses were then conducted to compare between 
genotypes within time bins. Post hoc analyses were done using the multcomp R package (173). 
Animals were removed from analysis if they had a value that was 3.29 standard deviations above 
the mean or had poor video tracking and could not be analyzed.  
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3.7 Figures 
  
 
 
118 
Figure 1: Gtf2ird1 binds preferentially to promoters in conserved, active sites in the genome. A Gtf2ird1 
binding peaks are annotated primarily in promoters and gene bodies. The distribution of peak annotations is 
significantly different from random sampling the genome. B Gtf2ird1 peaks were enriched in H3K4me3 sites 
marking active regions of the genome and to a lesser extent in H3K27me3 marking repressed regions. C GO 
analysis of genes that have Gtf2ird1 bound to the promoter. D The conservation of sequence in Gtf2ird1 bound 
peaks is significantly higher than expected by chance. E Motifs of transcription factors enriched under Gtf2ird1 
bound peaks. 
 
Figure 2: Gtf2i binds at promoters in conserved, active sites in the genome.  A Gtf2i binding sites are annotated 
mostly in gene promoters and the gene body. The distribution of peaks is significantly different than would be 
expected by chance. B 78.7% of Gtf2i peaks overlap with H3K4me3 peaks marking active regions. 20.7% of the 
Gtf2i peaks fall within H3K27me3 peaks marking inactive regions. C GO analysis of genes that have Gtf2i bound at 
the promoter. D Epigenome browser shot of Gtf2i peak bound within the Src gene. E Genomic sequence under Gtf2i 
peaks are more conserved than we would expect by chance. F Motifs of transcription factors that are enriched in 
Gtf2i bound sequences. 
 
 
 
 
 
119 
Figure 3: Comparison of Gtf2ird1 and Gtf2i binding sites. A Gtf2i and Gtf2ird1 have different distributions of 
annotated binding sites. B Gtf2ird1 bound sequences are more conserved than Gtf2i bound sequences. C The 
overlap of genes that have Gtf2i and Gtf2ird1 bound at their promoters. D GO analysis of genes that have both Gtf2i 
and Gtf2ird1 bound at their promoters. E Epigenome browser shot of Mapk14 showing peaks for both Gtf2i and 
Gtf2ird1.  
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Figure 4: Frameshift mutation in Gtf2ird1 exon three results in a decreased amount of an N-truncated 
protein with diminished binding at Gtf2ird1 promoter and has little effect on transcription in the brain. A 
The sequence of exon three of Gtf2ird1 that was targeted by the gRNA underlined with the PAM sequence in blue. 
The mutant allele contains a one base pair insertion of an adenine nucleotide that results in a premature stop codon. 
B Breeding scheme of the intercross of Gtf2ird1+/- to produce genotypes used in the experiments. C, D Mutation in 
Gtf2ird1 does not affect the protein or transcript levels of Gtf2i.  E Frameshift mutation decreases the amount of 
protein in Gtf2ird1-/- and causes a slight shift to lower molecular weight. F The abundance of Gtf2ird1 transcript 
increases with increasing dose of the mutation. G Schematic of Gtf2ird1 upstream regulatory element (GUR) that 
shows the three Gtf2ird1 binding motifs. The arrows indicate the location of the primers for amplifying the GUR in 
the ChIP-qPCR assay.  H,I WT ChIP of Gtf2ird1 shows enrichment of the GUR over off target regions. There is 
more enrichment in the WT genotype compared to the Gtf2ird1-/- genotype. J Profile plots of Gtf2ird1 ChIP-seq data 
confirms diminished binding at the Gtf2ird1 promoter. K Differential peak analysis comparing WT and Gtf2ird1-/- 
ChIP-seq data showed only the peak at Gtf2ird1 is changed between genotypes with an FDR <0.1. L Differential 
expression analysis in the E13.5 brain comparing WT and Gtf2ird1-/- showed only Gtf2ird1 as changed with FDR < 
0.1. M The presence of Gtf2ird1 at gene promoters is not evenly distributed across expression levels. N The 
expression of genes bound by Gtf2ird1 is not different compared to all other genes between WT and Gtf2ird1-/- 
mutants. 
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Figure 5: Homozygous Frameshift mutation in Gtf2ird1 is sufficient to cause behavioral phenotypes. A 
Homozgyous mutants have worse balance than WT littermates in ledge task. B Homozygous mutants bury fewer 
marbles than WT and heterozygous littermates. C Overall activity levels are not affected when both sexes are 
combined. D There is no difference in time spent in the center of the apparatus between genotypes. E Acquisition 
phase of fear condition paradigm. WT animals freeze more during the last five minutes of the task. F WT animals 
showed greater freezing in contextual fear memory task than Gtf2ird1+/-. G There were no differences between 
genotypes in cued fear.  
 
Figure 6: Mutating both Gtf2i and Gtf2ird1 does not result in larger differences in brain transcriptomes. A 
Generation of double mutant. gRNA target is underlined in exon five of Gtf2i with the PAM sequence in blue. The 
two base pair deletion results in a premature stop codon within exon five. The Gtf2ird1 mutation is a large 590 base 
pair deletion covering most of exon three as shown in the IGV browser shot. B Heterozygous intercross to generate 
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genotypes for ChIP and RNA-seq experiments. The homozygous double mutants are embryonic lethal but are 
present up to E15.5. C The two base pair deletion in Gtf2i decreases the protein by 50% in heterozygous mutant and 
no protein is detected in the homozygous E13.5 brain. D The mutation decreases the abundance of Gtf2i transcript 
consistent with nonsense-mediated decay. E The 590 base pair deletion in Gtf2ird1 leads to decrease protein levels 
in heterozygous and homozygous mutants. There is still a small amount of protein made in the homozygous mutant. 
F The 590 base pair deletion increases the amount of Gtf2ird1 transcript. G Volcano plot comparing the expression 
in the E13.5 brain of WT and heterozygous double mutants. The highlighted genes represent an FDR < 0.1. H The 
presence of Gtf2i at the promoters does not correlate with the expression of a gene. I The fold change of genes 
between WT and homozygous double mutants that have Gtf2i bound at their promoters were slightly upregulated 
when compared to the fold change of genes that did not have Gtf2i bound. 
 
Figure 7: Gtf2i does not modify the phenotype of Gtf2ird1 mutation. A  Breeding scheme for behavior 
experiments. B The Gtf2i+/-/Gtf2ird1-/- animals fell off ledge sooner than WT littermates. C There was main effect of 
genotype on marbles buried. Post hoc analysis showed that the Gtf2i+/-/Gtf2ird1-/- buried fewer marbles than the 
Gtf2ird1-/- genotype.  D The Gtf2i+/-/Gtf2ird1-/- had increased overall activity levels in a one hour activity task. E 
The Gtf2i+/-/Gtf2ird1-/- showed decreased time in the center of the apparatus compared to WT, with the Gtf2ird1+/- 
 
 
125 
and Gtf2i+/-/Gtf2ird1+/- having intermediate values. F All genotypes showed increased freezing with increased 
number of footshocks. G All genotypes showed a similar contextual fear response. H There was a main effect of 
genotype on cued fear with the Gtf2ird1+/- and Gtf2i+/-/Gtf2ird1-/- showing an increased fear response compared to 
WT. 
 
Supplemental Figure 1: Differential peak binding comparing the WT and homozygous Gtf2i IP. A The 
highlighted peaks have an FDR < 0.1 and a log2FC > 0. These were used as the high confidence Gtf2i peaks.  
 
Supplemental Figure 2: RNA-seq analysis of E13.5 brain comparing the WT and Gtf2ird1+/- mutants. A Only 
Gtf2ird1  showed a difference with FDR < 0.1.   
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Supplemental Figure 3: The effects of frameshift mutation in Gtf2ird1. A Female heterozygous and homozygous 
mutants have increased activity levels. B There is no difference in activity levels in male mice. C There is no 
difference between genotypes in females with respect to the time spent in the center of the apparatus. D There is no 
difference between genotypes in males with respect to the time spent in the center of the apparatus. E All genotypes 
showed a contextual fear response. Baseline refers to the first two minutes of the task on day one and context refers 
to the first two minutes of the task on day two. F There was no difference in shock sensitivity between genotypes. 
 
Supplemental Figure 4: RNA-seq analysis of homozygous double mutant. A The homozygous double mutant 
showed significant changes (FDR < 0.1, highlighted in green) across many genes. Genes are labeled that had an 
FDR < 0.1 and a log2FC > 1 or log2FC < -1. B GO analysis of all nominally significant genes. 
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Supplemental Figure 5: Biochemical and behavioral characterization of the Gtf2ird1+/- x Gtf2i+/-/Gtf2ird1+/- . A, 
B Western blot and qPCR confirm decrease in Gtf2i protein and mRNA. C Western blot shows that the large 
Gtf2ird1 deletion decreases the protein, but adding the one base pair insertion mutation does not further decrease the 
protein made. D Gtf2ird1 mutation increases mRNA abundance. E Replication of ledge task in independent cohort. 
F Gtf2i+/-/Gtf2ird1-/- females have increased activity levels. G Gtf2i+/-/Gtf2ird1-/-  males to a lesser extent have 
increased. H All genotypes showed a contextual fear memory response. I There is no difference between genotypes 
in shock sensitivity. 
Table 1: Behavior and animal cohort for Gtf2ird1+/- x Gtf2ird1+/- 
 
Table 2: Behavior and animal cohorts for the Gtf2ird1+/- x Gtf2i+/-/Gtf2ird1+/- 
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Supplemental Table S1: Table of summary statistics and statistical tests  
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Chapter 4: Gtf2i and Gtf2ird1 mutation are 
not sufficient to reproduce mouse phenotypes 
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region 
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4.1 Abstract 
Williams syndrome is a neurodevelopmental disorder caused by a 1.5-1.8Mbp deletion on 
chromosome 7q11.23, affecting the copy number of 26-28 genes. Phenotypes of Williams 
syndrome include cardiovascular problems, craniofacial dysmorphology, deficits in visual-spatial 
cognition, and a characteristic hypersocial personality. There are still no genes in the region that 
have been consistently linked to the cognitive and behavioral phenotypes, although human 
studies and mouse models have led to the current hypothesis that the general transcription factor 
2 I family of genes, GTF2I and GTF2IRD1, are responsible. Here we test the hypothesis that 
these two transcription factors are sufficient to reproduce the phenotypes that are caused by 
deletion of the Williams syndrome critical region (WSCR). We compare a new mouse model 
with loss of function mutations in both Gtf2i and Gtf2ird1 to an established mouse model lacking 
the complete WSCR. We show that the complete deletion model has deficits across several 
behavioral domains including social communication, motor functioning, and conditioned fear 
that are not explained by loss of function mutations in Gtf2i and Gtf2ird1. Furthermore, 
transcriptome profiling of the hippocampus shows changes in synaptic genes in the complete 
deletion model that are not seen in the double mutants.	Thus,	we	have	thoroughly	defined	a	set	of	molecular	and	behavioral	consequences	of	complete	WSCR	deletion,	and	shown	that	genes	or	combinations	of	genes	beyond	Gtf2i	and	Gtf2ird1	are	necessary	to	produce	these	phenotypic	effects.	
4.2 Introduction 
Contiguous gene disorders provide a unique opportunity to understand genetic 
contributions to human biology, as their well-defined genetic etiology delimits specific genomic 
regions strongly affecting particular phenotypes. Williams syndrome (WS; OMIM #194050) is 
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caused by a 1.5-1.8Mbp deletion of 26-28 genes on chromosome 7q11.23 in the Williams 
syndrome critical region (WSCR). Williams syndrome is phenotypically characterized by 
supravalvular aortic stenosis, craniofacial dysmorphology, and a distinct cognitive profile 
consisting of intellectual disability, severe visual-spatial deficits, yet relatively strong language 
skills. Other common cognitive and behavioral difficulties include high levels of anxiety, 
specific phobias, and a characteristic hypersocial personality manifested as strong eye contact, 
indiscriminate social approach, and social disinhibition  (see (2, 14, 15) for reviews). Despite 
increased social interest, individuals with Williams syndrome have difficulties with social 
awareness and social cognition (20, 174). In contrast, the reciprocal duplication results in 
dup7q11.23 syndrome (OMIM #609757), which presents with both similar and contrasting 
phenotypes to WS, such as high levels of anxiety yet less social interest (175). It is also 
associated with autism spectrum disorders (121). The recurrent deletion and duplications of 
chr7q11.23 indicate that one or more genes in this region are dose sensitive and have a large 
effect on human cognition as well as human social behavior.  
 Substantial efforts have been taken to understand which genes in the WSCR contribute to 
different aspects of the phenotype. Three approaches have driven advances in genotype-
phenotype correlations in the WSCR: phenotyping individuals with atypical deletions in the 
region, human induced pluripotent stem cell models, and mouse models. Patients with atypical 
deletions have firmly connected haploinsufficiency of the elastin  (ELN) gene with supravalvular 
aortic stenosis and other elastic tissue difficulties in WS (6, 104). However, human studies have 
not conclusively linked other genes to specific phenotypes. Three atypical deletions that span the 
ELN gene to the typical telomeric breakpoints showed the full spectrum of the WS phenotype, 
suggesting that most of the phenotypes are driven by the telomeric end of the deletion, which 
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contains genes for two paralogous transcription factors GTF2I and GTF2IRD1 (34, 35). Indeed, 
most of the atypical deletions that have been reported that delete the centromeric end of the 
region and don’t affect the copy number of GTF2I and GTF2IRD1, show mild to none of the 
characteristic facial features or cognitive and behavioral phenotypes of WS (31–33, 36–40, 99). 
While there are contrasting examples of deletions that spare GTF2I and still have mild facial 
characteristics of WS, lower IQ, and the overfriendly social phenotype (40, 176), the 
preponderance of evidence from these rare partial deletions have led to the dominant hypothesis 
being that GTF2I and GTF2IRD1 mutation are necessary to cause the full extent of the social, 
craniofacial, visual-spatial and anxiety phenotypes. However, there are limitations to these 
human studies, primarily due to the rarity of partial deletions. First, because of the variable 
expressivity of the phenotypes even in typical WS, it can be difficult to confidently interpret any 
phenotypic deviation in the rare partial deletions (20, 56, 174). Second, given the rarity of WS 
and partial deletions, and lack of relevant primary tissue samples, it is challenging to link genetic 
alterations to the specific downstream molecular and cellular changes that could mediate the 
organismal phenotypes. 
 To overcome this second barrier, researchers have turned to using patient induced 
pluripotent stem cells to study the effects of the WSCR deletion and duplication on different 
disease relevant cell types (44, 45, 47–49). While linking molecular changes to organismal 
behavior is not possible with cell lines, this approach is amenable to studying cellular and 
molecular phenotypes, such as changes to the transcriptome and cellular physiology. By studying 
differentiated neural precursor cells from an individual with a typical WS deletion and an 
individual with an atypical deletion that spares the copy number of the FZD9 gene, Chailangkarn 
et al. (45) showed that FZD9 is responsible for some of the cellular phenotypes, such as 
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increased apoptosis and morphological changes. Lalli et al. (49) used a similar approach to show 
that knocking down the BAZ1B gene in differentiated neurons was sufficient to reproduce the 
transcriptional differences and deficits in differentiation that were observed in WS differentiated 
neurons. Finally, Adamo et al. (44) studied the effects of GTF2I on iPSCs from typical WS 
deletions, dup7q11.23, and typical controls. By overexpressing and knocking down GTF2I in the 
three genotypes, they showed that GTF2I was responsible for 10-20% of the transcriptional 
changes. Overall, using iPSCs from patients with WS has highlighted a role for both the GTF2I 
family and other less appreciated genes in the molecular consequences of the WSCR mutation. 
This suggested the possibility that several genes may play a role in the cognitive phenotypes and 
GTF2I alone may not be sufficient for all neural molecular changes and hence cognitive 
phenotypes. However, iPSC studies face the limitation that they cannot be used to model whole 
organismal effects like anxiety or social behavior. Further, while some cellular and molecular 
phenotypes can be evaluated, both gene expression and cellular physiology using in vitro 
differentiation systems do not perfectly reflect the phenotype of mature neural cells, fully 
integrated into a functioning or dysfunctioning brain.  
 Mouse models have been used to link genes in WSCR to specific molecular and cellular 
phenotypes, as well as to the functioning of conserved organismal behavioral circuits that could 
be related to human cognitive phenotypes. Mouse models are particularly suitable because a 
region on mouse chromosome five is syntenic to the WSCR, enabling models of corresponding 
large deletions, including a mouse line with a complete deletion  (CD) of the WSCR genes that 
shows both behavioral disruptions and altered neuronal morphology (93). In addition, a key 
advantage over human partial deletions is that researchers can easily manipulate the mouse 
genome to delete targeted subsets of genes in the locus, and generate large numbers of animals 
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with identical partial mutations, enabling statistical analyses to overcome variable expressivity. 
For example, there are mouse models of large deletions that show that genes in the distal and 
proximal half of the region may contribute to separate and overlapping phenotypes (94). 
Likewise, many single gene knockouts exist that show some phenotypic similarities to the human 
syndrome, though a limitation is that some of these studies model full homozygous loss of 
function, rather than a hemizygous decrease in gene dose. Nonetheless, specifically for Gtf2ird1 
(92, 100, 101) and Gtf2i (29, 67, 96), multiple mouse models of either gene have shown 
extensive behavioral deficits including social and anxiety-like behaviors, some of which present 
contrasting evidence. However, each of these studies has been conducted in isolation, by 
different labs, with fairly different phenotyping assays, making it difficult to directly compare 
findings to other mouse models of WS.  
 Mouse models uniquely enable a direct way to test the sufficiency of individual 
mutations to recreate the organismal phenotypes detected when the entirety of the WSCR is 
deleted. By crossing different mutant lines together, we can create genotypes unavailable in 
human studies and conduct a well-powered and controlled study to directly test if specific gene 
mutations are sufficient to reproduce particular phenotypes of the full deletion. Since both human 
and mouse literature suggest that GTF2IRD1 and GTF2I each contribute to the molecular, 
cognitive, and social phenotypes, we set out here to test if loss of function of both of these genes 
is sufficient to recapitulate the phenotypes of the entire WSCR deletion at both the molecular and 
behavioral circuit levels, or if instead, as hinted by the iPSC studies and other human mutations, 
other or more genes may be involved. Using CRISPR/Cas9 we generated a new mouse line that 
has loss of function mutations in both Gtf2i and Gtf2ird1 on the same chromosome. We then 
crossed them to the CD full deletion model to directly compare behavior and transcriptomes of 
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the Gtf2i/Gtf2ird1 mutants to both WT and CD littermates. Examining both previously defined 
and newly characterized behavioral and molecular disruptions, we demonstrate that mutation of 
these two genes is not sufficient to replicate any of the CD phenotypes. In contrast to a dominant 
hypothesis arising from human partial deletions, this study provides strong evidence that 
Gtf2i/Gtf2ird1 mutation alone may not be responsible for key WS cognitive and behavioral 
phenotypes.  
4.3 Results 
4.3.1 Generation and validation of Gtf2i and Gtf2ird1 loss of function mutation 
on the same chromosome. 
Prior work from comparing phenotypes of humans with partial deletions of the WSCR 
highlighted GTF2I and GTF2IRD1 as likely involved in cognitive phenotypes in WS (34, 38, 
39). Likewise, single gene mutant mouse models of both genes showed that each may contribute 
to relevant phenotypes (92, 96, 97, 100, 101). We wanted to test if heterozygous loss of function 
mutants of both Gtf2i and Gtf2ird1 are sufficient to replicate the phenotypes that are caused 
when animals are hemizygous for the entire WSCR (Figure 1A).  
Therefore, to test the sufficiency of these genes, we generated a mutant of Gtf2i and 
Gtf2ird1 genes on the same chromosome using CRIPSR/Cas9. Two gRNAs were designed to 
target constitutive exons of Gtf2i or Gtf2ird1 (Figure 1B) and were co-injected with Cas9 
mRNA into the eggs of the FVB strain. Of the 57 pups born we detected 21 editing events using 
the T7 endonuclease assay. From these animals PCR amplicons around each targeted site were 
deeply sequenced and mutations were characterized via manual inspection of the reads in IGV. 
Of the founders there were five that only had mutations in Gtf2i, five with mutations only in 
Gtf2ird1, and 15 that had mutations in both genes (Supplemental Figure 1A). Most founders 
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had more than one allele within a gene indicating high rates of mosaicism (60%, 15/25 mice). 
Breeding a selection of the mosaic founders to WT animals revealed that some of the founders 
were mosaic in the germline as well (40%, 4/10 mice), with one founder transmitting three 
different alleles.  
 To test if haploinsufficiency of both Gtf2i and Gtf2ird1 is sufficient to replicate the 
phenotype of hemizygosity of the entire WSCR, we moved forward with characterizing a mouse 
line that has a G > C polymorphism followed by an eight base pair insertion in exon five of Gtf2i 
and a five base pair deletion in exon three of Gtf2ird1; these will be referred to as the Gtf2i* 
mouse line (Figure 1B). These mutations are inherited together indicating that they are on the 
same chromosome. The mutations cause frameshifts and introduce premature stop codons in 
early constitutive exons (Figure 1B), and were thus expected to trigger nonsense mediated decay 
and lead to loss-of-function alleles, mimicking the effective gene dosage of WSCR region 
deletions for these two genes.  
 We first performed RT-qPCR and western blots to confirm the effects of the frameshift 
mutations at the transcript and protein levels in embryonic day 13.5 (E13.5) littermates that were 
WT, heterozygous, and homozygous mutant at the locus. We used E13.5 brains for two reasons 
1) homozygosity of Gtf2i null mutants is embryonic lethal (87, 96) and 2) both Gtf2i and 
Gtf2ird1 proteins are more highly expressed during embryonic time points in the brain, with 
undetectable levels of Gtf2ird1 in the WT adult mouse brain (Supplemental Figure 1B and C). 
 The frameshift mutation in exon five of Gtf2i reduced the amount of transcript detected 
by qPCR, consistent with nonsense mediated decay. This mutation led to a 50% decrease of the 
protein in heterozygous animals and no protein in homozygous mutants (Supplemental Figure 
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1D). Indeed we were not able to recover pups that were homozygous for the Gtf2i* mutations 
after birth, but we were able to harvest homozygous embryos up to E15.5. The embryos had 
exencephaly consistent with other Gtf2i mouse models (87, 96).  
 In contrast, the frameshift mutations in exon three of Gtf2ird1 increased the amount of 
transcript, as expected. Increases in transcript of Gtf2ird1 due to a loss of function mutation have 
been described in another Gtf2ird1 mouse model, and both EMSA and luciferase reporter assays 
indicated that Gtf2ird1 protein represses the transcription of the Gtf2ird1 gene (66). The increase 
in transcript was commensurate with the dosage of the mutation (Supplemental Figure 1E). 
However, we saw that the protein levels in our mutants did not change with dosage of the 
mutation and did not follow the trend of the transcript (Supplemental Figure 1E).  
Production of detectable protein after the frameshift was surprising, especially since the 
increased Gtf2ird1 mRNA levels were indeed consistent with prior studies of loss of functional 
Gtf2ird1 protein, so we investigated this phenomena further. We noticed that the homozygous 
Gtf2ird1 protein bands looked slightly shifted in the western blots. This lead us to hypothesize 
that there could be a translation reinitiation event at the methionine in exon three downstream of 
the frameshift mutation in a different open reading frame (Supplemental Figure 1F). In another 
targeted mutation of Gtf2ird1, where the entire exon two, which contains the conical start codon, 
was removed, the authors noted that there was still three percent of protein being made, and the 
product that was made was similarly shifted (66). From our mutation we would expect a 65aa N-
terminal truncation, which corresponds to a 7KDa difference between WT. We ran a lower 
percentage PAGE gel to get better separation between WT and homozygous animals and we saw 
a slight shift, suggesting that there was reinitiation of translation at methionine-65 in a different 
open reading frame (Supplemental Figure 1G). This was indicative of the loss of the N-
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terminal end of the protein, which contains a leucine zipper that is thought to be important in 
DNA binding (66). This is consistent with the mRNA evidence that the allele is loss of function. 
We therefore tested the hypothesis that we had abolished the DNA binding capacity of 
the truncated protein, to confirm loss of function. We performed ChIP-qPCR and pulled down 
DNA bound to Gtf2ird1 protein and then amplified the promoter region of Gtf2ird1, which has 
previously been shown to be bound by the Gtf2ird1 protein. We compared this to two off-target 
regions in the genome near Bdnf and Pcbp3. We performed this experiment in E13.5 brains of 
WT and homozygous Gtf2i* embryos. There was a 15-20 fold enrichment of the on target 
Gtf2ird1 promoter region compared to the off target regions in the WT animals, while the 
truncated protein did not show any enrichment  (Supplemental Figure 1H,I). This suggested 
that while a truncated protein was still being made it did not have the DNA binding functionality 
of the WT protein. This indicated that the frameshift mutation in exon three of Gtf2ird1 was a 
loss-of-function mutation and provided evidence that the N-terminal end of the protein, which 
contains a leucine zipper, is necessary for DNA binding. Thus, we confirmed we had generated a 
mouse line with loss of function alleles on the same chromosome for these Gtf2i* genes. 
 To test the sufficiency of mutation in these two transcription factors to replicate 
phenotypes observed by deleting the entire WSCR, we crossed the Gtf2i* mutant to the CD 
mouse (Figure 1C), which is hemizygous from exon five of Gtf2i to Fkbp6 (Figure 1A). The 
Gtf2i* mutants were generated on the FVB/AntJ background, whereas the CD mice were 
generated on the C57BL/6J background. Therefore, we only used the first generation from this 
cross for all experiments to ensure all mice had the same genetic background. As above, we 
assessed the transcript and protein levels of genotypes from this cross to confirm loss of function. 
Again, the CD/Gtf2i* genotype was embryonic lethal, but we did observe that genotype up to 
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E15.5. The levels of Gtf2i transcript and protein were similar between CD heterozygous and 
Gtf2i* heterozygous animals (Figure 1D). The levels of Gtf2ird1 transcript increased in Gtf2i* 
animals similar to what was seen in Gtf2i* heterozygous animals on the pure FVB/AntJ 
background. In contrast, the CD heterozygous animals had decreased levels of Gtf2ird1 
transcript. In the CD/Gtf2i* animals the level of transcript returned to WT levels. Again, the 
levels of Gtf2ird1 transcript were not reflected in the protein levels. We saw a trend to similar 
slight decreases in protein levels in the both heterozygous genotypes; however, they were not 
significantly different from WT levels. This was interesting because in the CD animals were 
missing one entire copy of this gene, opposed to a frameshift mutation. This also suggested that 
the frameshift mutation in exon three of Gtf2ird1 did affect the amount of protein being made, 
but not drastically. We did see a significant decrease in protein levels (60% of WT) in the 
CD/Gtf2i* genotype (Figure 1E). Again suggesting that the frameshift mutation was decreasing 
the levels of protein.  
4.3.2 Gtf2i* mutation is not sufficient to reproduce WSCR-mediated 
alterations of vocal communication  
We next tested if haploinsufficiency for both genes would recapitulate behavioral 
phenotypes seen in mice hemizygous for the entire WSCR (CD mice) (Table 1). Since single 
gene knockout studies of both Gtf2i and Gtf2ird1, and larger deletion models showed evidence 
for disrupted social behavior we wanted to directly compare the effects of Gtf2i* 
haploinsufficiency to the effects of hemizygosity of the entire WSCR on social behavior.  
We first measured maternal separation induced ultrasonic vocalizations (USVs) in 
postnatal day three and postnatal day five pups. This is a form of developmental communication 
and was shown to be increased in mice that had three or four copies of Gtf2i compared to mice 
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with normal copy number or only one functional copy (29). We saw a significant effect of day 
(F1,116.00=5.43, p=0.021) and genotype on the call rate (F2,60.7= 6.09, p=0.004), as well as a 
genotype by day interaction (F2,61.64=6.80, p=0.002). Post hoc analysis within day showed that on 
day five CD mice made fewer calls than WT littermates  (p<0.001) and Gtf2i* mutant littermates 
(p=0.045) (Figure 2A). We included the weight of the mouse as a covariate to make sure the 
decrease in call number was not due to differences in weight. We saw that weight has a trending 
effect (F1,75.48=3.95, p =0.05), but the day by genotype interaction term remained significant. 
We also observed differences in the temporal and spectral features of the calls. There was 
a significant effect of genotype on pause length between bouts (F2,60=11.9069, p=4.31e-5), with 
CD mice exhibiting longer pauses on day five compared to WT mice ( p=0.0004) and Gtf2i* 
mice (p=0.0014); this is correlated with fewer calls produced by CD animals (Supplemental 
Figure 2A). There was a also significant genotype by day interaction for the duration of a call 
bout (F2,61=7.26, p=0.001), with CD mice exhibiting a shorter duration on day five compared to 
WT (p=0.046) (Supplemental Figure 2B). Overall, our study of vocalization provides evidence 
that Gtf2i and Gtf2ird1 mutation alone are not sufficient to produce a CD-like deficit in this 
behavior.  
Maternal-separation induced USVs are only produced during a transient period of 
development from postnatal day three to postnatal day 10, peaking at postnatal day seven and 
postnatal day nine in FVB/AntJ and C57BL/6J strains, respectively (177). Therefore the 
alteration in the CD animals could reflect an overall shift in developmental trajectory. To assess 
this, we checked weight gain and developmental milestones in our cohorts. No differences in 
developmental weights were observed between genotypes. The detachment of the pinnae at 
postnatal day five, a physical milestone, was similar across all genotypes  (χ2=2.593, p=0.4628, 
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Supplemental Table 1). However, there were weight deficits in CD animals in adulthood 
(Supplemental Figure 2C). There was a significant effect of day on weight (F4,240=1610.9, p < 
2.2e-16), a significant effect of genotype (F2,60=7.2059, p=0.001568), and a significant day by 
genotype interaction (F8,240=6.9258, p=3.332e-8). These data suggest that gross developmental 
delay in CD animals does not explain the observed communication deficit.  
4.3.3 Gtf2i* mutation is not sufficient to reproduce WSCR-mediated 
alterations of social behavior  
We went on to test adult social behaviors. We first applied the standard three-chamber 
social approach, which has not been reported in CD mice. In this task the mice are allowed to 
freely explore an apparatus with three chambers: a center chamber, a social chamber that 
contains a cup with a sex and age-matched mouse, and an empty chamber that only contains an 
empty cup (Figure 2B). This test measures the voluntary social approach of mice. We saw the 
expected preference for the social stimulus across all mice (F1,53=83.2013, p=1.894x10-12), with 
no impact of genotype (F2,53=1.1516, p=0.3239) or genotype by stimulus interaction 
(F2,53=0.5845, p=0.5609). Post hoc comparisons within genotypes confirmed that all genotypes 
spent significantly more time investigating the social stimulus than the empty cup (WT p <0.001; 
Gtf2i* p < 0.001; CD p=0.00456; Figure 2C). Thus, sociability as measured in this task is not 
sensitive enough to discern a hypersocial phenotype in these animals.  
In a test for social novelty, a novel stranger mouse was then placed in the empty cup. All 
genotypes showed the expected preference for the novel stimulus animal  (F1,53=50.3816, 
p=3.137x10-9), again with no effect of genotype  (F2,53=1.3948, p=0.2568) or genotype by 
stimulus interaction (F2,53=0.5642, p=0.5722). Post hoc comparisons showed that all the 
genotypes spent significantly more time investigating the novel stimulus  (WT p < 0.001; Gtf2i* 
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p =0.00321; CD p=0.0012; Supplemental Figure 2D). Additionally in this task, we did notice a 
significant effect of genotype on overall distance traveled (F2,53=3.98, p 0.024) with the Gtf2i* 
mutants traveling further distance than the WT animals in the sociability trial (p=0.0305; 
Supplemental Figure 2E), and a corresponding trend during  the social novelty trial (F2,53=2.87, 
p=0.115). This suggests that the double mutants have a slight hyperactive phenotype in this task 
that is not seen in the CD mutants.  
Previous reports on social phenotypes in mouse models of WS have described a lack of 
habituation to a social stimulus. To test this we repeated the three-chamber social approach task 
in a new cohort of animals with an extended sociability trial to test if the Gtf2i* mutants or the 
CD animals showed the preference for the social stimulus after the prolonged amount of time. 
Similar to the classic three-chamber results we saw a significant effect of the social stimulus in 
the first five minutes (F1,56=19.3683, p=4.891e-5), there was a trend of a genotype effect 
(F2,56=3.098, p=0.053) and no interaction (F2,56=0.4650, p=0.6350). Interestingly, we observed a 
significant preference for the social chamber in the WT and Gtf2i* mutants, but the CD animals 
only trended in this direction (Supplemental Figure 2F). To determine if the CD mutants do 
indeed maintain a prolonged social interest compared to WT littermates, we examined the last 
five minutes of the 30 minute sociability trial. While there was a significant effect of stimulus  
(F1,56=4.82, p=0.03), there was still no effect of genotype (F2,56=0.0523, p=0.949) or an 
interaction (F2,56=0.454, p=0.637). In fact, the significant effect of chamber was driven by the 
proportion of animals investigating the novel empty cup more than the social stimulus 
(Supplemental Figure 2G). These data lead us to conclude that the double mutants and CD 
animals show a WT-like habituation to social stimulus in this task.  
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 We also tested social dominance in the tube test in these mice. Previous studies using 
partial deletions of the WSCR showed that the proximal deletion which contains Gtf2i and 
Gtf2ird1 as well as deletions of both the proximal and distal regions in mice resulted in different 
win/loss ratios than WT mice and mice lacking just the distal end of the WSCR (94). In contrast, 
here, the Gtf2i* and CD animals did not exhibit dominance behavior different than chance would 
predict (WT vs Gtf2i* p=0.8318, WT vs CD p=1). Gtf2i* and CD animals also had similar 
proportions of wins when paired together (Gtf2i* vs CD p=0.6291) (Figure 2D).  
The contrasts in our findings with those reported in prior papers could be due to 
differences in background strain. Different inbred mouse strains show different dominance 
behavior (178), and other phenotypes, such as craniofacial morphology in WS models has been 
shown to be strain dependent (39, 95, 101). We tested the effects of the background strain of the 
Gtf2i* and CD models by performing the same task on the respective background of each line 
and comparing them to their WT littermates. Thi showed that the Gtf2i* mutants had a WT-like 
phenotype while the CD mice had a submissive phenotype with significantly more losses to WT 
littermates (Supplemental Figure 2H). Thus, the submissive phenotype of the CD allele is 
dependent on strain which is not observed in the Gtf2i* mutants. 
 Finally, we tested the male mice in a resident-intruder paradigm. In this task, male mice 
were singly housed for 10 days to establish their territory and, in a series of three test days, novel 
WT C57BL/6J animals were introduced into their territories as intruders. This task measures 
both social interactions and bouts of aggression between two freely moving animals (Figure 2E). 
In our study, only one mouse showed aggressive behavior towards the intruder mouse, so we did 
not further quantify this behavior. Assessment of the social interactions showed a significant 
main effect of genotype  (F2,31=5.241, p=0.011) with no effect of day (F2,62=2.470, p=0.093) or 
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day by genotyping interaction (F4,62=0.1095, p=0.978). Post hoc tests within each day showed 
that the CD animals spent less total time on day two (p=0.0248) and day three (p=0.0318) 
engaged in anogenital sniffing compared to the WT animals (Figure 2F). These differences 
could not be explained by differences in total activity levels between the genotypes (F2,31=1.399, 
p=0.262; Supplemental Figure 2I). The decrease in total time spent in anogenital sniffing was 
driven by a shorter average bout time (F2,31=5.852, p=0.007, Supplemental Figure 2J) and not 
the number of times the animals initiated the sniffing behavior (F2,31=2.7961, p=0.0765; 
Supplemental Figure 2K). The same differences also held for nose-to-nose sniffing (Figure 
2G). There was a significant effect of genotype (F2,31= 3.737, p=0.0352) and no effect of day 
(F2,62=3.01, p=0.056) or day by genotype interaction (F4,62=0.8156, p=0.520). Post hoc analysis 
showed that on day two the CD animals participated in nose-to-nose sniffing significantly less 
than the WT animals (p=0.0160), while the trend was present in the other days but was not 
significant. These results indicated that some aspect of social behavior was disrupted in these 
animals and Gtf2i* mutants could not recapitulate the full CD phenotype. While we predicted 
that the WS models would show increased social interest similar to the human condition, 
individuals with WS have difficulties with other aspects of social behavior, such as social 
cognition and social awareness (20, 174), which may be reflected in these data.  
4.3.4 Gtf2i* mutation is not sufficient to reproduce WSCR mediated 
alterations of motor behavior 
Along with a characteristic social behavior, WS also presents with other cognitive 
phenotypes including poor coordination, increased anxiety, specific phobias, repetitive 
behaviors, and mild intellectual impairment (21). Human studies and mouse models have 
suggested that GTF2I and GTF2IRD1 contribute in aspects of the visual-spatial deficits and other 
cognitive phenotypes (36, 38). These genes are also highly expressed in the cerebellum, which 
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could contribute to the coordination problems (72, 78). Therefore, we next tested if CD mice had 
any motor phenotypes and if haploinsufficiency of these two transcription factors were sufficient 
to reproduce any deficits.  
 We performed a sensorimotor battery to assess balance, motor coordination and strength 
in mutants and WT littermates. All genotypes were similar in the time to initiate walking, and 
reach the top of a 60 degree inclined screen or a 90 degree inclined screen. All genotypes were 
able to hang onto an inverted screen for the same amount of time (Supplemental Figure 3A-D). 
CD animals were significantly quicker on turning around on a pole and quicker to get off of the 
pole than WT animals (Supplemental Figure 3E-F), which may be related to body size. There 
was a significant effect of genotype on time to fall in the ledge task (H2=12.505,p=0.001925), in 
which CD animals fell off the ledge faster than either WT (p=0.0071) or Gtf2i* (p=0.0069) 
littermates (Figure 3A). Similarly, there was a significant effect of genotype on the time spent 
balancing on a platform task  (H2= 7.1578, p=0.02791) (Supplemental Figure 3G). Despite their 
comparable performance in strength and coordination tasks, the CD animals tended to have 
poorer balance, while the double mutants performed similar to WT animals. These findings 
suggest that other genes in the WSCR contribute to this balance deficit. 
To test motor coordination in a more sensitive manner, we evaluated the mice on an 
accelerating rotarod. This task was performed over three days and tests coordination by 
quantifying how long a mouse can stay on a rotating rod. There was a main effect of day  (F2,339 
= 81.58, p< 2.2x10-16 ) and a main effect of sex (F1,63=10.0227, p = 0.002383), but no main 
effect of genotype (F2,63=2.0394, p=0.13861). We did not observe a sex by genotype interaction 
(F2,63=0.8155, p=0.447035) but did see a day by genotype interaction (F4,333=3.6270, 
p=0.006558). A post hoc comparison between genotypes within each day of testing showed that 
 
 
150 
Gtf2i* animals fell off more quickly compared to CD animals on day three (p=0.04) with no 
difference between WT and CD animals (Supplemental figure 3H). In contrast to the balance 
deficit seen on the ledge task but consistent with pole and screen performance, the rotarod results 
showed that all genotypes have similar motor coordination.  
Marble burying is a species-specific behavior that assesses the natural tendency of mice 
to dig. This task also requires motor skills and has been used as a proxy for repetitive behaviors 
(179), which are seen in individuals with WS. It has been previously shown that CD animals 
bury fewer marbles than WT littermates (90, 91). Here we similarly show that there was 
significant effect of genotype in this task (F2,66=15.243, p=3.61x10-6). CD animals buried fewer 
marbles than both WT (p<0.001), and Gtf2i* mutants  (p=0.000265)  (Figure 3B), indicating 
that Gtf2i* mutation is not sufficient to recapitulate CD phenotype. The differences in marble 
burying was not explained by any differences in activity levels between the genotypes during the 
task (F2,65=0.8974, p=0.4126; Supplemental Figure 3I). However, we did see a significant 
effect of genotype on distance traveled in the center of the apparatus (F2,66=13, p=0.0015), with 
CD mice traveling less distance in the center compared to WT (p=0.0301) and Gtf2i* (p=0.002) 
littermates (Figure 3C). There was also a corresponding significant effect of genotype on time 
spent in the center (F2,66=14.389, p=0.00075) with CD mice spending less time in the center than 
WT (p=0.0079) and Gtf2i* (p=0.0017) littermates. Avoidance of the center is generally 
interpreted in rodents as an increase in anxiety-like behavior (Figure 3D). Thus, these results 
provided further support to the hypothesis that genes besides Gtf2i* contribute to an anxiety-
related phenotype. It also suggested that the decreased marbles buried may be secondary to the 
decreased time in center and could reflect a phenotype secondary to anxiety rather than a direct 
stereotypy phenotype.  
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Finally, to test if the mutants have normal sensorimotor gating we looked at PPI. Similar 
to other tasks, contrasting evidence has been observed in WS mouse models in this task. Mouse 
of models of just Gtf2i showed no phenotype (96), whereas the proximal deletion mice showed 
decreased PPI; however, when combined with the distal deletion the phenotype that was 
suppressed (94). Here we show that all genotypes exhibited the expected increased PPI with an 
increasing pre-pulse stimulus (F2,112=620.61, p < 2e-16), but with no effect of genotype 
(F2,56=0.7742,p=0.466) or a pre-pulse by genotype interaction (F4,112=1.926,p=0.111)  
(Supplemental Figure 3J). A decrease was observed for overall startle response to the 120dB 
stimulus by CD animals, but when we included weight in the statistical model this effect 
disappeared (genotype F2,55=1.48, p=0.2365; weight F1,55=26,001, p=4.34e-6). Thus, the only 
phenotypic difference seen simply reflected the smaller size of the CD mice and not a change in 
sensorimotor gating (Supplemental Figure 3K).  
4.3.5 WSCR mutation does not produce robust anxiety-like behaviors 
 WS patients have heightened anxiety (21), and mouse models of Gtf2i (67, 96) and 
Gtf2ird1 (100, 101) mutations have produced mixed evidence to support the role of these genes 
in anxiety phenotypes. Larger deletion models that have either the proximal or distal regions 
deleted showed anxiety-like phenotypes in the open field, but not in light-dark boxes (94). 
Similarly the CD model has been shown to not have any differences in the open field task (93). 
We wanted to directly compare animals with Gtf2i and Gtf2ird1 mutations to CD animals in the 
same tasks to test exploratory and anxiety-like phenotypes. First, we looked at the behavior of 
the mice in an one hour locomotor activity task. We did not see any effect of genotype on the 
total distance traveled (F2,66=0.6324, p=0.53449), however there was a trend towards a time by 
genotype interaction (F10,330=1.7817, p=0.06283; Figure 3E) with the Gtf2i* mutants traveling 
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further distance. This was consistent with the behavior observed during the three-chamber social 
approach task. In contrast to the marble burying task, here we did not see a significant main 
effect of genotype on the time spent in the center of the chamber (F2,66=2.3104, p=0.10720) 
though we observed a trend in the first ten minutes for CD mice to spend less time in the center 
(Figure 3F). However, the Gtf2i* mice did not show a similar trend. To further test for anxiety-
like phenotypes, we performed elevated plus maze testing. Across the three days of testing, all 
genotypes spent similar percent time in the open arms of the apparatus (F2,63=0.6351, p=0.5332; 
Supplemental Figure 3L). Overall, our experiments indicate there may be a subtle increase on 
some tasks in anxiety-like behavior in CD mice. However, if there is such a phenotype, we see 
no evidence that Gtf2i* mutations are sufficient to produce it.  
4.3.6 Gtf2i* mutation is not sufficient to reproduce WSCR mediated 
alterations of fear conditioning 
 Finally, as patients with WS have both intellectual disability and increased prevalence of 
phobias (21, 180), we tested associative learning and memory of the mice using a contextual and 
cued fear conditioning paradigm. These behaviors are also mediated by brain regions that have 
shown to be altered in mouse models of WS and human patients, namely the amygdala and 
hippocampus. Individuals with WS have altered structural and functional reactivity in the 
hippocampus and amygdala as reviewed in (15) compared to typically developing controls. Both 
of these regions play a role in both contextual and cued fear conditioning (181). Likewise, CD 
mice have been shown to have altered morphology and physiology in the hippocampus (93, 182), 
thought to be important in contextual fear conditioning.  
We therefore tested associative learning and memory of the animals using a three day 
conditioned fear task (Figure 4A). During the conditioning trial on day one we saw a significant 
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difference in baseline freezing during the first two minutes, when the mice were initially 
exploring the apparatus. There was a main effect of genotype  (F2,53=5.31,p=0.00794) and a main 
effect of minute (F1,53=7.28, p=0.009), with the CD animals freezing more than the WT animals 
(p=0.04) and the Gtf2i* mutants (p=0.05) during minute one prior to any shock. By minute two 
of baseline, all animals showed similar levels of freezing. During the pairing of the foot shock 
with the context and tone during minutes three through five, we saw a significant effect of time 
(F2,106=100.3071, p < 2.2x10-16) and genotype (F2,53=3.4304, p=0.039723) as well as a time by 
genotype interaction (F4,106=3.9736, p = 0.004812). Specifically, all mice increased the amount 
of freezing after each foot shock, but after the last foot shock the Gtf2i* mutants froze less than 
the CD animals (p=0.002; Figure 4B), but similarly to the WT littermates. On the subsequent 
day, to test contextual fear memory, mice were put back in the same apparatus and freezing 
behavior was measured. Comparing the average of the first two minutes of freezing during fear 
memory recall on day two to the baseline of the conditioning day, we saw that all genotypes 
exhibited contextual fear memory; indicated by the increased levels of freezing when put back in 
the same context they were conditioned in (F1,53=36.4882, p=1.56x10-7; Supplemental Figure 
4A). Looking across time during the fear memory recall we saw a significant effect of time 
(F7,371=2.7166, p=0.009291) with no main effect of genotype  (F2,53=1.2507, p=0.294625), but a 
time by genotype interaction (F14,371=2.499, p=0.002085). Post hoc analysis within time showed 
that CD mice froze more than WT and Gtf2i* littermates during minute three of the task (Figure 
4C). 
To test cued fear conditioning, on the subsequent day the mice were put in a different 
context and were played the tone that was paired with the foot shock during the conditioning 
day. All animals had similar freezing behavior during baseline (F2,53=1.061, p=0.353). For the 
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duration of the tone, there was a significant effect of time (F7,371=21.5824, p<2x10-16) but no 
effect of genotype (F2,53=0.3014, p=0.741) or genotype by time interaction (F14,371=0.2128, 
p=0.999) (Figure 4D). Finally, the differences in freezing behavior could not be explained by 
sensitivity to the foot shock as all mice showed similar behavioral responses to increasing shock 
doses (F2,56=1.4521, p=0.2427; Supplemental Figure 4B). Overall, CD mice showed an 
enhancement of fear response to a contextual fear memory, and mutations in Gtf2i* were not 
sufficient to reproduce this phenotype. 
4.3.7 Gtf2i* mutation is not sufficient to reproduce WSCR mediated 
alterations of hippocampal gene expression. 
 In addition to permitting behavioral phenotyping, mouse models also allow for well-
powered and controlled examination of the molecular consequences of mutation in the 
environment of a fully developed and functioning central nervous system. Therefore, we turned 
from behavioral phenotyping of cognitive tasks to molecular phenotyping in the brains of these 
mice to 1) identify candidate molecular mediators of the behavioral phenotypes and 2) determine 
to what extent any transcriptional phenotype of WSCR mutation might be mediated by the 
haploinsufficiency of these two transcription factors. We specifically focused on the 
hippocampus, since we saw deficits in marble burying and differences in contextual fear 
memory, two behaviors thought to be mediated by hippocampal function (159, 181). Other 
studies in the CD animals have also shown there to be differences in LTP in the hippocampus as 
well as differences in Bdnf levels (91, 182). Yet the transcriptional consequences genome-wide 
of WSCR loss hav not been characterized in the hippocampus.  
 First, we conducted a targeted analysis of the genes in the WSCR locus. Of the 26 genes 
that make up the WSCR, only 15 were measurably expressed in the adult mouse hippocampus. 
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Consistent with expectation, all genes in the WSCR region showed a decrease in RNA 
abundance in the CD animals, and genes that lie immediately outside the region were not 
affected. Gtf2i* mutants only showed disruption of Gtf2i and Gtf2ird1 in directions consistent 
with what was previously seen in our RT-qPCR. This confirmed the genotype of the samples, 
and indicated that these transcription factors are not robust trans regulators of any other genes in 
the locus  (Figure 5A).  
 Next, we conducted differential expression analysis comparing WT to CD littermates to 
identify the molecular consequences of WSCR loss. At an FDR < 0.1 we found 39 genes to be 
differentially expressed. Of the 39 genes, 15 were genes that are located in the WSCR. This 
small number of differentially expressed genes was surprising given that several of the WSCR 
genes are described as transcription factors. In addition to these differentially expressed genes, 
the magnitude of the changes were small (Figure 5B and Supplemental Figure 5A). 
Interestingly, Slc23a1 showed to be slightly but consistently more lowly expressed in the CD 
animals compared to the WT animals. This is a GABA transporter, suggesting that inhibitory 
signaling could be altered in the hippocampus. This gene has also been shown to decreased in 
WS-derived cortical neurons (45). Also of note, the Iqgap2 gene was shown to be elevated in the 
CD animals compared to WT animals. This gene was also upregulated in WS iPSCs (44). We 
also looked at genes that have been investigated previously in the CD mouse, such as Bdnf and 
Pi3kr (90, 91) and we show that there was little change in gene expression between genotypes 
(Supplemental Figure 5B).  
 To determine if Gtf2i* loss is sufficient to drive these transcriptional changes, we next 
examined differential expression comparing Gtf2i* mutants to WT littermates. In contrast to 
WSCR mutation, we found only Gtf2i and Gtf2ird1 to be differentially expressed at an FDR < 
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0.1 (Figure 5C). To get a broader idea of how similar the transcriptomes of the two genotypes 
are we compared the genes that are nominally up and downregulated between each mutant line 
and WT controls. We saw that there was about a 9% overlap between CD and Gtf2i* up and 
down regulated genes  (Figure 5D). This is slightly below the amount of genes shown to be 
changed by GTF2I in iPSCs (44). Again this suggests that other genes in the WSCR are driving 
90% of the transcriptional changes in the CD hippocampus.  
To understand what role the nominally changed genes have in common we conducted a 
GO analysis. The biological processes that the CD genes were found to be involved in included 
synaptic functioning as well as nervous system differentiation. Interestingly processes that 
control balance were enriched and we and others have reported on balance deficits in CD 
animals (Figure 5E). When comparing these to 1000 random differential gene lists these 
biological processes are very specific to the genotype comparisons. For instance, out 1000 
random test, positive regulation of excitatory synapses only occurred in the top 10 enriched GO 
terms two times (Supplemental Table 2). The cellular components that the genes are enriched 
for are extracellular, which is a similar result to the iPSC studies (44), as well as synapses. The 
molecular function ontologies, which are enriched for the differentially expressed genes included 
calcium binding  (Supplemental Figure 5). When comparing these to randomly determined 
gene expression changes, all but the extracelluar components seem to be specific to the CD 
versus WT comparison  (Supplemental Table 2). In contrast, the Gtf2i* GO analysis showed 
that these genes are enriched for more general organ system development and are not very 
nervous system specific  (Figure 5F and Supplemental Table 3).  
Overall, we have shown that the hemizygous loss of the WSCR has a mild but significant 
effect on the hippocampal transcriptome. Yet, the changes that do occur point to aberrations in 
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synapses and nervous system development. Furthermore, loss of function mutations in Gtf2i and 
Gtf2ird1 have an even smaller effect on the transcriptome and can only account for 9% of the 
changes incurred by loss of the WSCR.  
4.4 Discussion  
Contiguous gene disorders such as WS provide insight into regions of the genome that 
have large effects on specific aspects of human cognition and behavior. The specific cognitive 
profile of WS is characterized by deficits in visual-spatial processing with relative strengths in 
language, and the archetypal behavioral profile consists of increased social interest, strong eye 
contact, high levels of anxiety, and in some cases specific phobias and hyperactivity. Here we 
used a new mouse model to test if loss of the paralogous transcription factors Gtf2i and Gtf2ird1 
are sufficient to phenocopy the behaviors and transcriptomic changes of mice that lack the entire 
WSCR.  
 Overall, CD mice consistently have more severe phenotypes than the Gtf2i* mutants. We 
saw that the CD animals have a deficit in social communication as measured by maternal 
separation induced pup ultrasonic vocalizations. The Gtf2i* mutants on average make fewer calls 
than the WT littermates, however not significantly so, but this may suggest that these two 
transcription factors contribute slightly to this phenotype but other genes in the region are 
necessary to produce the full phenotype seen in the CD animals. Previously it was shown that 
animals that have increased copy number of Gtf2i increased the number of pup USVs emitted 
while animals with only one copy produced similar number of calls to WT animals (29). This 
was interpreted as increased separation anxiety. Here we see that lower copy number of the 
entire region produces the opposite effect of increased Gtf2i copy number. Decreased USVs 
could mean there is a lack of motivation to make the calls or an inability to make as many calls. 
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A model of Gtf2ird1 mutant animals was shown to have different USV production due to a 
difference in the muscle composition of the larynx (92). This has not been shown in the CD 
animals but it could contribute to the phenotype as well as differences in the skull morphology 
(93). Another possible explanation is that since the production of USVs is a developmentally 
regulated trait, it could be that deleting 26 genes could disrupt typical developmental trajectories. 
While we do not see any gross developmental problems such as lower weight or delayed 
detachment of pinnae, the deletion could have a more severe effect on brain development, thus 
affecting developmentally regulated behavioral traits. 
 To our surprise, there was no detectable social phenotype in the Gtf2i* mutants or CD 
animals in the classical three-chamber social approach assay. Our results showed that all 
genotypes on average prefer to investigate the social stimulus for a similar amount of time. The 
preference for social novelty is also intact across all the groups. In an attempt to test if the WS 
models fail to habituate to a social stimulus we showed that after thirty minutes of having the 
opportunity to investigate an unfamiliar mouse or an empty cup, all genotypes habituate to the 
social stimulus and by the end of the thirty minutes seem to have a small preference for the 
empty cup. The three-chamber social approach task has been done in the larger partial deletion 
models where they have shown that the proximal deletion and the trans full deletion models have 
a significant preference for the social stimulus, and the WT and distal deletion mice do not show 
a preference, suggesting that the proximal deletion, which harbors genes such as Gtf2i and 
Gtf2ird1, are involved in this social task (94). Mouse models that are haploinsufficient for only 
Gtf2i have shown in the three-chamber approach task that after eight minutes WT animals 
investigate a novel object the same amount as a social stimulus, but the Gtf2i mutants still have a 
significant preference suggesting a lack of habituation (96). In another Gtf2i model, Martin et al. 
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compared animals with one, two, three, and four copies of Gtf2i in the three-chamber social 
approach task, and showed that only animals with one and three copies of Gtf2i displayed a 
significant preference for the social stimulus (97), but WT animals did not. These three-chamber 
social approach tests are interpreting a lack of significance as evidence for increased social 
behavior and not directly comparing the levels of investigation between genotypes (183). 
Furthermore, in some cases the WT controls are not showing the expected preference for the 
social stimulus, thus, possibly confounding interpretation of the mutant preference.  
The three-chamber social approach assay has come under recent criticism due to how 
dependent it is on activity levels of mice and its lower heritability compared to tests of direct 
social interaction (184). The CD animals had not previously been tested in this procedure 
exactly, but have been tested in a modified social approach where the time spent investigating a 
mouse in a cup is measured but with no competing non-social stimulus (90, 91, 93). The data 
showed that the CD animals investigated the social stimulus for more time than the WT animals 
and delivery of Gtf2i cDNA by AAV9 via the magna cisterna can return the investigation time to 
normal levels (90). Here, we showed that all animals preferred the social stimulus. It is possible 
that the standard social approach suffers from several confounding factors, such as lower 
heritability, as well as activity and anxiety-like components that make this task less sensitive to 
detect a hypersocial phenotype in WS models. It could also be that the three-chamber social task 
does not test the specific aspects of social behavior that are disrupted in WS models. For 
example, newer tasks, such as social operant tasks that test motivation to receive a social 
stimulus may more directly test the aspects of social behavior that are affected in WS. This task 
has been performed on Gtf2i mutants and mice that have only one copy of Gtf2i will work harder 
to receive a social reward (97).  
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Direct social tasks have higher heritability than the three-chamber social approach and 
offer a more natural social experience (184), which may make them a more sensitive assay for 
testing social behaviors. Direct tasks have shown that Gtf2i models have increased nose-to-nose 
investigation time (97), mouse models lacking the proximal end of the region have increased 
investigation frequency (94), and Gtf2ird1 mutants make fewer aggressive actions but show 
increased following time (101). We employed the resident-intruder paradigm as a full contact 
social assay. While we did not see bouts of aggression from any of the genotypes, we could see 
differences in social investigation. To our surprise, the CD animals spent less time overall in 
anogenital sniffing and nose-to-nose sniffing of the intruder animals when compared to WT 
littermates. The double mutants were not significantly different from the WT animals but had 
intermediate values between the WT and CD animals. This phenotype was being driven by the 
decreased time per bout of investigation in the CD animals, as all genotypes had a similar 
frequency of the sniffing behavior. This result was contrary to what would be predicted from the 
human condition and previous mouse results. However, while individuals with WS are described 
as having prosocial behavior in terms of increased social approach and friendliness (19), they 
also have difficulties maintaining long term relationships because of deficits in other aspects of 
social behavior (20, 27, 28, 174), and on scales measuring social reciprocity often score in the 
autistic range (174). In addition, there is a high co-morbidity with ADHD which has features of 
impulsiveness (22).  While the CD animals did not show the expected increase in social interest, 
this may be a manifestation of attention deficits that are present from deleting the 26 genes in the 
WSCR, but this needs to be examined. Loss-of-function mutations in Gtf2i and Gtf2ird1 were 
not sufficient to produce as strong an effect in these investigative behaviors. However, the 
somewhat intermediate effect suggests they could contribute to it.  
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One limitation of our study is that some aspects of the social phenotype in the models 
tested here could be masked by the mouse background strain. While we have controlled for 
mouse background strain in our experiments by only using the F1 generation of the FVB/AntJ 
and C57BL/6J cross, the hybrid background may prevent the manifestation of a social phenotype 
caused by the mutations tested. For example, it has been documented that craniofacial 
phenotypes in Gtf2ird1 models are sensitive to background strain (39, 78, 95, 101). Here, the 
double mutants and CD animals on the hybrid background showed no dominance phenotype in 
the tube test. However, when we tested each mutation on the respective mouse background 
strain, we saw that the CD animals had a submissive phenotype, but the double mutants did not. 
Studies done in the larger partial deletions have shown altered win/loss ratios in the tube test in 
the proximal deletion and full trans deletion models (94), suggesting that the CD models on the 
C57BL/6J background can replicate this phenotype, but other genes in the proximal region 
besides Gtf2i and Gtf2ird1 are also required.  
In this study, we have replicated several of the phenotypes previously seen in the CD 
animals, such as marble burying and balance deficits (91, 93, 182). It was shown that CD 
animals bury fewer marbles than WT animals and rescuing the Gtf2i levels in the hippocampus 
did not rescue this phenotype. Both the results presented here and in Borralleras et al. suggest 
that other genes in the region beyond Gtf2i and Gtf2ird1 are important in this behavior. Here we 
have extended the results to suggest that there could be an anxiety-like component to the marble 
burying deficit. By tracking the animals during the task we see that CD animals spend less time 
and travel less distance in the center of the apparatus. This could preclude them from burying as 
many marbles in the center. It could also be that the CD animals do not show the normal 
motivation to dig.  
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CD animals showed difficulty in balancing tasks, but normal motor coordination. Motor 
coordination of WS has been tested using the rotarod.  The larger partial deletion models showed 
that the distal deletion and proximal deletion mice had intermediate phenotypes with the full 
trans deletion mice falling off the rotarod sooner (94). Similarly the CD mice have shown 
deficits in the rotarod and addition of Gtf2i coding sequence does not rescue this phenotype 
(182). The CD mice in this study did not show a deficit in the rotarod despite having poor 
balance on the ledge and platform tasks. CD animals were not able to balance on a ledge or 
platform as long as their WT and Gtf2i* mutant littermates. This suggests that motor 
coordination, as tested by our rotarod paradigm, is intact in these WS models, but balance is 
specifically affected in the CD animals. The discrepancy could be due to body size. The adult 
CD animals are significantly smaller than the WT and Gtf2i* mutants, which could make staying 
on the wider rotarod less challenging. This study also used a different accelerating paradigm 
where the rod itself is continuously accelerating until the mouse falls off while other paradigms 
test the mice at different continuous rotation speeds.  
Along with balance and coordination problems, individuals with WS tend to have 
specific phobias and high levels of non-social anxiety (21). We showed that CD animals had an 
altered fear conditioning response. We saw that the CD animals have an increased fear response 
in contextual fear but not cued fear. It was previously reported that CD animals showed a slight 
decrease in freezing but was not significant (93). Two separate Gtf2ird1 mutations have shown 
contrasting results, one showed an increased fear response (99) while another showed decreased 
fear response (101). It could be that this hybrid background used here is more sensitive to see 
increases in freezing because FVB/AntJ do not exhibit as much freezing in conditioned fear tasks 
as C57BL/6J animals (185). The observed increased contextual fear response could be due to 
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differences in the hippocampus and amygdala, both regions that have been shown to be disrupted 
in WS.  We did not see a robust anxiety-like behavior phenotypes in one hour locomotor task or 
the elevated plus maze, which is consistent with previous findings in the CD model (93). 
However, we did see reduced time and distance traveled in the center during the marble burying 
task. Perhaps suggesting that the novel environment in combination with the novel marbles can 
induce slightly higher levels of anxiety in the CD model.   
Given the behavioral differences in marble burying and contextual fear, two behaviors 
thought to be mediated by the hippocampus (159, 181), we examined the transcriptomes of the 
hippocampus of the Gtf2i* mutants and CD animals and compared them to WT littermates. This 
provided the first transcriptional profile documenting the consequences of the 26 gene deletion in 
a mature brain, and allowed us to determine what portion of that was driven by Gtf2i* proteins. 
Surprisingly, we did not see any significantly differentially expressed genes between the Gtf2i* 
mutants and WT littermates, besides the mutated genes themselves. Looking at the overlap of 
nominally differentially expressed genes between CD-WT and Gtf2i*-WT comparisons, showed 
a small overlap of about 9%. This is slightly less than the estimate from Adamo et al., of 15-20% 
of genes dysregulated in WS iPSCs being attributed to reduced levels of GTF2I. Perhaps these 
general findings suggest that Gtf2i and Gtf2ird1 contribute to small transcriptional changes 
broadly across the genome, and in combination with other genes in the WSCR more profound 
neural specific gene disruptions become apparent. 
Our transcriptional studies overall showed limited impact of Gtf2i* mutation in the brain.  
The global brain transcriptome of Gtf2i mutants has not been investigated, but brain 
transcriptome studies of Gtf2ird1 knockout mouse models have not found any evidence of 
differentially expressed genes (88). These data suggest that in the adult hippocampus these two 
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transcription factors do not greatly affect the transcriptome. There are some limitations to this 
negative result.  It could be that we are diluting some of the signal because we are studying the 
effects on the transcriptome of the whole hippocampus, which has a diverse cellular 
composition. Larger effect sizes might be detected in more homogenous cellular populations.  
Likewise, if these genes regulate dynamics of gene expression rather than baseline values, 
greater differences might become apparent after experimental manipulations that activate 
transcription.   
One additional limitation of our study is that the mutated Gtf2ird1 allele is still producing 
an N-terminally truncated protein.  However, we show that N-truncated Gtf2ird1 does not bind to 
its known target, the promoter region of Gtf2ird1, and this absence leads to increased RNA from 
the locus, consistent with a loss of its transcriptional repressor function.  Thus, we confirmed this 
truncated protein is a loss of function for the only known roles for Gtf2ird1. However, it is 
possible that the protein does have other unknown functions we could not assay here. It has also 
been proven to be a remarkably challenging gene to completely disrupt, across multiple studies 
(66, 101).  The combination of the upregulation of its RNA upon deletion with the ability to re-
initiate at a variety of downstream codons is intriguing.  One possibility is that Gtf2ird1 has an 
unusual amount of homeostatic regulation at both transcriptional and translational levels that are 
attempting to normalize protein levels.  Another possibility is that these kinds of events are 
actually quite common across genes, but that they are detected in Gtf2ird1 because the WT 
protein is at such low abundance it is on par with what is actually an infrequent translation re-
initiation event.  Our detection of Gtf2ird1 protein in the brain required substantial optimization 
and is still only apparent in younger brains. Indeed, in validations of mutations of more abundant 
proteins, the immunoblots may not be routinely developed long enough to see a trace re-
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initiation event that might occur.  Regardless, future studies aimed at understanding the 
transcriptional and translational regulation of this unusual gene would be of interest. 
Examining the profile of CD mutants compared to WT littermates, we do define a 
number of transcriptionally dysregulated genes. Of the genes in WSCR that are expressed in the 
hippocampus all had decreased expression in the CD animals. In addition, there were 24 genes 
outside the WSCR that had a FDR < 0.1 between CD and WT controls. Among these genes is 
Slc23a1, the GABA vesicle transporter, which is down regulated in CD animals. Interestingly 
this gene was also found to be down regulated in human iPSC derived neurons from individuals 
with WS (45). This points to aberrant inhibitory activity in the CD brain, which could lead to 
functional deficits. Also consistent with other human WS derived iPSC studies, the gene Iqgap2 
was shown to be upregulated in the CD hippocampus (44), and has the potential to interact with 
the cytoskeleton through actin binding (186). Broadening the analysis to include nominally 
differentially expressed genes and conducting systems-level analyses, the CD-WT comparison 
highlighted genes involved in the positive regulation of excitatory postsynaptic potential. 
Chailangkarn et al. showed that WS derived iPSC neurons had increased glutamatergic synapses. 
Our data also showed some signal in the GO term for postsynaptic density assembly. Taken 
together these data suggest abnormal synapse functioning in the CD animals and potentially 
altered inhibitory/excitatory balance.  This also suggests pharmacological agents that increase 
GABA tone may be of use in reversing some WS phenotypes.  The RNA-seq data also had signal 
in neuromuscular processes controlling balance. Altered gene expression in the CD animals 
could be contributing to the balance deficits. In contrast to the synapse and neural specific GO 
term enrichment seen in the CD-WT comparison, comparing the transcriptomes of the Gtf2i* 
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mutants and WT shows signal in more general organ development, such as ossification and eye 
development.  
Taken together, our results support the hypothesis that other genes in the WSCR besides 
Gtf2i and Gtf2ird1 are necessary to produce some phenotypes that are seen when the entire 
WSCR is deleted. While these two transcription factors have been highlighted in the human 
literature as large contributors to the WS phenotype, the literature is also consistent with a model 
where most genes contribute to aspects of different phenotypes in WS, but the full phenotypic 
effects occur when all the genes are deleted  (Figure 6). Studying patients with atypical deletions 
highlights the variability of the region. Even within families that have inherited small deletions 
some of the cardiovascular, cognitive, and craniofacial phenotypes have incomplete penetrance 
(31, 32, 40). Comparing the deletion sizes and corresponding phenotypes shows a large overlap 
of genes that are deleted, but no clear pattern of which specific phenotypes are affected. Many of 
atypical deletions described to date that do not have Gtf2i and Gtf2ird1 deleted show no 
overfriendly phenotype, but there are examples where this is not true. Recent work in zebrafish 
that was done to dissect which genes in the 16p11.2 region contribute to craniofacial 
dysmorphology led to a similar conclusion, that multiple genes in the region contribute to the 
phenotype but in combination some have synergistic effects and others have additive effects 
(102). Sanders et al. also suggested that copy number variations with higher gene content are 
more likely to have several genes of smaller effect sizes suggesting an oligogenic pattern of 
contribution (121). Our data suggests that looking beyond the general transcription factor 2I 
family at possible combinations of more genes in the region may more completely reproduce the 
WS phenotype. Given the ease of making new mouse models with current genome editing 
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technology, a combinatorial dissection of the region is feasible and could lead to interesting new 
insight into the underlying mechanisms that contribute to the phenotypic spectrum of WS. 
4.5 Materials and Methods 
Generating genome edited mice 
sgRNAs were designed to target early constitutive exons of the mouse Gtf2i and Gtf2ird1 
genes. The gRNAs were cloned into the pX330 Cas9 expression plasmid (Addgene) and 
transfected into N2a cells to validate the cutting ability of each gRNA using the T7 enzyme 
assay. Primers used to amplify target regions tested by the T7 enzyme assay are in Supplemental 
Table 4. One guide was selected for each gene based on cutting activity  (Supplemental Table 4). 
The gRNAs were in vitro transcribed using MEGAShortScript  (Ambion) and Cas9 mRNA was 
in vitro transcribed, G-capped, and poly-A tailed using the mMessageMachine kit (Ambion). The 
mouse genetics core at Washington University School of Medicine co-injected the Cas9 mRNA 
(25ng/ul) along with both gRNAs (13ng/ul of each gRNA) into FVB/NJ fertilized eggs and 
implanted the embryos into recipient mothers. This resulted in 57 founders. Founders were 
initially checked for any editing events using the T7 assay. There were 36 animals with no 
editing events. We deep sequenced the expected cut sites, as described below, in the remaining 
21 founders to identify which alleles were present.. Founders were crossed to wild type  (WT) 
FVB/AntJ  (https://www.jax.org/strain/004828) animals, which are different from FVB/NJs at 
two loci; Tyrc-ch results in a chinchilla coat color and they are homozygous WT for the 
129P2/OlaHSd Pde6b allele, which prevents them from developing blindness due to retinal 
degeneration. Coat color was visually genotyped and the functional FVB/AntJ Pde6b allele was 
genotyped using primers recommended by Jackson labs  (Supplemental Table 5). The mice 
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were crossed to FVB/AntJ until the mutations were on a background homozygous for the 
FVB/AntJ coat color and Pde6b alleles. 
Genotyping 
Initial founder genotyping was performed by deep sequencing amplicons around the 
expected cuts sites of each gRNA. Primers were designed around the cut sites using the NCBI 
primer blast tool. To allow for Illumina sequencing we concatenated the Illumina adapter 
sequences to the designed primers (Supplemental Table 5). The regions surrounding the cut 
sites were amplified using the following thermocycler conditions: 95° C 4 minutes, 95° C 35 
seconds, 58.9° C 45 seconds, 72° C 1 minute 15 seconds, repeat steps 2 through 4 35 times, 72° 
C for 7 minutes, hold at 4° C. A subsequent round of PCR was performed to add the requisite 
Illumina P5 and P7 sequences as well as sample specific indexes using the following 
thermocycler conditions: 98° C 3 minutes, 98° C 10 seconds, 64° C 30 seconds, 72° C 1 minute, 
repeat steps 2 through 4 20 times, 72° C 5 minutes, hold 4° C. The PCR amplicons were pooled 
and run on a 2% agarose gel and the expected band size was gel extracted using the NucleoSpin 
gel extraction kit (Macherye-Nagel). The samples were sequenced on a MiSeq. The raw fastq 
files were aligned to the mm10 genome using bwa v0.7.17 –mem with default settings (140), and 
the bam files were visualized using the integrated genome visualizer  (IGV )v2.3.29 to determine 
the genotype.  
 Once the alleles of the founder lines were shown to be in the germline, we designed PCR 
genotyping assays that can distinguish mutant and WT alleles. Since the Gtf2i mutation and the 
Gtf2ird1 mutation are in linkage and are always passed on together, primers were designed that 
would only amplify the five base pair deletion in exon three of Gtf2ird1. The primer was 
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designed so that the three prime end of the forward primer sits on the new junction formed by the 
mutation with an expected size of 500bp. Beta actin primers, with an expected size of 138bp, 
were also used to help ensure specificity of the mutation specific Gtf2ird1 primers as well as act 
as a PCR control  (Supplemental Table 5). The CD animals were genotyped using primer 
sequences provided by Dr. Victoria Campuzano and primers that amplify the WT Gtf2ird1 allele 
as a PCR control  (Supplemental Table 5).  
 PCR was performed on toe clippings that were incubated overnight at 55° C in tail lysis 
buffer  (10mM Tris pH 8, 0.4M NaCl, 2mM EDTA, 0.1% SDS, 3.6U/mL Proteinase K  (NEB)). 
The proteinase K was inactivated by incubation at 99° C for 10 minutes. 1ul of lysate was used 
in the PCR reactions. Two bands indicated a heterozygous mutation in Gtf2i and Gtf2ird1. The 
cycling conditions for the 5bp Gtf2ird1 deletion were: 95° C 4 minutes, 95° C 35 seconds, 66.1° 
C 45 seconds, 72° C 1 minute 15 seconds, repeat steps 2 through 4 35 times, 72° C for 7 minutes, 
hold at 4° C. The cycling conditions for the CD genotyping were: 95° C 4 minutes, 95° C 35 
seconds, 58° C 45 seconds, 72° C 1 minute 15 seconds, repeat steps 2 through 4 35 times, 72° C 
for 7 minutes, hold at 4° C.  
Western blotting 
E13.5 whole brains were dissected in cold PBS and immediately frozen in liquid nitrogen 
and stored at -80°C until genotyping was performed. Frozen brains were homogenized in 500ul 
of 1x RIPA buffer (10mM Tris HCl pH 7.5, 140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% 
DOC, 0.1% SDS, 10mM Na3V04, 10mM NaF, 1x protease inhibitor (Roche)) and RNAase 
inhibitors (RNasin (Promega) and SUPERase In (Thermo Fisher Scientific) and incubated on ice 
for 20 minutes. Lysates were cleared by centrifugation at 10,000g for 10 minutes at 4° C. The 
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lysate was split into two 100ul aliquots for protein analysis and 250ul of lysate was added to 
750ul of Tizol LS (Thermo Fisher Scientific) for RNA analysis. Protein concentration was 
quantified using a BCA assay and loaded at 25-50ug in 1x Lamelli Buffer with B-
mercaptoethanol onto a 4-15% TGX protean gel (Bio-Rad). In some experiments to achieve 
greater separation to detect the N-truncation, the protein lysates were instead run on a 7.5% TGX 
protean gel (Bio-Rad). The protein was transferred to PVDF 0.2um membrane by wet transfer. 
The membrane was blocked for one hour at RT with TBST 5% milk. The membranes were cut at 
75KDa, and the top of the membrane was probed for either Gtf2i or Gtf2ird1, and the bottom of 
the membrane was probed for Gapdh, with the following primary antibodies: Rabbit anti-
GTF2IRD1 (1:500, Novus, NBP1-91973), Mouse anti-GTF2I (1:1000 BD Transduction 
Laboratories, BAP-135), and Mouse anti-Gapdh  (1:10,000, Sigma Aldrich, G8795). Primary 
antibodies were incubated overnight at 4° C in TBST 5% milk. We used the following secondary 
antibodies: HRP-conjugated Goat anti Rabbit IgG (1:2000, Sigma Aldrich, AP307P) and HRP-
conjugated Goat anti Mouse IgG (1:2000, Bio Rad, 1706516) and incubated for 1 hour at room 
temperature. Signal was detected using Clarity Western ECL substrate (Bio-Rad) in a MyECL 
Imager (Thermo Scientific). Quantification of bands was performed using Fiji (NIH) (187) 
normalizing to Gapdh levels and a WT reference sample.  
Transcript measurement using RT-qPCR 
Total RNA from E13.5 brains lysates was extracted from Trizol LS using the Zymo 
Clean and Concentrator-5 with on column DNAase I digestion and eluted in 30ul of water. RNA 
quantity and purity was determined using a Nanodrop 2000 (Thermo Scientific). cDNA was 
prepared using 1ug of total RNA and the qscript cDNA synthesis kit (Quanta Biosciences). 25ng 
of cDNA was used in a 10ul RT-qPCR reaction with 2x PowerUP SYBR Green Master Mix 
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(Applied Biosystems) and 500nM primers that would amplify constitutive exons of Gtf2ird1 
(exons 8/9), Gtf2i (exons 25/27) or Gapdh (Supplemental Table 5). The RT-qPCR was carried 
out in a QuantStudio6Flex machine (Applied Biosystems) with the following cycling conditions: 
95° C 20 seconds, 95° C 1 second, 60° C 20 seconds, repeat steps 2 through 3 40 times.  There 
were three biological replicates per genotype in all experiments and each cDNA was assessed in 
triplicate technical replicates. Relative transcript abundance of Gtf2i and Gtf2ird1 was 
determined using the deltaCT method normalizing to Gapdh.  
ChIP-qPCR 
Chromatin preparation 
Chromatin was prepared by homogenizing one frozen E13.5 brain in 10mL of 1x cross-
linking buffer (10mM HEPES pH7.5, 100mM NaCl, 1mM EDTA, 1mM EGTA, 1% 
Formaldehyde (Sigma)) using the large clearance pestle in a Dounce homogenizer and allowed 
to crosslink for 10 minutes at room temperature with end-over-end rotation. The formaldehyde 
was quenched with 625ul of 2M glycine. The cells were spun down at 200g at 4° C and the pellet 
was washed with 10mL 1x PBS 0.2mM PMSF and spun again. The pellet was resuspended in 
5mL L1 buffer (50mM HEPES pH 7.5, 140 mM NaCl, 1mM EDTA, 1mM EGTA, 0.25% Triton 
X-100, 0.5% NP40, 10.0% glycerol,1mM BGP (Sigma), 1x Na Butyrate (Millipore), 20mM 
NaF, 1x protease inhibitor (Roche)) and homogenized using the low clearance pestle in a Dounce 
homogenizer to lyse the cells and leave the nuclei intact. The homogenate was spun at 800g for 
10 minutes at 4° C to pellet the nuclei. The pellet was washed in 5mL of L1 buffer and spun 
again and resuspended in 5mL of L2 buffer (10mM Tris-HCl pH 8.0, 200mM NaCl, 1mM BGP, 
1x Na Butyrate, 20mM NaF, 1x protease inhibitor) and incubated at room temperature for 10 
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minutes while shaking. The nuclei were pelleted by spinning at 800g for 10 minutes and 
resuspended in 950ul of L3 buffer (10mM Tris-HCl pH 8.0, 1mM EDTA, 1mM EGTA, 0.3% 
SDS, 1mM BGP, 1x Na Butyrate, 20mM NaF, 1x protease inhibitor) and transferred to a 
milliTUBE 1mL AFA Fiber (100)(Covaris). The sample was then sonicated to a DNA size range 
of 100-500bp in a Covaris E220 focused-ultrasonicator with 5% duty factor, 140 PIP, and 
200cbp. The sonicated samples were diluted to 0.1% SDS using 950ul of L3 buffer and 950ul of 
3x Covaris buffer (20mM Tris-HCl pH 8.0, 3.0% Triton X-100, 450mM NaCl, 3mM EDTA). 
The samples were spun at max speed in a tabletop centrifuge for 10 minutes at 4° C to pellet any 
insoluble matter. The supernatant was pre-cleared by incubating with 15ul of protein G coated 
streptavidin beads (ThermoFisher) for two hours at 4° C.  
Chromatin IP 
GTF2IRD1 antibody (Rb anti GTF2IRD1 NBP1-91973 LOT:R40410) was conjugated to 
protein G coated streptavidin beads by incubating 6ug of antibody (10ul) with 15ul of beads in 
500ul TBSTBp (1x TBS, 0.1% Tween 20, 1%BSA, .2mM PMSF) and end-over-end rotation for 
one hour at room temperature. The antibody-conjugated beads were washed three times with 
500ul of TBSTBp. 400ul of the pre-cleared lysate was added to the antibody-conjugated beads 
and rotated end-over-end at 4° C overnight. 80ul of the pre-cleared lysate was added to 120ul of 
1x TE buffer with 1% SDS and frozen overnight to be the input sample.  
 The IP was washed two times with a low salt buffer (10mM Tris-HCl pH 8.0, 2mM 
EDTA, 150mM NaCl, 1.0% Triton X-100, 0.1% SDS), two times with a high salt buffer (10mM 
Trish-HCl pH 8.0, 2mM EDTA, 500mM NaCl, 1.0% Triton X-100, 0.1% SDS), two times with 
LiCl wash buffer (10mM Tris-HCl pH 8.0, 1mM EDTA, 250mM LiCl (Sigma), 0.5% 
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NaDeoxycholate, 1.0% NP40), and one time with TE (10mM Tris-HCl pH 8.0, 1mM EDTA) 
buffer. The samples were eluted from the beads by incubating with 100ul of 1x TE and 1% SDS 
in an Eppendorf thermomixer R at 65° C for 30 minutes, mixing at 1400rpm. This was repeated 
for a total of 200ul of eluate. The samples and input were then de-crosslinked by incubating in a 
thermocycler (T1000 Bio-Rad) for 16 hours at 65° C. The samples were incubated with 10ug of 
RNAseA (Invitrogen) at 37° C for 30 minutes. The samples were then incubated with 140ug of 
Proteinase K (NEB) at 55° C in a thermomixer mixing at 900rpm for two hours. The DNA was 
extracted using phenol/chloroform/isoamyl alcohol (Ambion) and cleaned up using Qiagen PCR 
purification kit and eluted two times using 30ul of buffer EB for a total of 60ul. The 
concentration was assessed using the highsensitivity DNA kit for qubit (Thermo Fisher 
Scientific). A portion of the input DNA was run on a 2% agarose gel post stained with ethidium 
bromide to check the DNA fragmentation.  
ChIP qPCR 
Primers were designed to amplify the region around the Gtf2ird1 transcription start site 
(TSS), which has been shown to be a target of Gtf2ird1 binding (66). Two primer sets were also 
designed to amplify off target regions, one 10kb upstream of the Bdnf TSS and one 7Kbp 
upstream of the Pcbp3 TSS. These were far enough away from any TSS that it would be unlikely 
that there would be a promoter region. The primers can be found in Supplemental Table 5. A 
standard curve was made by diluting the input sample for each IP sample 1:3, 1:30, and 1:300. 
The input, the input dilutions, and the IP samples for each genotype condition were run in 
triplicate using the Sybr green Power UP mastermix (AppliedBiosystems) and primers at a final 
concentration of 250nM. The PCR was carried out in a QuantStudio6Flex machine (Applied 
Biosystems) with the following cycling conditions: 50° C for 2 minutes, 95° C for 10 minutes, 
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95° C 15 seconds, 60° C for 1 minute, repeat steps 3 through 4 40 times. Relative concentrations 
for the IP samples were determined from the standard curves for that sample and primer set. The 
on target relative concentration for each genotype was divided by either off target relative 
concentration to determine the enrichment of Gtf2ird1 binding.  
Hippocampus RNA-sequencing 
Library preparation 
The hippocampus was dissected from adult animals of the second behavior cohort 
(Table1). We used six animals of each genotype, three males and females of the WT and CD 
animals and two males and four females of the Gtf2i* genotype. The hippocampus was 
homogenized in 500ul of 1x RIPA supplemented with two RNAse inhibitors, RNAsin and 
SUPERase In, and 250ul of the homogenate was added to 750ul of Trizol LS and stored at -80° 
C until RNA extraction. RNA was extracted using the Zymo clean and concentrator-5 kit 
following the on column DNAse I digestion protocol and eluted in 30ul of water. The quality and 
concentration of the RNA was determined using a nanodrop 2000 and Agilent RNA 
Highsenstivity Tape screen ran on the TapeStation 2000 (Agilent). All RINe scores were above 
seven.  
 1ug of RNA was used as input and rRNA was depleted using the NEBNext rRNA 
Depletion kit (Human/Mouse/Rat). RNA-seq libraries were prepared using the NEB Next Ultra 
II RNA library Prep Kit for Illumina. The final uniquely indexed libraries for each sample were 
amplified using the following thermocycler conditions: 98° C for 30 seconds, 98° C 10 seconds, 
65° C 1 minute and 15 seconds, 65° C 5 minutes, hold at 4° C, repeat steps 2 through 3 6 times. 
Each sample had a unique index. Samples were pooled at equal molar amounts and 1x50 reads 
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were sequenced on one lane of a HiSeq3000 at the Genome Technology Access Center at 
Washington University School of Medicine. The RNA-seq data is available at GEO with 
accession number (submitted, waiting on accession number).  
RNA-seq analysis 
The raw reads were trimmed of Illumina adapters and bases with base quality less than 25 
using the Trimmomatic Software (161). The trimmed reads were aligned to the mm10 mouse 
genome using the default parameters of STARv2.6.1b (169). Samtools v1.9 (141) was used to 
sort and index the aligned reads. Htseq-count v0.9.1 (170) was used to count the number of reads 
that aligned to features in the Ensembl GRCm38 version 93 gtf file.  
 The htseq output was analyzed for differential gene expression using EdgeR v3.24 (165). 
Lowly expressed genes were defined as genes that had a cpm less than two across all samples. 
Lowly expressed genes were then filtered out of the dataset. We used the exactTest function to 
make pairwise comparisons between the three groups: WT versus Gtf2i*, WT versus CD, and 
CD versus Gtf2i*. Genes were considered differentially expressed if they had an FDR< 0.1.  
 GO analysis was performed using the goseq R package (188). Nominally significant up 
and down regulated genes for each comparison were considered differentially expressed genes 
and the background gene set included all expressed genes after filtering out the lowly expressed 
genes. The top 10 most significant go terms for each ontology category were reported. To test 
how unlikely it is to see these go terms given the differentially expressed genes from the 
genotype comparisons, we shuffled the genotypes among the samples and repeated the 
differential expression analysis and go term analysis 1000 times and counted how many times 
the same go terms were identified in the top ten most significant go terms.  
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Behavioral tasks 
Animal statement 
All animal testing was done in accordance with the Washington University in St. Louis 
animal care committee regulations. Mice were same sex and group housed with mixed genotypes 
in standard mouse cages measuring 28.5 x 17.5 x 12cm with corn cob bedding and ad libitum 
access to food and water in a 12 hour light dark cycle, 6:00am-6:00pm light. The temperature of 
the colony rooms was maintained at 20-22° C and relative humidity at 50%. Two cohorts of mice 
were used in the behavior and RNA-seq experiments. The CD animals (Del (5Gtf2i-
Fkbp6)1Vcam) were a gift from Dr. Victoria Campuzano and have been previously described 
(93) and were maintained on the C57BL/6J strain  (https://www.jax.org/strain/000664). The first 
behavior cohort (Table 1) used Gtf2i* and CD females as breeders. The second behavior cohort 
(Table 1) used just CD female breeders as male CD animals were frequently not successful at 
breeding. Male and female mice were included in the behavior tasks. Experimenters were blind 
to genotype during all testing. Besides the maternal separation induced pup ultrasonic 
vocalization, all behaviors were done in adult animals older than 60 days and less than 150 days 
old. Mice were moved to the testing facility at least 30 minutes before the test to allow the mice 
to habituate to the room. The male experimenter was present during this habituation so the mice 
could also acclimate to the experimenter. Sex differences were assessed in all experiments, and 
are discussed when they were significant. Otherwise, the data is presented with the males and 
females pooled. Animals were removed from analysis if they were outliers, defined as having 
values greater than 3.5 standard deviations above or below the mean for their genotype group. 
Animals were also removed if the video and tracking quality were too poor to be analyzed. All 
filtering was conducted blind to genotype.  
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Maternal separation induced pup ultrasonic vocalization 
To assess early communicative behaviors we performed maternal separation induced pup 
ultrasonic vocalization (USVs). Animals were recorded on postnatal day three and postnatal day 
five, days when FVB/AntJ animals begin to make the most calls (177). The parents were placed 
in a new cage, and the home cage containing the pups was placed in a warming box  (Harvard 
Apparatus) set at 33° C for at least 10 minutes prior to the start of recording. Pups were 
individually placed in an empty standard-mouse cage (28.5 x 17.5 x 12cm) located in a MDF 
sound-attenuating box (Med Associates) that measures 36 x 64 x 60cm. Prior to recording, the 
pup’s skin temperature was recorded using a noncontact HDE Infrared Thermometer, as it has 
been shown that decreased body temperature elicits increased USVs (189). There was no 
difference in body temperature between genotypes (F2,61= 2.521, p=0.089)(Supplemental Table 
1). USVs were detected using an Avisoft UltraSoundGate CM16 microphone placed 5cm above 
the bottom of the cage, Avisoft UltraSoundGate 416H amplifier, and Avisoft Recorder software 
(gain=3dB, 16bits, sampling rate =250kHz). Animals were recorded for 3 minutes, weighed, 
checked for detachment of pinnae, and then placed back into the home cage in the warming 
chamber. After all animals had been recorded the parents were returned to the home cage. 
Sonograms of the recordings were prepared in MATLAB (frequency range =25-120kHz, FFT 
[Fast Fourier Transform] size=512, overlap=50%, time resolution =1.024ms, frequency 
resolution = 488.2Hz) along with number of syllables and spectral features using a previously 
published protocol (177, 190) based on validated methods (191). 
Sensorimotor battery 
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We assessed motoric initiation, balance, coordination, and strength as described in (171, 
192) over two days using the following tasks: day 1) walking initiation, ledge, platform, pole; 
day 2) 60 screen, 90 screen, and inverted screen. Each task was performed once then the animals 
were allowed a 20 minute break then the tests were repeated in reverse order to control for 
practice effects. The two trials for each task were then averaged to be used in analysis. Walking 
initiation was tested by recording the time it takes for the mouse to exit a demarcated 24 x 24cm 
square on top of a flat surface. To assess balance, the mice were placed on a plexiglass ledge 
with a width of 0.5cm and a height of 38cm. We recorded how long the mouse balanced on the 
ledge up to 60 seconds. Another test of balance required the mouse to balance on a wooden 
platform measuring 3.0cm in diameter, 3.5cm thick and was 25.5cm high. The amount of time 
the animal balanced on the platform was recorded up to 60 seconds. Motor coordination was 
tested by placing the mouse at the top of a vertical pole with the head facing upward. The time it 
took the mouse to turn so the head was facing down was recorded as well as the time it took the 
mouse to reach the bottom of the pole up to 120 seconds. On day two the mice performed screen 
tasks that assessed coordination and strength. Mice were placed head facing downward in the 
center of a mesh wire grid that had 16 squares per 10cm and was 47cm off the ground and 
inclined at 60 degrees. The time it took the mice to turn and reach the top of the screen was 
recorded up to 60 seconds. Similarly the mice were placed in the center facing downward of 
mesh wire screen with 16 squares per 10cm, elevated 47cm from the surface of a utility cart, and 
inclined at 90 degrees. The time it took the mice to turn around and reach the top was recorded 
up to 60 seconds. To test strength, the mice were placed in the center of a mesh wire grid used 
for the 90 screen task and then inverted so the mouse was hanging from the screen that was 
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elevated 47cm. The time the mouse was able to hang onto the screen up to 60 seconds was 
recorded. 
One hour locomotor activity 
  We tested the animals’ general exploratory activity and emotionality in an one hour 
locomtor activity  task (171). Animals were placed in the center of a standard rat cage (47.6 x 
25.4 x 20.6cm) and allowed to explore the cage for one hour in a sound-attenuating enclosure 
with the lightening set to 24 lux. The one hour sessions were video recorded and the animals 
position and horizontal movements were tracked using the ANY-maze software (Stoelting Co.: 
RRID: SCR_014289). The apparatus was split into two zones: a 33 x 11cm center zone, and a 
bordering 5.5cm edge zone. ANY-maze recorded total distance traveled in the apparatus, and 
total distance traveled, time spent, and entries into each zone. The mouse was considered to have 
entered a zone when 80% of the body was detected within the zone. The rat cages are thoroughly 
cleaned with 70% ethanol between mice.  
Marble burying 
Marble burying is a task that measures the natural digging behavior of mice and is 
correlated to compulsive behaviors and hippocampal function (179). Following our previously 
published methods (171), a standard rate cage (47.6 x 25.4 x 20.6cm) was filled with autoclaved 
aspen bedding to a depth of 3cm and placed in a sound-attenuating enclosure with lighting set to 
24 lux. 20 glass marbles were arranged in 5 x 4 grid on the surface of the bedding. Mice were 
placed in the center of the rat cage and allowed 30 minutes to explore and bury the marbles. The 
session was recorded using a digital camera and the animals horizontal movements and position 
in the apparatus were tracked using ANY-maze with the same center and edge zones as 
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described in the one hour activity task. After 30 minutes mice were put back in their home cage 
and the number of marbles not buried was counted by two observers. A marble was considered 
buried if 2/3 of the marble was underneath the bedding. The average of the two scorers was used 
to calculate the average number of marbles buried. The marbles and rat cages were thoroughly 
cleaned with 70% ethanol between mice.  
Three-chamber social approach 
To assess voluntary sociability and preference for social novelty we used the three-
chamber social approach assay as previously described (171, 193, 194). The task took place in a 
plexiglass arena with two partitions with rectangular openings  (5 x 8cm) dividing the arena into 
three chambers that each measure 19.5 x 39 x 22cm. The openings could be closed using 
plexiglass doors that slide into the openings. The task consisted of four consecutive 10 minute 
trials. During trial one the animals were habituated to the middle chamber with the openings to 
the side chambers closed. In trial two the animals were allowed to explore the entire apparatus. 
Trial three was the sociability trial. In one side chamber there was an empty steel pencil cup 
(Galaxy Pencil/Utility Cup, Spectrum Diversified Designs, Inc.) that was placed upside with an 
upside clear drinking cup secured to the top to prevent animals from climbing on top of the cup; 
this was the empty side. In the other side chamber there was an identical pencil cup that housed 
an age- and sex-matched, sexually naive, unfamiliar C57BL/6J stimulus animal; this was the 
social side. The pencil cups allowed sniffing behavior to occur and exchange of odor cues, but 
limited physical contact to prevent aggressive behaviors. The experimental animal was allowed 
to explore the whole apparatus. The side of the empty cup and social cup were counterbalanced 
across all the samples. In trial four we tested preference for social novelty. A new stranger 
stimulus animal was placed in the formerly empty cup. All stimulus animals were habituated to 
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the apparatus and the cups for 10 minutes one day prior to testing. Each stimulus animal was 
used only once per day. During all trials the task was video recorded and the animal’s position, 
animal’s head, and movement was tracked with ANY-maze software. We quantified how much 
time the animal spent in each chamber, as well as distance traveled and number of entries. A 2cm 
area around the cups was defined as the investigation zone, and the animal’s head was used to 
determine when it was investigating the stimulus animals or the empty cup. The first five 
minutes of the social and novelty trials were analyzed because this is when the majority of the 
social investigation occurs (195). The entire apparatus was thoroughly cleaned after each animal 
using 2% chlorhexidine  (Zoetis). The stimulus cups were cleaned using 70% ethanol.  
Modified social approach 
To test for habituation to social stimuli over extended amounts of time, we slightly 
modified the social approach task. We used the same apparatus as described above. We included 
an additional day of habituation to the apparatus for the experimental animals on the day prior to 
the actual test to ameliorate novelty induced exploration of the apparatus and to potentiate 
exploration of the investigation zones. During the habituation day the animals were placed in the 
center chamber for 10 minutes with the doors to the side chambers closed. Next, the animals 
were allowed to explore the whole apparatus for 20 minutes. The stimulus animals were 
habituated to the cups in the apparatus for 30 minutes prior to the test day. Trial one and trial two 
were the same as the social approach described above. For trial three, the sociability trial, the 
experimental animals were placed in a cylinder in the center chamber, while the empty cup and 
stimulus animal cup were being placed in the side chambers. This ensures a random starting 
direction for the experimental mouse so we could make an unbiased measure of which chamber 
the experimental mouse chose to enter first. The sociability trial lasted for 30 minutes, in which 
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the experimental animal was allowed to freely explore the apparatus and investigate the empty 
cup and social cup. The social novelty trial was not conducted.  
Tube test of social dominance 
The tube test of social dominance tests for social hierarchy behaviors in mice (171, 196). 
This task took place over five days. Days one and two were habituation trials. During day one, 
the animals were placed in the left entrance of a clear acrylic tube measuring 3.6cm in diameter 
and 30cm in length and allowed to walk through the entire tube and exit the tube on the right 
side. Day two was the same but the mice started on the opposite side of the tube. These two 
habituation days allow the mice to acclimate to the tube, and potentiates task performance. On 
each of three consecutive test days, two mice of different genotypes were placed in the entrances 
to the tube and allowed to meet in the middle, at a clear acrylic partition. When both mice were 
at the acrylic partition, it was removed and the trial began. The trial ended when one mouse was 
pushed out or backed out of the tube so that all four paws were out of the tube, or two minutes 
had passed. The mouse that remained in the tube was considered the dominant winner and the 
mouse that was no longer in the tube was considered the submissive loser. If both mice were still 
in the tube after two minutes it was considered a tie. Each mouse was tested only once each day, 
and the mice were tested against a novel mouse each day. After each test, the tube was cleaned 
with 2% chlorhexidine  (Zoetis) solution. All of the test sessions were recorded using a USB 
camera connected to a PC laptop  (Lenovo). The observer scored the test from the videos.  
Rotarod 
The accelerating rotarod  (Rotamex-5; Columbus Instruments, Columbus, OH) tests 
motor coordination, motor learning, and balance. We used a previously published rotarod 
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paradigm (172, 197, 198) that tests animals on three conditions: 1) stationary rod 2) continuous 
rotation and 3) accelerating rotation during three different sessions that were separated by three 
days to minimize motor learning. During each day the animals had five trials; one stationary 
trial, two continuous trials, and two accelerating trials. During the stationary trial, the animals 
were placed on the stationary rod and the time that the animals stayed on the rod was recorded up 
to 60 seconds. During the continuous trials, the animals were placed on the rod rotating at three 
rotations per minute. The time the animals stayed on the rotating rod was recorded up to 60 
seconds. In the accelerating trials, the animals were placed on the rod that was rotating at two 
rotations per minute. Once the animals were on the rotating rod, the rod began to accelerate at 
0.1rpm and reached 17rpm at 180 seconds. The time the animals stayed on the rod up to 180 
seconds was recorded. The two trials for the continuous rotation and accelerating rotation during 
each session were averaged for analysis. If an animal fell off the rod during any session within 
the first five seconds, the animal was placed back on the rod and the time was reset up to two 
times. If the mouse fell off within five seconds on the third try that time was recorded.  
Elevated Plus Maze 
The elevated plus maze was used to assess anxiety-like behaviors in mice using 
previously published protocols (152, 194, 199). The apparatus had two closed arms that 
measured 36 x 6.1 x 15cm, two open arms, and a central platform that measured 5.5 x 5.5cm. 
The time spent in the open arms was used as a measure of anxiety-like behavior in mice, since 
mice prefer to be in an enclosed area. Each mouse was tested once per day for three consecutive 
days. During the test the animals had five minutes to freely explore the apparatus. The animals 
position, movement, entries into each arm, and time spent in each arm were determined by beam 
breaks of pairs of photocells arranged in a 16 (x-axis) x 16 (y-axis) grid. Beam breaks were 
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monitored by the Motor Monitor software (Kinder scientific). The test was conducted in the dark 
with black lights, and was recorded by an overhead digital camera using the night vision setting.  
Pre-pulse inhibition (PPI) 
To test for normal sensorimotor gating and normal acoustic startle response we 
performed PPI on the animals. Mice were placed in a cage located on top of a force transducer 
inside of a sound-attenuating box with a house light on (Kinder Scientific). The force transducer 
measured the startle response of the animals in Newtons. We used a protocol adapted from (194, 
200). The protocol was run using the Startle Monitor II software (Kinder scientific). The protocol 
started with five minutes of acclimation to the 65dB background white noise, which is played 
continuously throughout the procedure. After acclimation there were 65 trials that pseudo-
randomly alternated between different stimulus conditions, beginning with five consecutive trials 
of the startle stimulus, which was a 40msec 120dB pulse of white noise. The middle trials cycled 
through blocks of pre-pulse conditions, blocks of non-startle conditions, where only the 
background noise is played, and two blocks of startle conditions. Each block consisted of five 
trials. The testing ended with single trials of pulses played at 80dB, 90dB, 100dB, 110dB, 
followed by five more startle trials of 120dB. There were three different pre-pulse conditions, 
where a pulse of 4dB, 8dB, or 16dB white noise above the background sound was played 
100msec preceding the 120dB startle stimulus. The average startle response during the middle 
two blocks of startle trials was considered to be the animal’s acoustic startle response(ASR). 
Each trial measured the startle of the animal for 65msec after the stimulus, and the average force 
in Newtons across this time was used as the startle response. The pre-pulse inhibition was 
calculated as the difference of the average ASR and the startle response during the respective 
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pre-pulse trial (PP) divided by the ASR of the startle trials multiplied by 100: ((ASR – 
PP)/ASR)*100.  
Contextual and Cued Fear Conditioning 
Contextual and cued fear conditioning were used to assess associative learning and 
memory. We followed a previously published method (172, 201). The test occurred over three 
days. A camera placed above the apparatus recorded the session. Freezing behavior during each 
minute was detected in .75s intervals using the FreezeFrame (Actimetrics, Evanston, IL) 
software. Freezing behavior was defined as no movement except for normal respiration, and is 
presented as percent time freezing per minute. During day one, animals were allowed to explore 
the Plexiglas chamber (26cm x 18cm x 18cm; Med Associates Inc.) with a metal grid floor and a 
peppermint scent that was inaccessible to the animals. A trial light in the chamber turned on for 
the duration of the five minute trial. During the first two minutes animals were habituated to the 
apparatus, and freezing during this time was considered the baseline. An 80db white noise tone 
was played for 20 seconds at 100 seconds, 160 seconds, and 220 seconds during the test. During 
the last two seconds of the tone (conditioned stimulus CS) a 1.0mA foot shock (unconditioned 
stimulus UCS) was delivered. The mice were returned to their home cage at the end of the five 
minute trial. On day two contextual fear memory was tested. The animals were placed into the 
same chamber with peppermint scent and the illuminated light and no tone or shock was 
delivered. Freezing behavior was measured over the eight minute task. The amount of time 
freezing in the first two minutes on day two was compared to the baseline freezing on day one to 
test the effects of the contextual cues associated with the UCS from day one. On day threed the 
animals were placed in a new context, a chamber with black walls, and a partition that creates a 
triangle shaped area and an inaccessible coconut odor. During this 10 minute task, the trial light 
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was on for the entire duration. The animals explored the apparatus for the first two minutes to 
determine baseline freezing and then the same 80dB (CS) tone from day one was played for eight 
minutes. The freezing behavior during this time tested the effects of the CS associated with the 
UCS shock from day one. Shock sensitivity was tested for each mouse three days after the cued 
fear test following the procedure previously described in (172). Mice were placed in the chamber 
with the wire grid floor and delivered a two second shock of 0.05mA. The mA of the shock was 
increased by 0.05mA up to 1.0mA. At each shock level the animal’s behavior was observed and 
the current level at which the animal flinched, exhibited escape behavior, and vocalized was 
recorded. Once the animal had exhibited each of the behaviors the test ended. Shock sensitivity 
assessment served to confirm differences in conditioned fear freezing were not confounded by 
differences in reactivity to the shock current. 
Resident intruder 
The resident-intruder paradigm, as described previously (202), was used as a direct social 
interaction test. Only males were used in this experiment. Male mice were individually housed in 
standard mouse cages for 10 days. Cages were not changed so the mice could establish a 
territory. The testing took place over three days in which the home cage of the experimental 
animal was placed in a sound-attenuating box in the dark with two infrared illuminators placed in 
the box. A clear Plexiglas covering with holes was placed over the cage to prevent animals from 
jumping out of the cage. A digital camera using the night vision setting recorded the task. On 
each day a WT C57BL/6J stimulus animal (intruder), age and sex matched was introduced into 
the experimental animal’s (resident) home cage. The animals were allowed to interact for 10 
minutes after which the stimulus animal was removed from the cage. A stimulus animal was only 
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used once per day. The testing was repeated for two more days, during which the experimental 
animals were paired with novel intruders. 
 The videos were tracked using Ethovision XT 13 software (Noldus Information 
Technology) using the social interaction module. This module allows for simultaneous tracking 
of two unmarked animals. The initial tracking was further corrected manually using the track 
editing tools, to ensure the head and the tail points were oriented correctly. All of the video 
tracks were smoothed first with the loess method and then with the minimal distance moved 
method. The variables of interest were the mean bout of time, frequency, and the cumulative 
duration of time that the experimental animal’s nose was less than 0.6cm from the stimulus 
animal’s nose, interpreted as nose-to-nose sniffing, or when the experimental animal’s nose was 
less than 0.45cm from the tail base of the stimulus animal, interpreted as anogenital sniffing. 
These distance thresholds were determined by an experimenter blind to genotype, examining the 
videos using the plot integrated view functionality to ensure that the events called by the 
software accurately defined the social behavior.  
Statistical Analysis 
All statistical tests were performed in R v3.4.2. Western blots and qPCR were analyzed 
using a one factor ANOVA and the post hoc Tukey all pairwise comparison test was used 
determine differences between groups using the multcomp package (173).  
 For all behavior tests the data was assessed for univariate testing assumptions of 
normality and equal variances. Normality was assessed using the Shapiro-Wilkes test as well as 
manual inspection of qq plots. Equality of variances was tested using the Levene’s test. 
Behaviors that violated these assumptions were analyzed using non parametric tests. Repeated 
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measures were analyzed using linear mixed models with the animal as the random effect. 
Significance of fixed effects were tested using the Anova function from the Car (203) package in 
R. Post hoc testing was done using the Tukey HSD test from the multcomp package. Tukey HSD 
test ‘within time point’ was used for post hoc repeated measures comparisons, as appropriate. 
See Supplemental Tables 1 and 6 for descriptions of all statistical tests. 
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4.7 Figures  
 
Figure 1. Generation of double mutant Gtf2i* model. A  Schematic of the syntenic WSCR in mouse on 
chromosome 5. The two transcription factors being tested here are highlighted in grey and the genes that are deleted 
in the CD animals are highlighted in yellow. B Gene models of Gtf2i and Gtf2ird1 showing the multiple isoforms of 
each gene. The WT sequences with the gRNA target underlined and the PAM highlighted in blue with the mutant 
sequences below along with the corresponding amino acid sequence. C  Breeding scheme for the behavior tasks D. 
E13.5 whole brain Gtf2i western and qPCR of Gtf2i* x CD. Gtf2i protein and transcript are similarly reduced in the 
Gtf2i* and CD animals. E E13.5 whole brain Gtf2ird1 western and qPCR of Gtf2i* x CD. Gtf2ird1 protein is 
slightly reduced in the Gtf2i*/CD brain compared to WT. Gtf2ird1 transcript is increased in the Gtf2i* genotype, 
decreased in the CD genotype, and returns to WT levels in Gtf2i*/CD genotype. * p < 0.05, ** p < 0.01, *** p < 
0.001  
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Figure 2. CD mice have deficits in ultrasonic vocalizations and decreased social investigation. A Callrate across 
two days shows that on postnatal day 5 CD animals produce fewer ultrasonic vocalizations than either WT or Gtf2i* 
littermates. B Schematic of the three-chamber social approach task. C All genotypes show preference for social 
stimulus in three-chamber social approach assay. D Gtf2i* and CD animals show similar dominance behavior to WT 
animals in the tube test for social dominance. E Schematic of the resident intruder paradigm. F CD animals show 
decreased time engaged in anogential sniffing in resident intruder task. G CD animals show decreased time engaged 
in nose-to-nose sniffing in resident intruder task. * p < 0.05, ** p < 0.01, *** p < 0.001 Sample sizes are shown as 
numbers in parentheses 
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Figure 3. CD mice have motor deficits. A CD mice fall off a ledge sooner than WT or Gtf2i* mutants. B CD mice 
bury fewer marbles than either the WT or Gtf2i* mutants. C CD mice travel less distance in the center during marble 
burying task D CD animals spend less time in the center during marble burying task. E All genotypes travel similar 
distance in open field. F All genotypes spend similar time in the center during open field. * p < 0.05, ** p < 0.01, 
*** p < 0.001 Sample sizes are shown as numbers in parentheses 
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Figure 4. CD mice have more severe contextual fear phenotypes than double mutants. A The conditioned fear 
task design. Day one animals are delivered a tone and then a footshock throughout the five minute task. Day twp the 
animals are put in the same context without a footshock to measure contextual fear memory. Day three animals are 
put in a new chamber and delivered the tone to measure cued fear memory B Percent time freezing during 
conditioned fear acquisition. CD mice have increased baseline freezing during minute one and Gtf2i* mutants show 
decreased freezing during minute five C Percent time freezing during contextual fear memory recall. CD mice show 
elevated freezing during fear memory recall. D Percent time freezing during cued fear memory recall. All animals 
show increased freezing when the tone is played. * p < 0.05, ** p < 0.01, *** p < 0.001 Sample sizes are shown as 
numbers in parentheses 
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Figure 5. CD mice have altered mRNA for synaptic genes in a hippocampus transcriptome. A CD animals 
show decreased expression of the WSCR that are expressed in the hippocampus. B volcano plot comparing CD and 
WT differentially expressed genes.WSCR genes are highlighted in yellow and genes with FDR < 0.1 are highlighted 
in red. C Besides Gtf2i and Gtf2ird1 there are no significantly differentially expressed genes D There is a 9% 
overlap between nominally significantly up and down regulated genes between CD and Gtf2i* comparisons to WT 
controls. E CD differentially expressed genes are enriched for GO biological processes involved in synapses and 
nervous system development. F Gtf2i* differentially expressed genes are enriched for GO biological processed 
involved in more general organ development. 
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Figure 6. Human atypical deletions support oligogenic contribution of genes in the WSCR to phenotypes. 
Schematic of the WSCR on chr7q11.23. The arrows indicate the regions of low copy repeats. The typical deletion is 
demarcated using the yellow box. Atypical deletions demarcated in blue show no contribution to the WSCP. 
Atypical deletions demarcated in green show contribution to the WSCP. Atypical deletions demarcated in purple 
provide evidence of deletions that spare GTF2I and GTF2IRD1 that show contributions to across phenotypic 
domains including social behavior. Atypical deletions demarcated in red provide evidence that the telomeric region 
is sufficient to produce the full spectrum of phenotypes. The large amount of overlap of all deleted regions and the 
mild phenotypes present across the atypical deletions suggests an oligogenic pattern. SVAS (supravalvular aortic 
stenosis), WSCP (Williams syndrome cognitive pfofile) ID (intellectual disability) NT  (Not tested), - absent, + 
present, -/+ milder than typical WS.  
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Supplemental Figure 1. Generation of loss of function mutations in Gtf2i and Gtf2ird1. A The number of 
founders from gRNA injection shows that two gRNAs are efficient at mutating both targets and have high rates of 
mosaicism. B Gtf2i protein is more highly expressed in the embryonic brain and is detectable in the adult brain, each 
time point includes two biological replicates. C Gtf2ird1 protein is more highly expessed in the embryonic brain and 
not detectable in the adult brain, each time point includes two biological replicates. D Gtf2i protein and transcript 
levels are decreased in  the heterozyous Gtf2i* mice and not detectable in the homozygous Gtf2i* E13.5 brain.  E 
Gtf2ird1 protein is not decreased in heterozygous or homozygous Gtf2i* E13.5 brain, but the transcript is increased 
in heterozygous and homozygous animals. F Schematic of the consequences of the 5 bp deletion in Gtf2ird1 
showing the potential translation re-initation methionine in a new open reading frame. G A slight shift of Gtf2ird1 
protein in animals homozygous and hemizgyous for the 5 bp deletion in exon 3 of Gtf2ird1, suggesting an N-
terminal truncation of Gtf2ird1. H ChIP qPCR of the enrichment of the Gtf2ird1 upstream regulatory sequence 
(GUR)  over an off target sequence 7kbp upstream of Bdnf transcription start site in WT versus Gtf2i* homozygous 
E13.5 brain. I  ChIP qPCR of the enrichment of the Gtf2ird1 upstream regulatory sequence (GUR)  over an off 
target sequence 10kbp upstream of Pcbp3 transcription start site in WT versus Gtf2i* homozygous E13.5 brain. * p 
< 0.05, ** p < 0.01, *** p < 0.001 
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Supplemental Figure 2. Social behaviors in CD and Gtf2i* mutants. A CD animals have increased pauses 
between bouts of USVs. B CD animals have decreased duration of USVs. C CD animals have decreased weight in 
adulthood, developmental weight does not explain differences in USV. D All genotypes show preference for social 
novelty. E Double mutants show increased activity in the social approach and social novelty trials of three 
chambered social appraoch. F WT and double mutants show social preference in the first 5 minutes of the extended 
social approach, but the CD mice are trending. G None of the genotypes show preference for social stimulus during 
the last 5 minutes of the extended social approach. H CD mice on C57BL6/J background show a submissive 
phenotype in tube test of social dominance while the double mutants show no phenotype on FVB/ANTJ 
background. I All genotypes travel similar distance in the resident intruder task. J CD animals have decreased mean 
bout time of anogenital sniffing in the resident intruder task. K However all genotypes have similar frequencies of 
anogential sniffing. * p< 0.05, ** p < 0.01, *** p < 0.0001. Sample sizes are shown as numbers in parentheses 
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Supplemental Figure 3. Motor and anxiety phenotypes in double mutants and CD animals. A All animals 
show similar time to initiate walking. B All animals reach the top of a 60 degree inverted screen in similar amounts 
of time. C All animals reach the top of a 90 degree inverted screen in similar amounts of time. D All animals can 
hang onto an inverted screen for similar amounts of time. E CD animals are able to turn their bodies 180 degrees on 
a pole quicker than WT animals. F CD animals are able to reach the bottom of a pole quicker than WT littermates. 
G CD animals tend to fall off a platform more than double mutants. H On day 3 of the rotorod task double mutants 
fall off sooner than the CD animals. I  All genotypes travel similar total distances in the marble burying assay. J All 
genotypes show normal PPI. K CD animals have decreased startle to 120dB stimulus overall but this is due to 
decreased weight. L All genotypes spend similar amounts of time in the open arm during elevated plus maze. * p< 
0.05, ** p < 0.01, *** p < 0.0001. Sample sizes are shown as numbers in parentheses 
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Supplemental Figure 4. Contextual fear and shock sensitivity in WS mutant models. A All 
genotypes show a contextual fear response. B The response to foot shock is similar across all 
genotypes. * p < 0.05, ** p < 0.01, *** p < 0.001 Sample sizes are shown as numbers in 
parentheses 
 
Supplemental Figure 5. Small changes in hippocampal transcriptomes of WS models. A 
Fold change of differentially expressed genes between WT and CD animals at an FDR < 0.1 
normalized to WT levels. B Fold change of genes previously tested in CD hippocampus RNAseq 
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from Ortiz-Romero et al. 2018. C The top ten enriched Cellular Component gene ontologies for 
genes that are nominally up or down regulated between CD and WT animals. D The top ten 
enriched Cellular Component gene ontologies for genes that are nominally up or down regulated 
between Gtf2i* and WT animals. E The top ten enriched Molecular Function gene ontologies for 
genes that are nominally up or down regulated between CD and WT animals. F The top ten 
enriched Molecular Function gene ontologies for genes that are nominally up or down regulated 
between Gtf2i* and WT animals 
Table 1: Behavior and animal cohorts for the Gtf2i* x CD 
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Supplemental Table 1: Supplemental figures statistic table 
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Supplemental Table 2: Random GO enrichments for CD-WT comparison 
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Supplemental Table 3: Random GO enrichments for Gtf2i*-WT comparison 
 
Supplemental Table 4: Primers for CRISPR sgRNA, validation, and IVT 
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Supplemental Table 5: Genotyping and RT-qPCR primers 
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Supplemental Table 6: Main figures statistic table 
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Chapter 5: Conclusions and Future 
Directions 
Nathan Kopp 
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5.1 Significance 
In this thesis I have tested three extant hypotheses in the field of Williams syndrome 
biology, using both human and mouse genetics. First, I showed that variation on the remaining 
WSCR allele does not largely modify the social phenotype of individuals with WS as measured 
by the SRS.  The study highlighted two SNPs in BAZ1B and GTF2IRD1, both of which have 
been implicated in the cognitive phenotypes of WS, providing further support for their 
importance in the pathogenesis of WS. I used the data to further describe the genetic variation 
within the exonic compartment of the WSCR, which can be queried to test for associations with 
other clinical phenotypes of WS. While 85 individuals is a small sample size to detect variants 
that have low effect sizes, this was the largest genetic dataset of WS analyzed, and will exist as a 
foundation to which other larger studies can build.  
The second hypothesis I tested was how do the transcription factors Gtf2i and Gtf2ird1 
interact to affect behavior. These genes have been thought to contribute to the behavioral, 
cognitive, and craniofacial aspects of WS, but their affects on behavior have not been studied 
together. I leveraged the advantages of the mouse model system to study these genes. First, I 
generated a dataset that describes where these transcription factors bind in the developing brain 
and then tested the consequences of mutating just Gtf2ird1 or both transcription factors together 
to examine how they interact to potentially affect transcription and behavior. Surprisingly, I 
showed that both transcription factors have little consequence on whole brain transcription, but 
mutating them still results in behavioral deficits mainly driven by homozygosity of Gtf2ird1 
mutations. The work I have done is some of the first in vivo biochemical analysis of Gtf2ird1, 
and I showed that Gtf2ird1 is a difficult gene to knockout. These results help interpret the 
findings of other Gtf2ird1 mouse models that still show some Gtf2ird1 transcription and protein 
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product (66, 101). The Gtf2ird1 mouse model I characterized provided data that supports the 
functional role of the N-terminal end of the protein in behavior, although it did not result in 
decreased DNA binding genome wide. My data and methods will be useful to consider when 
designing future experiments around this gene. I also showed that knocking out Gtf2i along with 
Gtf2ird1 did not result in more severe phenotypes in the heterozygous state. This suggests that 
Gtf2ird1 is the main driver of the phenotypes tested in this study. Overall, I have created two 
new mouse lines to further model and study Williams syndrome and provided genomic datasets 
that can be used to generate future hypotheses concerning these two transcription factors.  
Finally, I used another Gtf2i/Gtf2ird1 double mutant mouse model and a mouse model 
that has the entire WSCR deleted (CD mouse) to test the current leading hypothesis that these 
two transcription factors are sufficient to replicate the phenotypes that are caused by deleting the 
whole region. My data suggests that these genes are not sufficient, which implicates the role of 
other genes in the region or an oligogenic contribution of several genes in the region. I also 
analyzed the adult hippocampal transcriptome of both mouse models and showed differences in 
synaptic genes in the CD compared to the double mutant, suggesting that synaptic functioning 
might be impaired in the CD animals that is not caused by Gtf2i or Gtf2ird1. These data should 
encourage studying the effects of other genes in the WSCR. Using the CRISPR/Cas9 technology 
will allow for the quick generation of mouse models with unique combinations of genes mutated 
so we can begin to dissect the interactions of the genes in the region, similarly to what has been 
done for other copy number disorders (102, 103, 204).  
Overall, this thesis has generated human and mouse genomic datasets that can be used to 
design future studies to elucidate genetic influences on WS phenotypes. It also describes three 
new mouse models that can be used in to further understand how the general transcription factor 
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2i family contributes to WS phenotypes. Finally, it supports a role for genes outside of the 
general transcription factor 2i family, encouraging further characterization of single gene knock 
out mouse models as well as models with combinations of genes knocked out.  
5.2 Future directions 
5.2.1 Human studies 
 I described the analysis of the whole exome of 85 individuals with WS and tested for 
genetics associations with the social phenotype. The exome enriches for variants in the coding 
regions of genes, which aids in the interpretation of their effects. However, the exome covers 
only 1% of the genome and with the growing number of whole genome studies, the human 
genetics field is learning more about the consequences of non coding variation. Thus, it would be 
beneficial to use whole genome sequencing to analyze how the full spectrum of genetic variation 
could modify the phenotypes in WS. First, it would be interesting to catalogue the non-coding 
variation of the WSCR and couple that with the exonic data to look for modifiers within the 
locus.  
Next, we could use the dense genotype data genome wide to calculate polygenic risk 
scores for different phenotypes of interest within the WS sample. I did this using the Psychiatric 
Genomics Consortium GWAS on ASD using the whole exome data, but this misses a lot of the 
common, noncoding variation that was genotyped. Using the whole genome data we could get a 
better understanding contribution of genomic variants to social behavior. Recently, it has been 
shown that high polygenic risk scores can convey similar risk to disease as monogenic causes 
(205). This information could be used to help explain the large variability of the social phenotype 
and other phenotypes of WS.   
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Finally, the genome data could be used to identify the breakpoints of the deletion in 
patients. This is important, because the current diagnostic method, clinical microarray, has 
difficulty accurately identifying the size of the deleted region due to the low copy repeats. I 
attempted to use the whole exome data to determine copy number of the NCF1 alleles by using 
the ratio of the two base pair deletion that distinguishes the pseudogenes from the functional 
copy. This gave promising results, but this strategy cannot distinguish the exact break point of 
the deletion. Since whole genome sequencing provides even coverage it could be used to detect 
the size of the deletion, which has been shown to affect cognitive and behavioral phenotypes 
(41). I have preliminarily tried to call the deletion size using the coverage from the whole 
genome sequencing data. I was able to identify atypical deletions, but the typical deletions all 
had similar profiles with drops in coverage in the area in the low copy repeats. We could 
potentially use the polymorphisms that distinguish between the functional and pseudogenes of 
the regions, but short read whole genome sequencing data may not be able to overcome the 
challenges of the repetitive regions. Long read technology could be used to try and surmount the 
difficulty of mapping to the region to better detect the breakpoints.  
5.2.2 Gtf2i and Gtf2ird1 mouse studies 
 I have generated several new mouse models that can be used as tools to understand Gtf2i 
and Gtf2ird1 biology. One of the more interesting findings from the mutations in Gtf2ird1 was 
not expected, and that is that this is a difficult protein to knock out. Two separate frameshift 
mutations that create premature stop codons with exon three, and a large deletion removing all 
but 14 base pairs of exon three of Gtf2ird1 resulted in more Gtf2ird1 transcript and slightly lower 
levels of a N-truncated protein. The tight regulation of the transcript and protein levels of 
Gtf2ird1 hints at a conserved important function. It would be interesting to further understand 
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how this transcript and protein are regulated. We have data to suggest that Gtf2ird1 transcripts 
that contain the mutant alleles are more stable than the WT transcript. Studying the mRNA 
dynamics and stability of Gtf2ird1 could provide insight on how it is regulated and lead to 
further investigation about why it is regulated so tightly. We have looked into using click-it 
technology to determine the half-life of the WT and mutant mRNA and have the potential to 
clone the mutated alleles into a plasmid vector, which could then be manipulated. This would 
also allow us to directly test if the N-truncated mutation is caused by the hypothesized translation 
re-initiation event at a downstream methionine using pharmaceutical manipulations in cell 
culture.  
 I was initially interested in phenotyping these mouse models for social behaviors, as other 
models knocking out Gtf2ird1 and Gtf2i have shown social phenotypes. In the social tasks we 
have done which include the three chamber social approach, tube test, and resident intruder, we 
have seen either no difference between genotypes, strain dependent effects, social effects in the 
opposite direction, or non replicable phenotypes. The CD model on the C57Bl/6J background 
should have the largest social phenotype as described in the mouse literature. The Dougherty lab 
has a new social operant paradigm that would allow us to test the social motivation of the CD 
animals, which we would predict to have increased motivation. We could then run our other WS 
models through this paradigm as well to test specifically for social motivation deficits.  
 We also see a conditioned fear response in the CD animals and the Gtf2i+/-/Gtf2ird1-/- 
genotype. The oxytocin system has been largely speculated to contribute to the phenotypes in 
WS (118, 206) and it has been shown to affect conditioned fear in mice (207). I have generated 
preliminary data that suggests oxytocin is slightly upregulated in the hypothalamus of CD 
animals, however, I have not noticed an increased in oxytocin positive neurons in the 
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hypothalamus. We can manipulate the oxytocin system, genetically or pharmaceutically, in CD 
animals to test if this rescues or exacerbates the behavioral phenotypes. I have also generated 
RNA-seq data from the adult hypothalamus of the CD and the Gtf2i* animals. This can further 
inform the involvement of oxytocin and vasopressin in behavioral phenotypes and be used to 
design downstream experiments regarding these neuropeptides.  
 I am also interested in understanding how other genes in the WSCR could possibly 
modify the effects of the general transcription factor 2i family. I have generated a new mouse 
model that has a frameshift mutation in just Gtf2i. Characterizing this model will let us 
understand the effects of Gtf2i on behavior without a Gtf2ird1 mutation. In collaboration with 
Dr. Kozel, we could cross our single mutants, double mutants, and the CD animals to a Baz1b 
knock out line to test how this chromatin modifier affects behavior.   
5.3 Summary 
 This thesis used both human and mouse genetics to further understand genetic 
contributions of the WSCR to behavior. I have analyzed the largest genetic dataset of humans 
with WS and showed that variants on the remaining WSCR allele do not largely affect the social 
phenotype, but there is suggesting evidence for the role of variants in the BAZ1B and GTF2IRD1 
genes. This dataset can be used to query other clinically relevant phenotypes of WS. Further, I 
have generated and characterized new mouse models of Gtf2i and Gtf2ird1 and showed that 
other genes in the WSCR are critical for causing the phenotypes seen when the whole region is 
deleted. The data produced here can be used to appreciate the genetic complexity of the WSCR 
and encourage research that looks at the interaction of the genes in the region.  
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